Michael A. Davies, M.D., Ph.D.

Peer-Reviewed Articles

1. Vashisht Gopal, YN, de Groot, EL, Loftin, K, Knighton, B, Ledesma, D, Hudgens, CW, Shamsutdinova, D, Ali, M, Ju, Z, Xiao, M, Kannan, T, Fontenot, G, Nakazawa, MS, Thomas, M, Wani, K, Stephan, C, Aung, PP, Kwong, L, Roszik, J, Akbani, R, Kossenkov, AV, Rebecca, VW, Sullivan, RJ, Herlyn, M, Davies, MA. Personalized targeting of BCL2 family proteins overcomes acquired resistance to BRAF-MEK inhibitors in preclinical melanoma. Nature communications 17(1), 2026. e-Pub 2026. PMID: 42362544.
2. Tlali MR, Kassanjee R, van den Heuvel LL, Rabie S, Joska J, Orrell C, Seedat S, Prozesky H, Adorjan K, Davies MA, Johnson LF, Haas AD. Suicidal thoughts and behaviours in Cape Town: A cross-sectional study of prevalence and social, contextual, and clinical correlates. SSM Ment Health 10, 2026. e-Pub 2026. PMID: 42559485.
3. Nader NE, Glathar AR, Byrnes EV, Joy M, Ge T, Elliott A, Jaehne R, Layding CJ, Tatsuoka CM, Sica G, Acharya R, Bao R, Cillo AR, Joon AY, Kumar S, Yanes RB, Wu X, Solis Soto LM, Arrechedera CA, Tamegnon A, Sanchez-Espiridion B, Tawbi HA, Burton EM, Davies MA, Pearce TM, Burns TF, Stabile LP, Zhang X, Bruno TC. Functionally active lymphoid aggregates correlate with improved prognosis in brain metastases. Cancer Discov, 2026. e-Pub 2026. PMID: 42684018.
4. Nyakato P, Euvrard J, Chinogurei C, Boulle A, Heyden EV, Davies MA. HIV care interruptions during the first year of antiretroviral therapy among adolescents and young adults living with HIV aged 15-24 years in Khayelitsha, South Africa. J Acquir Immune Defic Syndr, 2026. e-Pub 2026. PMID: 42562379.
5. Herb J, Bassett RL, Torres-Cabala CA, Prieto VG, Patel SP, Holder AM, Fisher SB, Lucci A, Wargo J, Amaria RN, Davies MA, Glitza Oliva IC, Tawbi HA, McQuade J, Ikeguchi AP, Wong MK, Diab AK, Gershenwald JE, Ross MI, Weiser R. Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection. Ann Surg Oncol 33(7):6700-6708, 2026. e-Pub 2026. PMID: 41838361.
6. Whitesell Skrivankova V, Pelteret R, Rabie S, Tlali M, Folb N, Rohner E, Chinogurei C, Ruffieux Y, Seedat S, Davies MA, Maartens G, Joska J, Haas AD. Risk of unnatural death following self-harm in South Africa: development and validation of multivariable prognostic models. BMJ Ment Health 29(1), 2026. e-Pub 2026. PMID: 42350059.
7. Tsingas K, Thomas M, Reale M, Xiao M, Wickramasinghe J, Chen Y, Duong B, Lucas A, Thacker G, Li H, Mou H, Ramirez-Salazar E, Elbasir A, Villanueva J, Xu X, Flowers A, Karakousis GC, Miura JT, Mitchell TC, Amaravadi RK, Schuchter LM, Liu S, Long Q, Hoon DSB, Ramos RI, Catbagan JJ, Bustos MA, Gershenwald JE, Simon JM, Wargo JA, Davies MA, Lu Y, Mills GB, Cohen S, Lawless A, Sharova T, Frederick DT, Flaherty KT, Hacohen N, Boland GM, Auslander N, Herlyn M. Melanoma-patient-derived xenograft multi-omics resource melPDomiX maps gain- and loss-of-function alterations. Cell Rep 45(6):117455, 2026. e-Pub 2026. PMID: 42234561.
8. Hunter M, Hannan L, Boulle A, Matjila M, Ismail M, Euvrard J, Davies MA, Kalk E. The impact of the COVID-19 pandemic on maternal mortality in a South African metropole (2020 - 2021): A retrospective cohort study. S Afr Med J 116(5):e3856, 2026. e-Pub 2026. PMID: 42246854.
9. Ali, MM, Alauddin, M, Mahmud, I, Joon, A, Momin, AB, Cortez, JR, Chen, H, Tan, L, Chan, W, Anantha, RW, Stolley, D, Shamsutdinova, D, Evans, KW, Merric-Bernstam, F, Herlyn, M, Thomas, M, Chen, Y, Davies, MA, Chattopadhyay, C. The Imipridone ONC206 Inhibits Tumor Growth and Improves Survival in Patient-Derived Xenograft Models of Uveal Melanoma. Cancers 18(12), 2026. e-Pub 2026. PMID: 42352430.
10. Wang J, Wee Y, Jacob T, Rogers A, Sorensen LK, Brooks DM, Gupta P, Tay JKH, Wilson EC, Liu T, Smith EA, Gopal YNV, Davies MA, McMahon M, Holmen SL, Judson-Torres RL, Wolff RK, Grossmann AH. Rapid activation of ARF6 after RAF inhibition augments BRAF(V600E) and promotes therapy resistance. Oncogene 45(23):2286-2298, 2026. e-Pub 2026. PMID: 42050077.
11. Akhave, NS, Holder, AM, Davies, MA, Pacha, O, Weiser, R, Cimo, AM, Meric-Bernstam, F, Naing, A. Phase 2 study of ivonescimab in patients with cutaneous squamous cell carcinoma 44(16):TPS9615-TPS9615, 2026. e-Pub 2026.
12. Dizman, N, Qiu, Y, Irajizad, E, Saha, S, Jiang, Y, Simon, JM, Burton, EM, Baruch, EN, Amaria, RN, Glitza, IC, Tawbi, H, Lorenzi, PL, Davies, MA, Gershenwald, JE, Peterson, CB, Ajami, NJ, Wargo, J, Fahrmann, JF, Daniel-MacDougall, CR, McQuade, JL. Microbiome-derived bile acids and association with dietary fiber intake to anti-tumor responses in patients with melanoma receiving immune checkpoint blockade (ICB) 44(16):9575, 2026. e-Pub 2026.
13. Amouzegar A, Wu X, Long JP, Chen GW, Wong JW, Prabhakaran S, Little L, Gumbs C, Bota N, Malke J, Simon J, Zhang J, Nagarajan P, Davies MA, Tawbi H, Amaria RN, Oliva ICG, Ikeguchi AP, Su S, Hanna EY, Weiser R, Bednarski B, Sims TT, Mitra D, Wargo J, Gershenwald JE, Scheet P, Yu Y, Huff C, Nelson KC, McQuade JL, Futreal PA. Germline variants in cancer susceptibility genes among patients with mucosal melanoma. NPJ Genom Med 11(1), 2026. e-Pub 2026. PMID: 42177185.
14. Rhoda JL, Hannan L, Madlala H, Malaba T, Myer L, Boulle A, Davies MA, Nyemba DC, Kalk E. Association between infant feeding practices and infant growth by maternal HIV and antiretroviral therapy status: a prospective study in Cape Town, South Africa. BMC Pregnancy Childbirth 26(1), 2026. e-Pub 2026. PMID: 42163194.
15. Almoiliqy M, Li P, Jung YH, Zheng D, Alshambky A, Koleilat MKI, Davies MA, Kwong LN. FGFR1 but not S6K1/2 drives intrinsic BRAF inhibitor resistance in melanoma. Cell Death Discov 12(1), 2026. e-Pub 2026. PMID: 42151121.
16. de Beer ST, Phelanyane F, Ingle SM, Slogrove AL, Eley BS, Kalk E, Heekes A, Anderson K, Boulle A, Davies MA, Jones HE. Infectious-cause hospitalisation in a province-wide cohort of children with antenatal HIV exposure compared to children without HIV exposure. AIDS 40(5):627-637, 2026. e-Pub 2026. PMID: 41385737.
17. Euvrard J, Keene CM, Heyden EV, Osler M, Pienaar D, Mahomed H, Meintjes G, Davies MA, Boulle A. Contemporary Disengagement From Antiretroviral Therapy in the Western Cape, South Africa: A Cross-Sectional Study. J Int AIDS Soc 29(5):e70124, 2026. e-Pub 2026. PMID: 42145055.
18. Tlali MR, Davies MA, Lombard C, Mathews C, Parry CD. Prevalence of alcohol use, associated risk factors, and the impact on the HIV care cascade among adolescent girls and young women in South Africa: Findings from the HERStory Study. S Afr Med J 116(4):e3164, 2026. e-Pub 2026. PMID: 42246842.
19. Bentebibel SE, McGrail DJ, Kochat V, Arslan E, Abdel-Wahab R, Pazdrak B, Murthy R, Tahon NHM, Cho SN, Duose DY, Wani K, Liu J, Haymaker C, Gomez JA, Sonnemann H, Katailiha AS, Nassif-Rausseo B, Rahim M, Li I, Mayer AT, Yang X, Hsu FJ, Zhang J, Johnson DH, Amaria RN, Glitza Oliva IC, Patel SP, Hwu P, Elsayes KM, Tawbi HA, Burks JK, Bernatchez C, Davies MA, Rai K, Lizee G, Ekmekcioglu S, Diab A. Intratumoral sotigalimab with pembrolizumab induces rapid activation of antigen presenting cells and drives anti-tumor responses in non-injected tumors in metastatic melanoma: A phase I/II study. Cancer Discov, 2026. e-Pub 2026. PMID: 42013310.
20. Tlali M, Kassanjee R, van den Heuvel LL, Rabie S, Joska J, Orrell C, Seedat S, Prozesky H, Adorjan K, Davies MA, Johnson LF, Haas AD. Suicidal thoughts and behaviours in Cape Town: a cross-sectional study of prevalence, social, contextual, and clinical correlates. medRxiv, 2026. e-Pub 2026. PMID: 41503461.
21. Rebecca, VW, Xiao, M, Kossenkov, AV, Godok, T, Brown, GS, Fingerman, D, Alicea, GM, Wei, M, Ji, H, Portuallo, ME, Bravo, J, Elad, V, Chen, Y, Toska, E, Fane, M, Couts, K, Villanueva, J, Nathanson, KL, Arun, KM, Warrier, G, Yin, X, Ding, J, Liu, Q, Goyal, Y, Gopal, YN, Davies, MA, Herlyn, M. Dasatinib resensitizes BRAF/MEK inhibitor efficacy in patient-derived xenografts from patients with progression on BRAF/MEK inhibitor treatment. iScience 29(2), 2026. e-Pub 2026. PMID: 41704766.
22. Anderson K, Madlala HP, Nyemba DC, Dinkele R, Smith M, Eley BS, Cotton MF, Muloiwa R, Spittal G, Kroon M, Boulle A, Myer L, Davies MA, Kalk E. Infectious morbidity among children HIV-exposed uninfected in South Africa. AIDS 40(2):170-177, 2026. e-Pub 2026. PMID: 40996698.
23. Brown LR, Smith M, van Schalkwyk C, Johnson LF, Mudaly V, Mohr-Holland E, Schaaf HS, Seddon JA, Hesseling AC, Nuttall J, Rabie H, Davies MA, Boulle A, du Preez K. Epidemiology of Pediatric Tuberculosis in the Western Cape: A Population-Based Study (2017-2023). Pediatrics 157(2), 2026. e-Pub 2026. PMID: 41494628.
24. Kleber TJ, Milton DR, Srinivasan S, Panthi B, Floyd W, Goethe EA, Davies MA, Tawbi HA, Glitza Oliva IC, Kaya D, Li J, Swanson TA, Perni S, Tom MC, Wang C, Prabhu SS, Weinberg JS, McCutcheon IE, Chung C, Ferguson SD, Beckham TH. Outcomes of patients with melanoma brain metastases treated with ipilimumab and nivolumab with or without upfront comprehensive stereotactic radiosurgery. Neuro-Onc Ad, 2026. e-Pub 2026.
25. Moolla H, Kassanjee R, Euvrard J, Maartens G, Prozesky HW, Fox MP, Orrell C, Fatti G, Tanser F, Wandeler G, Davies MA, Waal R, Nyakato P, Johnson LF. Estimates and predictors of HIV viral non-suppression in South African adults on antiretroviral treatment. J Int AIDS Soc 29(1):e70076, 2026. e-Pub 2026. PMID: 41555785.
26. Kleber TJ, Milton DR, Srinivasan S, Panthi B, Floyd W, Goethe EA, Davies MA, Tawbi HA, Glitza Oliva IC, Kaya D, Li J, Swanson TA, Perni S, Tom MC, Wang C, Prabhu S, Weinberg JS, McCutcheon IE, Chung C, Ferguson SD, Beckham TH. Outcomes of patients with melanoma brain metastases treated with ipilimumab and nivolumab with or without upfront comprehensive stereotactic radiosurgery. Neurooncol Adv 8(1):vdaf276, 2026. e-Pub 2026. PMID: 41664820.
27. Robert M, Saha S, Dizman N, Rohlfs M, Sirmans E, Simon J, Amaria RN, Glitza Oliva IC, Tawbi HA, Davies MA, Ikeguchi A, Basen-Engquist K, Schadler K, Roth ME, Song W, Zhang X, Ajami NJ, Cohen L, Wargo JA, Peterson CB, McQuade JL, Daniel CR. Investigating Chronic Toxicity, Diet, Patient-Reported Outcomes and the Microbiome in Immunotherapy-Treated Metastatic Melanoma Survivors: A New Frontier. Nutrients 18(1), 2025. e-Pub 2025. PMID: 41515159.
28. Mattei J, Ruitao L, Davies MA, Wong MK, Diab A, Haydu LE, Patel SP, Amaria RN, McQuade JL, Tawbi H, Burton EM, Glitza IC. Adjuvant therapy in mucosal melanoma: a single-center experience and review of the literature. Melanoma Res Publish Ahead of Print, 2025. e-Pub 2025. PMID: 41337670.
29. Chen PL, Roh W, Reuben A, Cooper ZA, Spencer CN, Prieto PA, Miller JP, Bassett RL, Gopalakrishnan V, Wani K, De Macedo MP, Austin-Breneman JL, Jiang H, Chang Q, Reddy SM, Chen WS, Tetzlaff MT, Broaddus RJ, Davies MA, Gershenwald JE, Haydu L, Lazar AJ, Patel SP, Hwu P, Hwu WJ, Diab A, Glitza IC, Woodman SE, Vence LM, Wistuba II, Amaria RN, Kwong LN, Prieto V, Davis RE, Ma W, Overwijk WW, Sharpe AH, Hu J, Futreal PA, Blando J, Sharma P, Allison JP, Chin L, Wargo JA. Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade. Cancer Discov 15(12):2574, 2025. e-Pub 2025. PMID: 41327972.
30. Han N, Loosli T, Anderegg N, Hauser A, Josi J, Davies MA, Johnson LF, Lessells R, Gunthard HF, Egger M, Kouyos RD. The effect of long-acting cabotegravir and rilpivirine treatment on drug resistance in South Africa: a modelling study. Lancet Glob Health 13(12):e2133-e2143, 2025. e-Pub 2025. PMID: 41240951.
31. Moolla H, Meintjes G, Davies MA, Kassanjee R, de Waal R, Johnson LF. Short-Term CD4 + Cell Count Declines During Antiretroviral Therapy Interruptions: A Focused Review. J Acquir Immune Defic Syndr 100(3):e11-e13, 2025. e-Pub 2025. PMID: 40828097.
32. Morad G, Damania AV, Melendez B, Singh BB, Veguilla FJ, Soto RA, Hoballah YM, Sahasrabhojane PV, Wong MC, Ahmed MM, Rico RN, Lewis KN, Wani K, Shamsutdinova DD, Lazcano Segura RN, Ingram DR, Goethe EA, Day A, Flores II, McDaniel LK, Chelvanambi M, Johnson SB, Dimitriou F, Gupta P, Oberai S, Zal MA, Doss P, Jamal MA, Hayase E, Wathoo C, Norberg LM, Jenkins SL, Nass S, Gumin J, Long L, Yang J, Bradley GR, Bekal MP, Dono AG, Pichardo-Rojas PS, Andrewes SW, Ballester LY, Losh JS, Liang J, Huo L, Nielsen DC, Parker Kerrigan BC, Brastianos PK, Fowlkes NW, Chang CC, Jenq RR, Gomez-Manzano C, Huse JT, Davies MA, Lazar AJ, Bhat KP, Tandon N, Esquenazi Y, Peterson CB, Puduvalli VK, Lang FF, Johnston CD, Bullman S, Ajami NJ, Ferguson SD, Wargo JA. Microbial signals in primary and metastatic brain tumors. Nat Med 31(11):3675-3688, 2025. e-Pub 2025. PMID: 41238915.
33. Joseph R, Marais G, Iranzadeh I, Alisoltani A, Hardie D, Davies M-A, Heekes A, Chetty N, Timmerman V, Hsiao N-Y, Williamson C. Intra-host SARS-CoV-2 diversity in immunocompromised people living with HIV provides insight into the evolutionary trajectory of SARS-CoV-2. J Virol 99(10):e0078025, 2025. e-Pub 2025. PMID: 40910685.
34. Guerrieri RA, Fischer GM, Cortez JR, Knighton BG, Ledesma DA, Hudgens CW, Delcid YF, Hu Q, Onana CYB, Carapeto FCL, Tezlaff MT, Huse JT, Hwu P, Burton EM, Glitza Oliva IC, Davies MA, Ferguson SD. Preclinical models of melanoma leptomeningeal disease to assess intrathecal checkpoint blockade. Sci Rep 15(1):34352, 2025. e-Pub 2025. PMID: 41038921.
35. Sharma A, Boyce Kennedy L, Van Swearingen AED, Ahluwalia MS, Bagley SJ, Chiang VL, Chung C, Cittelly DM, Daras M, Davies MA, Fecci PE, Haas-Kogan DA, Hattangadi-Gluth JA, Jerzak KJ, Kim MM, Malani R, Mehta MP, Moss NS, Neman J, Nguyen DX, Priceman SJ, Sahebjam S, Shih HA, Soffietti R, Wang N, Zimmer A, Goldberg S, Khasraw M, Anders CK, Lin NU. Intracranial metastases from solid tumors: Call to Action and Consensus from the Society for Neuro-Oncology and American Society of Clinical Oncology Collaborative. Neuro Oncol 28(2):319-333, 2025. e-Pub 2025. PMID: 41051254.
36. Baruch EN, Gleber-Netto FO, Nagarajan P, Rao X, Akhter S, Eichwald T, Xie T, Balood M, Adewale A, Naara S, Sathishkumar HN, Islam S, McCarthy W, Mattson BJ, Ferrarotto R, Wong MK, Davies MA, Jindal S, Basu S, Roversi K, Nikpoor AR, Ahmadi M, Ahmadi A, Harwood C, Leigh I, Gong D, Tallon de Lara P, Tao DL, Davidson TM, Ajami NJ, Futreal A, Rai K, Kochat V, Castillo M, Gunaratne P, Goepfert RP, Hernandez SD, Khushalani NI, Wang J, Watowich SS, Calin GA, Migden MR, Yuan M, Liu N, Ye Y, Hwang WL, Vermeer PD, D'Silva NJ, Bunimovich YL, Yaniv D, Burks JK, Gomez J, Dougherty PM, Tsai KY, Allison JP, Sharma P, Wargo JA, Myers JN, Talbot S, Gross ND, Amit M. Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy. Nature 646(8084):462-473, 2025. e-Pub 2025. PMID: 40836096.
37. Tiago M, Purwin TJ, Stefanski CD, da Silva RO, Fane ME, Chhabra Y, Haj JI, Teh JL, Kadamb R, Cai W, Rosenbaum SR, Chua V, Hacohen N, Davies MA, Villanueva J, Chervoneva I, Weeraratna AT, Erkes DA, Capparelli C, Aguirre-Ghiso JA, Aplin AE. Elevated NR2F1 underlies the persistence of invasive disease after treatment of BRAF-mutant melanoma. J Clin Invest 135(18), 2025. e-Pub 2025. PMID: 40955663.
38. Lehloa AJ, Kalk E, Davies MA, Nyemba D, Mehta U, Malaba T, Petro G, Boulle A, Myer L, Madlala HP. Comorbidities in pregnant South African women living with HIV and associations with adverse birth outcomes: a prospective cohort study. BMC Pregnancy Childbirth 25(1):924, 2025. e-Pub 2025. PMID: 40898079.
39. Phillips TK, Gomba Y, Mogoba P, Phelanyane F, Anderson K, Chi BH, Clouse K, Davies MA, Euvrard J, Knight L, Myer L, Abrams EJ. Routine Electronic Mother-Infant Data (REMInD): A proof-of-Concept Data to Care Study to Support Retention in Maternal HIV Treatment and Infant HIV Testing in Cape Town, South Africa. AIDS Behav 29(9):2689-2700, 2025. e-Pub 2025. PMID: 40240722.
40. Skrivankova VW, Rabie S, Tlali M, Folb N, Chinogurei C, Bennett S, Wesso A, Ruffieux Y, Cornell M, Seedat S, Egger M, Davies MA, Maartens G, Joska J, Haas AD. Incidence and prognostic factors of self-harm and subsequent unnatural death in South Africa: A cohort study. PLoS Med 22(9):e1004765, 2025. e-Pub 2025. PMID: 41004534.
41. Kehoe K, Morden E, Zinyakatira N, Heekes A, Jones HE, Walter SR, Jacobs T, Murray J, Buys H, Eley B, Redaniel T, Davies MA. Diarrhoeal admissions among children aged <5 years in public sector facilities in Western Cape Province, South Africa, before and during the COVID-19 pandemic (2019 - 2021). S Afr Med J 115(7):e2726, 2025. e-Pub 2025. PMID: 41378635.
42. Ruffieux Y, Joska JA, Lang R, Zheng C, Folb N, Kirk GD, Parcesepe AM, Silverberg MJ, Napravnik S, Gebo K, Jr JJE, Hogan BC, Althoff KN, Tlali M, Grelotti DJ, Loutfy M, Rebeiro PF, Davies MA, Egger M, Maartens G, Haas AD. Life-years lost associated with mental disorders in people with HIV: a cohort study in South Africa, Canada and the United States. J Int AIDS Soc 28(8):e70023, 2025. e-Pub 2025. PMID: 40826829.
43. Gastaldon C, Whitesell Skrivankova V, Schoretsanitis G, Folb N, Taghavi K, Davies MA, Cornell M, Salanti G, Mesa Vieira C, Tlali M, Maartens G, Egger M, Haas AD. Diagnosis of postpartum depression and associated factors in South Africa: a cohort study of 47,697 women. Epidemiol Psychiatr Sci 34:e41, 2025. e-Pub 2025. PMID: 40726088.
44. Burton EM, Milton DR, Tetzlaff MT, Wani K, Ross MI, Postow MA, Lazcano R, Glitza IC, Wong MK, Patel SP, Diab A, Gershenwald JE, McQuade JL, Betof Warner A, Prieto VG, Lee JE, Goepfert RP, Fisher SB, Song A, Malke J, Simon JM, Ariyan C, Torres-Cabala CA, Davies MA, Lazar A, Wargo JA, Tawbi HA, Amaria RN. Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma. J Clin Oncol 43(26):JCO2500494, 2025. e-Pub 2025. PMID: 40638872.
45. Erez N. Baruch, Frederico O. Gleber-Netto, Priyadharsini Nagarajan, Xiayu Rao, Shamima Akhter, Tuany Eichwald, Tongxin Xie, Mohammad Balood, Adebayo Adewale, Shorook Naara, Hinduja N Sathishkumar, Islam Shajedul, William McCarthy, Brandi J Mattson, Renata Ferrarotto, Michael K. Wong, Davies MA, Sonali Jindal, Sreyashi Basu, Karine Roversi, Amin Reza Nikpoor, Maryam Ahmadi, Ali Ahmadi, Catherine Harwood, Irene Leigh, Dennis Gong, Paulino Tallon De Torres, Veena Kochat, Micah Castillo, Preethi Gunaratne, Ryan P. Goepfert, Nikhil Khushalani, Jing Wang, Stephanie S. Watowich, George A Calin, Michael R. Migden, Mona Yuan, Naijiang Liu, Yi Ye, William L. Hwang, Paola Vermeer, Nisha D’Silva, Yuri L. Bunimovich, Dan Yaniv, Jared K Burks, Javier Gomez, Patrick M Dougherty, Kenneth Y. Tsai, James P Allison, Padmanee Sharma, Jennifer A. Wargo, Jeffrey N. Myers, Sebastien Talbot, Neil D. Gross, Moran Amit. Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy. Nature. e-Pub 2025.
46. Anderson K, Eley BS, Rabie H, Muloiwa R, Nuttall J, Frigati L, Le Roux DM, Wessels T, Murray J, Mudaly V, Sridhar G, Ragone L, Vannappagari V, Euvrard J, Boulle A, Davies MA. Hospitalization incidence among young children with HIV in the Western Cape, South Africa. AIDS 39(8):1065-1073, 2025. e-Pub 2025. PMID: 40116048.
47. Menzies AM, Davies MA. POLARIS: encorafenib plus binimetinib for people with BRAF V600-mutant melanoma with brain metastasis. Future Oncol 21(16):1-3, 2025. e-Pub 2025. PMID: 40503961.
48. Kennedy LB, Van Swearingen AED, Lee MR, Rogers LW, Sibley AB, Sheng J, Zhang D, Qin X, Lipp ES, Kumar S, Joon A, Shi P, Davies MA, Owzar K, Anders CK, Salama AKS. A comprehensive, multi-center, immunogenomic analysis of melanoma brain metastases. Acta Neuropathol Commun 13(1):123, 2025. e-Pub 2025. PMID: 40457397.
49. Dor G, Wilkinson E, Martin DP, Moir M, Tshiabuila D, Kekana D, Ntozini B, Joseph R, Iranzadeh A, Nyaga MM, Goedhals D, Maponga T, Maritz J, Laguda-Akingba O, Ramphal Y, MacIntyre C, Chabuka L, Pillay S, Giandhari J, Baxter C, Hsiao NY, Preiser W, Bhiman JN, Davies MA, Venter M, Treurnicht FK, Wolter N, Williamson C, von Gottberg A, Lessells R, Tegally H, de Oliveira T. Tracing the spatial origins and spread of SARS-CoV-2 Omicron lineages in South Africa. Nat Commun 16(1):4937, 2025. e-Pub 2025. PMID: 40436832.
50. Menzies AM, Long GV, Kohn A, Tawbi H, Webe J, Flaherty K, McArthur GA, Ascierto PA, Pfluger Y, Lewis K, Tsai KK, Hamid O, Prenen H, Fein L, Wang E, Guenzel C, Zhang F, Kleh JF, di Pietro A, Davies MA. A plain language summary of POLARIS: a study to look at different doses of encorafenib plus binimetinib for people with BRAF V600-mutant melanoma with brain metastasis. Future Oncol 21(14):1-9, 2025. e-Pub 2025. PMID: 40418081.
51. Patten G, Haas AD, Davies MA, Maartens G, Chinogurei C, Folb N, Kassanjee R. Association between changes in script renewal periods and HIV viral non-suppression: a cohort study of a South African private-sector HIV program. J Acquir Immune Defic Syndr, 2025. e-Pub 2025. PMID: 40366014.
52. Namukuta VE, Smith M, Bester D, van Niekerk M, Solomons R, van Toorn R, Schaaf HS, Seddon JA, Rabie H, Davies MA, Hesseling AC, du Preez K. Incidence, Disease Spectrum, and Outcomes of Tuberculous Meningitis in South African Children: The Initial Impact of COVID-19. Trop Med Infect Dis 10(5), 2025. e-Pub 2025. PMID: 40423357.
53. Soler-Saez I, Karz A, Hidalgo MR, Gomez-Cabanes B, Lopez-Cerdan A, Catala-Senent JF, Prutisto-Chang K, Eskow NM, Izar B, Redmer T, Kumar S, Davies MA, de la Iglesia-Vaya M, Hernando E, Garcia-Garcia F. Unveiling Common Transcriptomic Features between Melanoma Brain Metastases and Neurodegenerative Diseases. J Invest Dermatol 145(5):1135-1146, 2025. e-Pub 2025. PMID: 39326662.
54. Brown LR, Smith M, van Schalkwyk C, Johnson LF, Mudaly V, Mohr-Holland E, Schaaf HS, Seddon JA, Hesseling AC, Nuttall J, Rabie H, Davies MA, Boulle A, du Preez K. Epidemiological insights into paediatric tuberculosis trends in the Western Cape, South Africa. medRxiv, 2025. e-Pub 2025. PMID: 40313278.
55. Sperduto PW, Marqueen KE, Chang E, Li J, Davies MA, Ebner DK, Breen WG, Lamba N, Shih HA, Edwards D, Kim MM, Mahal A, Rahman R, Ankrah N, Boggs DH, Lewis C, Hyer D, Buatti JM, Johri F, Soliman H, Masucci L, Roberge D, Aneja S, Chiang V, Phuong C, Braunstein S, Dajani S, Sachdev S, Wan Z, Niedzwiecki D, Vaios E, Kirkpatrick JP, Pasetsky J, Wang TJC, Kutuk T, Kotecha R, Ross RB, Rusthoven CG, Nakano T, Tawbi HA, Mehta MP. Improved Survival and Prognostication in Melanoma Patients With Brain Metastases: An Update of the Melanoma Graded Prognostic Assessment. J Clin Oncol 43(16):JCO2401351, 2025. e-Pub 2025. PMID: 40245362.
56. Anderson K, Rabie H, Eley BS, Frigati L, Nuttall J, Kalk E, Heekes A, Smith M, Boulle A, Mudaly V, Davies MA. High Incidence of Tuberculosis in Young Children Living With HIV in the Western Cape, South Africa. J Acquir Immune Defic Syndr 98(5):506-514, 2025. e-Pub 2025. PMID: 39745685.
57. Kumar S, Pelster MS, Hasanov M, Guerrieri RA, Hudgens CW, Ledesma DA, Wang F, Fischer GM, Simon JM, Haydu LE, Katlowitz KV, Gopal YNV, McQuade JL, Kwong LN, Huse JT, Lazar AJ, Tetzlaff MT, Gershenwald JE, Joon AY, Chen K, Li Z, Ram PT, Ferguson SD, Davies MA. Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis. Acta Neuropathol Commun 13(1):75, 2025. e-Pub 2025. PMID: 40229864.
58. Lynsey Claus, Hannah E. Kostan, Marshall E. Hicks, Rony Avritscher, Davies MA. Durable Remission After Abscopal Effect Following Transcatheter Hepatic Arterial Embolization in a Patient with Mucosal Melanoma Refractory to Immunotherapy. Frontiers in Immunology. e-Pub 2025.
59. Freitas-Cortez MA, Masrorpour F, Jiang H, Mahmud I, Lu Y, Huang A, Duong LK, Wang Q, Voss TA, Kettlun Leyton CS, Wei B, Chan WK, Lin K, Zhang J, Tsouko E, Ganjoo S, Barsoumian HB, Riad TS, Hu Y, Leuschner C, Puebla-Osorio N, Wang J, Hu J, Davies MA, Puduvalli VK, Billon C, Burris TP, Lorenzi PL, Gan B, Welsh JW. Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteins. Mol Cancer 24(1):40, 2025. e-Pub 2025. PMID: 39901247.
60. Gouda, MA, Wei, Z, Rodon Ahnert, J, Davies, MA, Janku, F, Gray, R, Wang, V, McShane, LM, Rubinstein, L, Patton, DR, Williams, PM, Hamilton, SR, Liu, R, Bota, DA, Swiecicki, PL, Buchschacher, G, Tricoli, JV, Conley, BA, Arteaga, CL, Harris, LN, O'Dwyer, PJ, Chen, A, Flaherty, KT. Phase II Study of Copanlisib in Patients With PTEN Loss. JCO Precision Oncology 9, 2025. e-Pub 2025. PMID: 39913886.
61. Anderson K, Rabie H, Eley BS, Frigati L, Nuttall J, Kalk E, Heekes A, Sridhar G, Ragone L, Vannappagari V, Mudaly V, Boulle A, Davies MA. Mother-child dyads living with HIV in the Western Cape, South Africa: Undetectable = Undetectable?. J Int AIDS Soc 28(2):e26418, 2025. e-Pub 2025. PMID: 39888181.
62. Davies MA, de Gier B, Guy RL, Coelho J, van Dam AP, van Houdt R, Matamoros S, van den Berg M, Habermehl PE, Moganeradj K, Ryan Y, Platt S, Hearn H, Blakey E, Chooneea D, Vlaminckx BJM, Lamagni T, van Sorge NM. Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England. Emerg Infect Dis 31(2):229-236, 2025. e-Pub 2025. PMID: 39983683.
63. Guerrieri RA, Fischer GM, Kircher DA, Joon AY, Cortez JR, Grossman AH, Hudgens CW, Ledesma DA, Lazcano R, Onana CY, Knighton BG, Kumar S, Hu Q, Gopal YNV, McQuade JL, Deng W, Haydu LE, Gershenwald JE, Lazar AJ, Tetzlaff MT, Holmen SL, Davies MA. Oxidative Phosphorylation (OXPHOS) Promotes the Formation and Growth of Melanoma Lung and Brain Metastases. bioRxiv, 2025. e-Pub 2025. PMID: 39896644.
64. Hasanov, M, Kiany, S, Forget, MA, Bassett Jr, R, Davies, MA, Diab, A, Gershenwald, JE, Glitza, IC, Lee, JE, Lucci, A, McQuade, JL, Patel, SP, Ross, MI, Tawbi, H, Wargo, J, Wong, MK, Bernatchez, C, Hwu, P, Haymaker, CL, Amaria, RN. Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma. OncoImmunology 14(1), 2025. e-Pub 2025. PMID: 40815607.
65. Eliason, J, Krishnan, S, Fukuda, Y, Bustos, M, Winkowski, D, Cho, SN, Basi, A, Baird, R, Grimm, EA, Davies, MA, Hoon, DS, Uppore Kukkillaya, AR, Burks, JK, Ekmekcioglu, S. Characterizing spatial immune architecture in metastatic melanoma using high-dimensional multiplex imaging. Frontiers in immunology 16, 2025. e-Pub 2025. PMID: 40364843.
66. Tiago, M, Purwin, TJ, Stefanski, CD, da Silva, RO, Fane, M, Chhabra, Y, Haj, JI, Teh, JL, Kadamb, R, Cai, W, Rosenbaum, S, Chua, V, Hacohen, N, Davies, MA, Villanueva, J, Chervoneva, I, Weeraratna, AT, Erkes, DA, Capparelli, C, Aguirre-Ghiso, JA, Aplin, AE. Elevated NR2F1 underlies the persistence of invasive disease after treatment of BRAF-mutant melanoma. Journal of Clinical Investigation 135(15), 2025. e-Pub 2025. PMID: 40955663.
67. Jacob N, Kalk E, Heekes A, Phelanyane F, Anderson K, Davies MA, Rice B, Boulle A. The impact of evolving maternal antiretroviral therapy guidelines on vertical transmission of HIV in the Western Cape, South Africa. PLoS One 20(9):e0328612, 2025. e-Pub 2025. PMID: 40934266.
68. Claus LM, Kostan HE, Hicks ME, Avritscher R, Davies MA. Case Report: Durable remission after abscopal effect following transcatheter hepatic arterial embolization in a patient with mucosal melanoma refractory to immunotherapy. Front Immunol 16:1565355, 2025. e-Pub 2025. PMID: 40276508.
69. Phillips TK, Gomba Y, Mogoba P, Phelanyane F, Anderson K, Chi BH, Clouse K, Davies MA, Euvrard J, Knight L, Myer L, Abrams EJ. Routine Electronic Mother-Infant Data (REMInD): a proof-of-concept Data to Care study to support retention in maternal HIV treatment and infant HIV testing in Cape Town, South Africa. Res Sq, 2024. e-Pub 2024. PMID: 39711541.
70. Wee, Y, Wang, J, Wilson, EC, Rich, CP, Rogers, A, Tong, ZZ, DeGroot, E, Yennu Nanda, VG, Davies, MA, Ekiz, HA, Tay, JK, Stubben, C, Boucher, K, Oviedo, JM, Fairfax, KC, Williams, MA, Holmen, SL, Wolff, RK, Grossmann, AH. Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapy. Nature communications 15(1), 2024. e-Pub 2024. PMID: 39098861.
71. Brenner IR, Flanagan CF, Penazzato M, Webb KA, Horsfall SB, Hyle EP, Abrams E, Bacha J, Neilan AM, Collins IJ, Desmonde S, Crichton S, Davies MA, Freedberg KA, Ciaranello AL. Cost-effectiveness of viral load testing for transitioning antiretroviral therapy-experienced children to dolutegravir in South Africa: a modelling analysis. Lancet Glob Health 12(12):e2068-e2079, 2024. e-Pub 2024. PMID: 39577977.
72. de Beer ST, Davies MA, Phelanyane F, Jones HE, Ingle SM, Eley BS, Anderson K, Heekes A, Kalk E, Mendelsohn A, Boulle A, Slogrove AL. The Retrospective Implementation of Standardized In Utero HIV Exposure Definitions Using Routinely Collected Public Sector Data Across the Western Cape Province, South Africa. Pediatr Infect Dis J 43(11):1061-1064, 2024. e-Pub 2024. PMID: 39079034.
73. Rumke LW, Davies MA, Vestjens SMT, van der Putten BCL, Bril-Keijzers WCM, van Houten MA, Rots NY, Wijmenga-Monsuur AJ, van der Ende A, de Gier B, Vlaminckx BJM, van Sorge NM. Nationwide upsurge in invasive disease in the context of longitudinal surveillance of carriage and invasive Streptococcus pyogenes 2009-2023, the Netherlands: a molecular epidemiological study. J Clin Microbiol 62(10):e0076624, 2024. e-Pub 2024. PMID: 39194268.
74. Chattopadhyay C, Roszik J, Bhattacharya R, Alauddin M, Mahmud I, Yadugiri S, Ali MM, Khan FS, Prabhu VV, Lorenzi PL, Wei B, Burton E, Morey RR, Lazcano R, Davies MA, Patel SP, Grimm EA. Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma. Br J Cancer 131(11):1846-1857, 2024. e-Pub 2024. PMID: 39394450.
75. Li, J, Liu, W, Mojumdar, K, Kim, H, Zhou, Z, Ju, Z, Kumar, SV, Ng, PS, Chen, H, Davies, MA, Lu, Y, Akbani, R, Mills, GB, Liang, H. A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies. Nature Cancer 5(10):1579-1595, 2024. e-Pub 2024. PMID: 39227745.
76. Anderson K, van Zyl G, Hsiao NY, Claassen M, Mudaly V, Voget J, Heekes A, Kalk E, Phelanyane F, Boulle A, Sridhar G, Ragone L, Vannappagari V, Davies MA. HIV Drug Resistance in Newly Diagnosed Young Children in the Western Cape, South Africa. Pediatr Infect Dis J 43(10):970-976, 2024. e-Pub 2024. PMID: 39079031.
77. Bauer IE, Davies MA, Bona KA, Hararuk O, Shaw CH, Thompson DK, Kurz WA, Webster KL, Garneau M, McLaughlin JW, Packalen MS, Prystupa E, Sanderson NK, Tarnocai C. Peat profile database from peatlands in Canada. Ecology 105(10):e4398, 2024. e-Pub 2024. PMID: 39143756.
78. Shafi J, Virk MK, Kalk E, Carlucci JG, Chepkemoi A, Bernard C, McHenry MS, Were E, Humphrey J, Davies MA, Mehta UC, Patel RC. Pharmacovigilance in Pregnancy Studies, Exposures and Outcomes Ascertainment, and Findings from Low- and Middle-Income Countries: A Scoping Review. Drug Saf 47(10):957-990, 2024. e-Pub 2024. PMID: 38907172.
79. Schultz, DF, Davies, BA, Payne, JA, Martin, CP, Minard, AY, Childs, BG, Zhang, C, Jeganathan, K, Sturmlechner, I, White, TA, de Bruin, A, Harkema, L, Chen, H, Davies, MA, Jachim, S, LeBrasseur, NK, Piper, RC, Li, H, Baker, DJ, van Deursen, JM, Billadeau, DD, Katzmann, DJ. Loss of HD-PTP function results in lipodystrophy, defective cellular signaling and altered lipid homeostasis. Journal of cell science 137(18), 2024. e-Pub 2024. PMID: 39155850.
80. Ruffieux Y, Folb N, Grimsrud A, Hislop M, Dunn L, Rohner E, Namubiru AM, Chinogurei C, Cornell M, Davies MA, Egger M, Maartens G, Haas AD. Courier delivery of antiretroviral therapy: a cohort study of a South African private-sector HIV programme. J Int AIDS Soc 27(9):e26360, 2024. e-Pub 2024. PMID: 39295119.
81. Saberian, C, Milton, D, Simon, JM, Amaria, RN, Diab, A, McQuade, JL, Patel, SP, Tawbi, H, Yee, C, Wong, MK, McCutcheon, IE, Davies, MA, Ferguson, SD, Glitza, IC. Survival and treatment outcomes in patients with leptomeningeal disease from metastatic melanoma. Neuro-Oncology Practice 11(4):452-463, 2024. e-Pub 2024. PMID: 39006528.
82. Gellert, J, Agardy, DA, Kumar, S, Kourtesakis, A, Boschert, T, Jähne, K, Breckwoldt, MO, Bunse, L, Wick, W, Davies, MA, Platten, M, Bunse, T. Tumoral Interferon Beta Induces an Immune-Stimulatory Phenotype in Tumor-Associated Macrophages in Melanoma Brain Metastases. Cancer Research Communications 4(8):2189-2202, 2024. e-Pub 2024. PMID: 39056192.
83. Nyakato P, Schomaker M, Boulle A, Euvrard J, Wood R, Eley B, Prozesky H, Christ B, Anderegg N, Ayakaka I, Rafael I, Kunzekwenyika C, Moore CB, van Lettow M, Chimbetete C, Mbewe S, Ballif M, Egger M, Yiannoutsos CT, Cornell M, Davies MA. Correcting mortality estimates among children and youth on antiretroviral therapy in southern Africa: A comparative analysis between a multi-country tracing study and linkage to a health information exchange. Trop Med Int Health 29(8):739-751, 2024. e-Pub 2024. PMID: 38961819.
84. Kalk E, Heekes A, Lavies D, Jacobs L, Spencer C, Boutall A, Osman A, Stewart C, Davies MA, van Niekerk A, Fieggen K, Boulle A, Mehta U. Population-based prevalence of congenital defects in a routine sentinel site-based surveillance system in the Western Cape, South Africa. Birth Defects Res 116(8):e2388, 2024. e-Pub 2024. PMID: 39118354.
85. Smith P, Little F, Hermans S, Davies MA, Wood R, Orrell C, Pike C, Peters F, Dube A, Georgeu-Pepper D, Curran R, Fairall L, Bekker LG. A prospective randomised controlled trial investigating household SARS-CoV-2 transmission in a densely populated community in Cape Town, South Africa - the transmission of COVID-19 in crowded environments (TRACE) study. BMC Public Health 24(1):1924, 2024. e-Pub 2024. PMID: 39020307.
86. Moolla H, Davies MA, Davies C, Euvrard J, Prozesky HW, Fox MP, Orrell C, Von Groote P, Johnson LF. The effect of care interruptions on mortality in adults resuming antiretroviral therapy. AIDS 38(8):1198-1205, 2024. e-Pub 2024. PMID: 38814712.
87. White, BS, Woo, XY, Koc, S, Sheridan, T, Neuhauser, S, Wang, S, Evrard, YA, Chen, L, Pour, AF, Landua, J, Mashl, RJ, Davies, S, Fang, B, Rosa, MG, Evans, KW, Bailey, MH, Chen, Y, Xiao, M, Rubinstein, JC, Sanderson, BJ, Lloyd, M, Domanskyi, S, Dobrolecki, LE, Fujita, M, Fujimoto, J, Xiao, G, Fields, RC, Mudd, JL, Xu, X, Hollingshead, MG, Jiwani, S, Acevedo, S, Davis-Dusenbery, BN, Robinson, PN, Moscow, JA, Doroshow, JH, Mitsiades, N, Kaochar, S, Pan, CX, Carvajal-Carmona, L, Welm, AL, Welm, BE, Govindan, R, Li, S, Davies, MA, Roth, JA, Meric-Bernstam, F, Xie, Y, Herlyn, M, Ding, L, Chuang, JH. A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis. Cancer Research 84(13):2060-2072, 2024. e-Pub 2024. PMID: 39082680.
88. Ledesma DA, Marques-Piubelli ML, Li-Ning-Tapia E, Hudgens C, Gu J, Lazcano R, Casavilca-Zambrano S, Castillo M, Davies MA, Hwu WJ, Aung PP, Giubellino A, Curry JL, Torres-Cabala C. Apoptosis Pathway-Associated Proteins Are Frequently Expressed in Melanoma: A Study of 32 Cases With Focus on Acral Lentiginous Melanoma. Am J Dermatopathol 46(7):410-415, 2024. e-Pub 2024. PMID: 38718197.
89. Meric-Bernstam F, Lloyd MW, Koc S, Evrard YA, McShane LM, Lewis MT, Evans KW, Li D, Rubinstein LV, Welm AL, Dean DA, Srivastava A, Grover JW, Ha MJ, Chen H, Huang X, Varadarajan K, Wang J, Roth JA, Welm BE, Govindan R, Ding L, Kaochar S, Mitsiades N, Carvajal-Carmona LG, Herlyn M, Davies MA, Shapiro GI, Fields RC, Trevino JG, Harrell JC, Doroshow JH, Chuang JH, Moscow JA. Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations. Mol Cancer Ther 23(7):924-938, 2024. e-Pub 2024. PMID: 38641411.
90. Jacobs T, Morden E, Smith M, von Delft A, Kassanjee R, Mudaly V, Boulle A, Davies MA. Severe outcomes among adults with TB during COVID-19. IJTLD Open 1(7):292-298, 2024. e-Pub 2024. PMID: 39035425.
91. Sohn AH, Davies MA. Adults with perinatally acquired HIV in low- and middle-income settings: time for a generational shift in HIV care and global guidance. J Int AIDS Soc 27(7):e26338, 2024. e-Pub 2024. PMID: 39034739.
92. Chua V, Lopez-Anton M, Terai M, Tanaka R, Baqai U, Purwin TJ, Haj JI, Waltrich Jr FJ, Trachtenberg I, Luo K, Tudi R, Jeon A, Han A, Chervoneva I, Davies MA, Aguirre-Ghiso JA, Sato T, Aplin AE. Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress. PubMed 17(840), 2024. e-Pub 2024. PMID: 38861613.
93. Kassanjee R, Davies MA, Heekes A, Mahomed H, Hawkridge AJ, Morden E, Jacobs T, Cohen C, Moultrie H, Lessells RJ, Van Der Walt N, Arendse JO, Wolter N, Walaza S, Jassat W, von Gottberg A, Hannan PL, Feikin DR, Cloete K, Boulle A. COVID-19 Vaccine Uptake and Effectiveness by Time since Vaccination in the Western Cape Province, South Africa: An Observational Cohort Study during 2020-2022. Vaccines (Basel) 12(6), 2024. e-Pub 2024. PMID: 38932357.
94. Nyakato P, Boulle A, Wood R, Eley B, Rabie H, Egger M, Yiannoutsos CT, Davies MA, Cornell M. Self-transfers, Hospital Admissions and Mortality Among Children and Adolescents Lost to Follow-up From Antiretroviral Therapy Programs in the Western Cape, South Africa Between 2004 and 2019: Linkage to Provincial Records. Pediatr Infect Dis J 43(5):430-436, 2024. e-Pub 2024. PMID: 38451913.
95. Phillips TK, Kassanjee R, Maxwell N, Anderson K, Johnson L, Moolla H, Myer L, Chi BH, Euvrard J, Boulle A, Davies MA, Cornell M, de Waal R. ART history prior to conception: trends and association with postpartum disengagement from HIV care in Khayelitsha, South Africa (2013-2019): a retrospective cohort study. J Int AIDS Soc 27(4):e26236, 2024. e-Pub 2024. PMID: 38566482.
96. Kehoe K, Morden E, Zinyakatira N, Heekes A, Jones HE, Walter SR, Jacobs T, Murray J, Buys H, Redaniel MT, Davies MA. Lower respiratory tract infection admissions and deaths among children under 5 years in public sector facilities in the Western Cape Province, South Africa, before and during the COVID-19 pandemic (2019 - 2021). S Afr Med J 114(3):e1560, 2024. e-Pub 2024. PMID: 38525574.
97. Anderson K, Kalk E, Heekes A, Phelanyane F, Jacob N, Boulle A, Mehta U, Kassanjee R, Sridhar G, Ragone L, Vannappagari V, Davies MA. Factors associated with vertical transmission of HIV in the Western Cape, South Africa: a retrospective cohort analysis. J Int AIDS Soc 27(3):e26235, 2024. e-Pub 2024. PMID: 38528395.
98. Kasem J, Davies MAM, Chainey S, Ronca F. Musculoskeletal complaints in English law enforcement officers: a cross-sectional study. Int J Occup Saf Ergon 30(1):84-89, 2024. e-Pub 2024. PMID: 37434478.
99. Kassanjee R, Davies MA, Heekes A, Mahomed H, Hawkridge AJ, Wolmarans M, Morden E, Jacobs T, Cohen C, Moultrie H, Lessells RJ, Van Der Walt N, Arendse JO, Goeiman H, Mudaly V, Wolter N, Walaza S, Jassat W, von Gottberg A, Hannan PL, Rousseau P, Feikin D, Cloete K, Boulle A. COVID-19 vaccine uptake and effectiveness by time since vaccination in the Western Cape province, South Africa: An observational cohort study during 2020-2022. medRxiv, 2024. e-Pub 2024. PMID: 38343866.
100. Chattopadhyay C, Roszik J, Bhattacharya R, Alauddin M, Mahmud I, Yadugiri S, Ali MM, Khan FS, Prabhu VV, Lorenzi P, Burton E, Morey RR, Lazcano R, Davies MA, Patel SP, Grimm EA. Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma. bioRxiv, 2024. e-Pub 2024. PMID: 38293232.
101. Slogrove AL, Bovu A, de Beer S, Phelanyane F, Williams PL, Heekes A, Kalk E, Mehta U, Theron G, Abrams EJ, Cotton MF, Myer L, Davies MA, Boulle A. Maternal and birth outcomes in pregnant people with and without HIV in the Western Cape, South Africa. AIDS 38(1):59-67, 2024. e-Pub 2024. PMID: 37720974.
102. Chihana M, Conan N, Ohler L, Huerga H, Wanjala S, Masiku C, Szumilin E, Ellman T, Etard JF, Maman D, Davies MA. Changes Over Time in the Proportion of Advanced HIV Disease in Two High HIV Prevalence Settings in Ndhiwa (Kenya) and Eshowe (South Africa). J Int Assoc Provid AIDS Care 23:23259582241260219, 2024. e-Pub 2024. PMID: 38881294.
103. Hussey H, Vreede H, Davies MA, Heekes A, Kalk E, Hardie D, van Zyl G, Naidoo M, Morden E, Bam JL, Zinyakatira N, Centner CM, Maritz J, Opie J, Chapanduka Z, Mahomed H, Smith M, Cois A, Pienaar D, Redd AD, Preiser W, Wilkinson R, Boulle A, Hsiao NY. SARS-CoV-2 seroepidemiology in Cape Town, South Africa, and implications for future outbreaks in low-income communities. PLOS Glob Public Health 4(8):e0003554, 2024. e-Pub 2024. PMID: 39106267.
104. Menzies AM, Long GV, Kohn A, Tawbi H, Weber J, Flaherty K, McArthur GA, Ascierto PA, Pfluger Y, Lewis K, Tsai KK, Hamid O, Prenen H, Fein L, Wang E, Guenzel C, Zhang F, Kleha JF, di Pietro A, Davies MA. POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis. Neurooncol Adv 6(1):vdae033, 2024. e-Pub 2024. PMID: 38725995.
105. Tsondai PR, Davies MA, Singtoroj T, Maxwell N, Technau KG, Chokephaibulkit K, Lumbiganon P, Sohn AH. Creating a data collection and management platform to support measurement of adolescent HIV care transition processes within low- and middle-income countries: The GRADUATE project. PLOS Glob Public Health 4(8):e0002705, 2024. e-Pub 2024. PMID: 39102384.
106. Skrivankova VW, Hossmann S, Cornell M, Ballif M, Dupont C, Huwa J, Seintaridis K, Kalua T, Wandeler G, Kassanjee R, Haas AD, Technau KG, Fenner L, Low N, Davies MA, Egger M. Authorship inequalities in global health research: the IeDEA Southern Africa collaboration. BMJ Glob Health 8(12), 2023. e-Pub 2023. PMID: 38103897.
107. Baqai U, Kurimchak AM, Trachtenberg IV, Purwin TJ, Haj JI, Han A, Luo K, Pachon NF, Jeon A, Chua V, Davies MA, Gutkind JS, Benovic JL, Duncan JS, Aplin AE. Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanoma. J Biol Chem 299(12):105418, 2023. e-Pub 2023. PMID: 37923138.
108. Turmel-Courchesne L, Davies MA, Guene-Nanchen M, Strack M, Rochefort L. Rewetting increases vegetation cover and net growing season carbon uptake under fen conditions after peat-extraction in Manitoba, Canada. Sci Rep 13(1):20588, 2023. e-Pub 2023. PMID: 37996571.
109. Wee Y, Wang J, Wilson EC, Rich CP, Rogers A, Tong Z, DeGroot E, Gopal YNV, Davies MA, Ekiz HA, Tay JKH, Stubben C, Boucher KM, Oviedo JM, Fairfax KC, Williams MA, Holmen SL, Wolff RK, Grossmann AH. ARF6-dependent endocytic trafficking of the Interferon-gamma receptor drives adaptive immune resistance in cancer. bioRxiv, 2023. e-Pub 2023. PMID: 37873189.
110. Witt RG, Cass SH, Tran T, Damania A, Nelson EE, Sirmans E, Burton EM, Chelvanambi M, Johnson S, Tawbi HA, Gershenwald JE, Davies MA, Spencer C, Mishra A, Wong MC, Ajami NJ, Peterson CB, Daniel CR, Wargo JA, McQuade JL, Nelson KC. Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma. JAMA Dermatol 159(10):1076-1084, 2023. e-Pub 2023. PMID: 37647056.
111. de Beer ST, Slogrove AL, Eley B, Ingle SM, Jones HE, Phelanyane F, Anderson K, Kalk E, Boulle A, Davies MA. Change in HIV-related characteristics of children hospitalised with infectious diseases in Western Cape, South Africa, 2008-2021: a time trend analysis. J Int AIDS Soc 26 Suppl 4(Suppl 4):e26151, 2023. e-Pub 2023. PMID: 37909168.
112. Chagani S, De Macedo MP, Carapeto F, Wang F, Marzese DM, Wani K, Haydu LE, Peng W, Ong GT, Warren SE, Beechem JM, Hoon DSB, Mills GB, Tetzlaff MT, Lazar AJ, Kwong LN, Davies MA. Multiplatform Analysis Of Intratumoral Pten Heterogeneity In Melanoma. J Invest Dermatol 143(9):1779-1787.e1, 2023. e-Pub 2023. PMID: 36871660.
113. Portuallo ME, Lu DY, Alicea GM, Bolling J, Lee R, McQuade J, Warner AB, Davies M, Weeraratna A, Villanueva J, Rebecca VW. Diversity, equity, and inclusion in the melanoma research community. Pigment Cell Melanoma Res 36(5):441-447, 2023. e-Pub 2023. PMID: 37093838.
114. Cass SH, Tobin JWD, Seo YD, Gener-Ricos G, Keung EZ, Burton EM, Davies MA, McQuade JL, Lazar AJ, Mason R, Millward M, Sandhu S, Khoo C, Warburton L, Guerra V, Haydon A, Dearden H, Menzies AM, Carlino MS, Smith JL, Mollee P, Burgess M, Mapp S, Keane C, Atkinson V, Parikh SA, Markovic SN, Ding W, Call TG, Hampel PJ, Long GV, Wargo JA, Ferrajoli A. Efficacy of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma in Patients with Concomitant Chronic Lymphocytic Leukemia. Ann Oncol 34(9):796-805, 2023. e-Pub 2023. PMID: 37414216.
115. Baruch, EN, Nagarajan, P, Gleber-Netto, FO, Rao, X, Xie, T, Akhter, S, Adewale, A, Shajedul, I, Mattson, BJ, Ferrarotto, R, Wong, MK, Davies, MA, Jindal, S, Basu, S, Harwood, C, Leigh, I, Ajami, NJ, Futreal, A, Castillo, M, Gunaratne, PH, Goepfert, RP, Khushalani, N, Wang, J, Watowich, SS, Calin, GA, Migden, MR, Vermeer, PD, D'Silva, NJ, Yaniv, D, Burks, JK, Gomez, JA, Dougherty, PM, Tsai, KY, Allison, JP, Sharma, P, Wargo, J, Myers, JN, Gross, N, Amit, M. Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade. Research square, 2023. e-Pub 2023. PMID: 37503252.
116. Hasanov M, Milton DR, Davies AB, Sirmans E, Saberian C, Posada EL, Opusunju S, Gershenwald JE, Torres-Cabala CA, Burton EM, Colen RR, Huse JT, Glitza Oliva IC, Chung C, McAleer MF, McGovern SL, Yeboa DN, Kim BYS, Prabhu SS, McCutcheon IE, Weinberg JS, Lang FF, Tawbi HA, Li J, Haydu LE, Davies MA, Ferguson SD. Changes in Outcomes and Factors Associated with Survival in Melanoma Patients with Brain Metastases. Neuro Oncol 25(7):1310-1320, 2023. e-Pub 2023. PMID: 36510640.
117. Slogrove AL, Davies MA, Phelanyane F, De Beer S, Theron G, Williams PL, Abrams EJ, Cotton MF, Boulle A. Hypertensive disorders of pregnancy and HIV: analysis of a province-wide cohort during 2018 and 2019. AIDS 37(7):1047-1055, 2023. e-Pub 2023. PMID: 36779497.
118. Haas AD, Lienhard R, Didden C, Cornell M, Folb N, Boshomane TMG, Salazar-Vizcaya L, Ruffieux Y, Nyakato P, Wettstein AE, Tlali M, Davies MA, von Groote P, Wainberg M, Egger M, Maartens G, Joska JA. Mental Health, ART Adherence, and Viral Suppression Among Adolescents and Adults Living with HIV in South Africa: A Cohort Study. AIDS Behav 27(6):1849-1861, 2023. e-Pub 2023. PMID: 36592251.
119. Kassanjee R, Davies MA, Ngwenya O, Osei-Yeboah R, Jacobs T, Morden E, Timmerman V, Britz S, Mendelson M, Taljaard J, Riou J, Boulle A, Tiffin N, Zinyakatira N. COVID-19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa. J Int AIDS Soc 26(6):e26104, 2023. e-Pub 2023. PMID: 37339333.
120. Han A, Mukha D, Chua V, Purwin TJ, Tiago M, Modasia B, Baqai U, Aumiller JL, Bechtel N, Hunter E, Danielson M, Terai M, Wedegaertner PB, Sato T, Landreville S, Davies MA, Kurtenbach S, Harbour JW, Schug ZT, Aplin AE. Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth. Cancers (Basel) 15(13), 2023. e-Pub 2023. PMID: 37444561.
121. Yuan P, Teng D, de Groot E, Li M, Trousil S, Shen CH, Roszik J, Davies MA, Gopal YNV, Zheng B. Loss of AMPKα2 promotes melanoma tumor growth and brain metastasis. iScience 26(6):106791, 2023. e-Pub 2023. PMID: 37213225.
122. Shanmugam P, Lambropoulos JC, Davies MA. Grinding of silicon carbide for optical surface fabrication. Part II. Subsurface damage. Appl Opt 62(14):3788-3796, 2023. e-Pub 2023. PMID: 37706997.
123. Patten G, Sipambo N, Technau KG, Euvrard J, Ford N, Davies MA. Ongoing High Prevalence of Severe Immune Suppression Among Children in South Africa. J Acquir Immune Defic Syndr 92(4):273-280, 2023. e-Pub 2023. PMID: 36729553.
124. Glitza Oliva IC, Ferguson SD, Bassett R, Foster AP, John I, Hennegan TD, Rohlfs M, Richard J, Iqbal M, Dett T, Lacey C, Jackson N, Rodgers T, Phillips S, Duncan S, Haydu L, Lin R, Amaria RN, Wong MK, Diab A, Yee C, Patel SP, McQuade JL, Fischer GM, McCutcheon IE, O'Brien BJ, Tummala S, Debnam M, Guha-Thakurta N, Wargo JA, Burton EM, Tawbi HA, Davies MA. Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results. Nat Med 29(4):898-905, 2023. e-Pub 2023. PMID: 36997799.
125. Stejerean-Todoran I, Gimotty PA, Watters A, Brafford P, Krepler C, Godok T, Li H, Bonilla Del Rio Z, Zieseniss A, Katschinski DM, Sertel SM, Rizzoli SO, Garman B, Nathanson KL, Xu X, Chen Q, Oswald JH, Lotem M, Mills GB, Davies MA, Schön MP, Bogeski I, Herlyn M, Vultur A. A distinct pattern of growth and RAC1 signaling in melanoma brain metastasis cells. Neuro Oncol 25(4):674-686, 2023. e-Pub 2023. PMID: 36054930.
126. Vreeman RC, Yiannoutsos CT, Yusoff NKN, Wester CW, Edmonds A, Ofner S, Davies MA, Leroy V, Lumbiganon P, de Menezes Succi RC, Twizere C, Brown S, Bolton-Moore C, Takassi OE, Scanlon M, Martin R, Wools-Kaloustian K. Global HIV prevention, care and treatment services for children: a cross-sectional survey from the International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium. BMJ Open 13(3):e069399, 2023. e-Pub 2023. PMID: 36914183.
127. Anderson K, Iyun V, Eley BS, Rabie H, Ferreira T, Nuttall J, Frigati L, Van Dongen N, Davies MA. Hospitalization among infants who initiate antiretroviral therapy before 3 months of age. AIDS 37(3):435-445, 2023. e-Pub 2023. PMID: 36695356.
128. Patten GE, Euvrard J, Anderegg N, Boulle A, Arendse KD, von der Heyden E, Ford N, Davies MA. Advanced HIV disease and engagement in care among patients on antiretroviral therapy in South Africa: results from a multi-state model. AIDS 37(3):513-522, 2023. e-Pub 2023. PMID: 36695361.
129. Amaria RN, Postow M, Burton EM, Tetzlaff MT, Ross MI, Torres-Cabala C, Glitza IC, Duan F, Milton DR, Busam K, Simpson L, McQuade JL, Wong MK, Gershenwald JE, Lee JE, Goepfert RP, Keung EZ, Fisher SB, Betof-Warner A, Shoushtari AN, Callahan M, Coit D, Bartlett EK, Bello D, Momtaz P, Nicholas C, Gu A, Zhang X, Korivi BR, Patnana M, Patel SP, Diab A, Lucci A, Prieto VG, Davies MA, Allison JP, Sharma P, Wargo JA, Ariyan C, Tawbi HA. Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature 615(7953):E23, 2023. e-Pub 2023. PMID: 36894629.
130. Mnguni AT, Schietekat D, Ebrahim N, Sonday N, Boliter N, Schrueder N, Gabriels S, Sigwadhi LN, Zemlin AE, Chapanduka ZC, Ngah V, Yalew A, Jalavu T, Abdullah I, Tamuzi JL, Tembo Y, Davies MA, English R, Nyasulu PS. The clinical and epidemiological characteristics of a series of patients living with HIV admitted for COVID-19 in a district hospital. BMC Infect Dis 23(1):123, 2023. e-Pub 2023. PMID: 36855103.
131. Kehoe K, Morden E, Jacobs T, Zinyakatira N, Smith M, Heekes A, Murray J, le Roux DM, Wessels T, Richards M, Eley B, Jones HE, Redaniel MT, Davies MA. Comparison of paediatric infectious disease deaths in public sector health facilities using different data sources in the Western Cape, South Africa (2007-2021). BMC Infect Dis 23(1):104, 2023. e-Pub 2023. PMID: 36814192.
132. Wilmott JS, Tawbi H, Engh JA, Amankulor NM, Shivalingam B, Banerjee H, Vergara IA, Lee H, Johansson PA, Ferguson PM, Saiag P, Robert C, Grob JJ, Butterfield LH, Scolyer RA, Kirkwood JM, Long GV, Davies MA. Clinical features associated with outcomes and biomarker analysis of dabrafenib plus trametinib treatment in patients with BRAF-mutant melanoma brain metastases. Clin Cancer Res 29(3):521-531, 2023. e-Pub 2023. PMID: 36477181.
133. Davies MA, Morden E, Rousseau P, Arendse J, Bam JL, Boloko L, Cloete K, Cohen C, Chetty N, Dane P, Heekes A, Hsiao NY, Hunter M, Hussey H, Jacobs T, Jassat W, Kariem S, Kassanjee R, Laenen I, Roux SL, Lessells R, Mahomed H, Maughan D, Meintjes G, Mendelson M, Mnguni A, Moodley M, Murie K, Naude J, Ntusi NAB, Paleker M, Parker A, Pienaar D, Preiser W, Prozesky H, Raubenheimer P, Rossouw L, Schrueder N, Smith B, Smith M, Solomon W, Symons G, Taljaard J, Wasserman S, Wilkinson RJ, Wolmarans M, Wolter N, Boulle A. Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa. Int J Infect Dis 127:63-68, 2023. e-Pub 2023. PMID: 36436752.
134. de Waal R, Rabie H, Technau KG, Eley B, Sipambo N, Cotton M, Boulle A, Wood R, Tanser F, Fatti G, Egger M, Davies MA. Abacavir safety and effectiveness in young infants with HIV in South African observational cohorts. Antivir Ther 28(2):13596535231168480, 2023. e-Pub 2023. PMID: 37038365.
135. Rebecca VW, Xiao M, Kossenkov A, Godok T, Brown GS, Fingerman D, Alicea GM, Wei M, Ji H, Bravo J, Chen Y, Fane ME, Villanueva J, Nathanson K, Liu Q, Gopal YNV, Davies MA, Herlyn M. Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas. bioRxiv, 2023. e-Pub 2023. PMID: 36711814.
136. Slogrove AL, de Beer ST, Kalk E, Boulle A, Cotton M, Cupido H, Laughton B, Marlow M, Mehta U, Msolo N, Myer L, Powis KM, Schoeman E, Tomlinson M, Zunza M, Williams P, Davies MA. Survival and health of children who are HIV-exposed uninfected: study protocol for the CHERISH (Children HIV-Exposed Uninfected - Research to Inform Survival and Health) dynamic, prospective, maternal-child cohort study. BMJ Open 13(1):e070465, 2023. e-Pub 2023. PMID: 36593001.
137. Hahn AW, Menk AV, Rivadeneira DB, Augustin RC, Xu M, Li J, Wu X, Mishra AK, Gide TN, Quek C, Zang Y, Spencer CN, Menzies AM, Daniel CR, Hudgens CW, Nowicki T, Haydu LE, Khan MAW, Gopalakrishnan V, Burton EM, Malke J, Simon JM, Bernatchez C, Putluri N, Woodman SE, Vashisht Gopal YN, Guerrieri R, Fischer GM, Wang J, Wani KM, Thompson JF, Lee JE, Hwu P, Ajami N, Gershenwald JE, Long GV, Scolyer RA, Tetzlaff MT, Lazar AJ, Schadendorf D, Wargo JA, Kirkwood JM, DeBerardinis RJ, Liang H, Futreal A, Zhang J, Wilmott JS, Peng W, Davies MA, Delgoffe GM, Najjar YG, McQuade JL. Obesity is associated with altered tumor metabolism in metastatic melanoma. Clin Cancer Res 29(1):154-164, 2023. e-Pub 2023. PMID: 36166093.
138. Vellano CP, White MG, Andrews MC, Chelvanambi M, Witt RG, Daniele JR, Titus M, McQuade JL, Conforti F, Burton EM, Lastrapes MJ, Ologun G, Cogdill AP, Morad G, Prieto P, Lazar AJ, Chu Y, Han G, Khan MAW, Helmink B, Davies MA, Amaria RN, Kovacs JJ, Woodman SE, Patel S, Hwu P, Peoples M, Lee JE, Cooper ZA, Zhu H, Gao G, Banerjee H, Lau M, Gershenwald JE, Lucci A, Keung EZ, Ross MI, Pala L, Pagan E, Segura RL, Liu Q, Borthwick MS, Lau E, Yates MS, Westin SN, Wani K, Tetzlaff MT, Haydu LE, Mahendra M, Ma X, Logothetis C, Kulstad Z, Johnson S, Hudgens CW, Feng N, Federico L, Long GV, Futreal PA, Arur S, Tawbi HA, Moran AE, Wang L, Heffernan TP, Marszalek JR, Wargo JA. Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy. Nature 613(7945):E3, 2023. e-Pub 2023. PMID: 36627494.
139. Hermans LE, Booysen P, Boloko L, Adriaanse M, de Wet TJ, Lifson AR, Wadee N, Papavarnavas N, Marais G, Hsiao NY, Rosslee MJ, Symons G, Calligaro GL, Iranzadeh A, Wilkinson RJ, Ntusi NAB, Williamson C, Davies MA, Meintjes G, Wasserman S. Changing character and waning impact of COVID-19 at a tertiary centre in Cape Town, South Africa. S Afr J Infect Dis 38(1):550, 2023. e-Pub 2023. PMID: 38223432.
140. Chaudhri A, Bu X, Wang Y, Gomez M, Torchia JA, Hua P, Hung SH, Davies MA, Lizee GA, von Andrian U, Hwu P, Freeman GJ. The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy. Front Immunol 14:1237715, 2023. e-Pub 2023. PMID: 37771579.
141. Vadlamudi NK, Basham CA, Johnston JC, Ahmad Khan F, Battista Migliori G, Centis R, D'Ambrosio L, Jassat W, Davies MA, Schwartzman K, Campbell JR. The association of SARS-CoV-2 infection and tuberculosis disease with unfavorable treatment outcomes: A systematic review. PLOS Glob Public Health 3(7):e0002163, 2023. e-Pub 2023. PMID: 37467225.
142. Mnguni AT, Schietekat D, Ebrahim N, Sonday N, Boliter N, Schrueder N, Gabriels S, Cois A, Tamuzi JL, Tembo Y, Davies MA, English R, Nyasulu PS. The interface between SARS-CoV-2 and non-communicable diseases (NCDs) in a high HIV/TB burden district level hospital setting, Cape Town, South Africa. PLoS One 18(10):e0277995, 2023. e-Pub 2023. PMID: 37796879.
143. Ismail M, Morden E, Hussey H, Paleker M, Jacobs T, Laenen I, Hunter M, Moodley M, Smith M, Mutemaringa T, Bam JL, Dane P, Heekes A, Boulle A, Davies MA. Evaluation of a public COVID-19 dashboard in the Western Cape, South Africa: a tool for communication, trust, and transparency. BMC Public Health 22(1):2453, 2022. e-Pub 2022. PMID: 36581823.
144. Nyakato P, Christ B, Anderegg N, Muhairwe J, Jefferys L, van Dijk J, Vinikoor MJ, van Lettow M, Chimbetete C, Phiri SJ, Egger M, Ballif M, Yiannoutsos CT, Schomaker M, Kassanjee R, Davies MA, Cornell M. High Unreported Mortality in Children and Youth (<25 Years) Living With HIV Who Were Lost to Care From Antiretroviral Therapy Programs in Southern Africa: Results From a Multicountry Tracing Study. J Acquir Immune Defic Syndr 91(5):429-433, 2022. e-Pub 2022. PMID: 36099024.
145. Hussey H, Vreede H, Davies MA, Heekes A, Kalk E, Hardie D, van Zyl G, Naidoo M, Morden E, Bam JL, Zinyakatira N, Centner CM, Maritz J, Opie J, Chapanduka Z, Mahomed H, Smith M, Cois A, Pienaar D, Redd AD, Preiser W, Wilkinson R, Chetty K, Boulle A, Hsiao NY. Epidemiology and outcomes of SARS-CoV-2 infection associated with anti-nucleocapsid seropositivity in Cape Town, South Africa. medRxiv, 2022. e-Pub 2022. PMID: 36523408.
146. McCann NC, Stanic T, Penazzato M, Flanagan CF, Abrams EJ, Dugdale CM, Johnson LF, Neilan AM, Davies MA, Freedberg KA, Fassinou P, Doherty M, Essajee S, Mushavi A, Soeteman DI, Ciaranello AL. Prevalence of undiagnosed HIV among children in South Africa, Cote d'Ivoire and Zimbabwe: a model-based analysis to inform paediatric HIV screening programmes. J Int AIDS Soc 25(12):e26045, 2022. e-Pub 2022. PMID: 36519674.
147. Hou J, Liang S, Xu C, Wei Y, Wang Y, Tan Y, Sahni N, McGrail DJ, Bernatchez C, Davies M, Li Y, Chen R, Yi SS, Chen Y, Yee C, Chen K, Peng W. Single-cell CRISPR immune screens reveal immunological roles of tumor intrinsic factors. NAR Cancer 4(4):zcac038, 2022. e-Pub 2022. PMID: 36518525.
148. Shadalou S, Gurganus D, Cassarly WJ, Davies MA, Suleski TJ. Design, fabrication, and characterization of a tunable LED-based illuminator using refractive freeform arrays. Opt Express 30(23):42749-42761, 2022. e-Pub 2022. PMID: 36366722.
149. Amaria RN, Postow M, Burton EM, Tezlaff MT, Ross MI, Torres-Cabala C, Glitza IC, Duan F, Milton DR, Busam K, Simpson L, McQuade JL, Wong MK, Gershenwald JE, Lee JE, Goepfert RP, Keung EZ, Fisher SB, Betof-Warner A, Shoushtari AN, Callahan M, Coit D, Bartlett EK, Bello D, Momtaz P, Nicholas C, Gu A, Zhang X, Korivi BR, Patnana M, Patel SP, Diab A, Lucci A, Prieto VG, Davies MA, Allison JP, Sharma P, Wargo JA, Ariyan C, Tawbi HA. Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature 611(7934):155-160, 2022. e-Pub 2022. PMID: 36289334.
150. Tlali M, Scheibe A, Ruffieux Y, Cornell M, Wettstein AE, Egger M, Davies MA, Maartens G, Johnson LF, Haas AD. Diagnosis and treatment of opioid-related disorders in a South African private sector medical insurance scheme: A cohort study. Int J Drug Policy 109:103853, 2022. e-Pub 2022. PMID: 36202041.
151. Tu H, McQuade JL, Davies MA, Huang M, Xie K, Ye Y, Chow WH, Rodriguez A, Wu X. Body mass index and survival after cancer diagnosis: A pan-cancer cohort study of 114 430 patients with cancer. Innovation (Camb) 3(6):100344, 2022. e-Pub 2022. PMID: 36353671.
152. Kassanjee R, Davies MA, Ngwenya O, Osei-Yeboah R, Jacobs T, Morden E, Timmerman V, Britz S, Mendelson M, Taljaard J, Riou J, Boulle A, Tiffin N, Zinyakatira N. COVID-19 among adults living with HIV: Correlates of mortality in a general population in a resource-limited setting. medRxiv, 2022. e-Pub 2022. PMID: 36299434.
153. Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome MJ, Amoako DG, Everatt J, Bhiman JN, Scheepers C, Tebeila N, Chiwandire N, du Plessis M, Govender N, Ismail A, Glass A, Mlisana K, Stevens W, Treurnicht FK, Subramoney K, Makatini Z, Hsiao NY, Parboosing R, Wadula J, Hussey H, Davies MA, Boulle A, von Gottberg A, Cohen C. Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa. Nat Commun 13(1):5860, 2022. e-Pub 2022. PMID: 36195617.
154. Aizer AA, Lamba N, Ahluwalia MS, Aldape K, Boire A, Brastianos PK, Brown PD, Camidge DR, Chiang VL, Davies MA, Hu LS, Huang RY, Kaufmann T, Kumthekar P, Lam K, Lee EQ, Lin NU, Mehta M, Parsons M, Reardon DA, Sheehan J, Soffietti R, Tawbi H, Weller M, Wen PY. Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions. Neuro-Oncology 24(10):1613-1646, 2022. e-Pub 2022. PMID: 35762249.
155. Mitra D, Rao PK, Nagarajan P, Bishop AJ, Farooqi AS, Gershenwald JE, Wargo J, Keung EZ, Fisher SB, Amaria RN, Davies MA, Ross MI, Guadagnolo BA. Outcomes after sphincter-sparing local therapy for anorectal melanoma: 1989-2020. Pract Radiat Oncol 12(5):437-445, 2022. e-Pub 2022. PMID: 35278716.
156. Edmonds A, Brazier E, Musick BS, Yotebieng M, Humphrey J, Abuogi LL, Adedimeji A, Keiser O, Msukwa M, Carlucci JG, Maia M, Pinto JA, Leroy V, Davies MA, Wools-Kaloustian KK. Clinical and programmatic outcomes of HIV-exposed infants enrolled in care at geographically diverse clinics, 1997-2021: A cohort study. PLoS Med 19(9):e1004089, 2022. e-Pub 2022. PMID: 36107857.
157. Slogrove AL, Burmen B, Davies MA, Edmonds A, Abrams EJ, Chadwick EG, Goetghebuer T, Mofenson LM, Paul ME, Thorne C, Williams PL, Vicari M, Powis KM. Standardized Definitions of In Utero Human Immunodeficiency Virus and Antiretroviral Drug Exposure Among Children. Clin Infect Dis 75(2):347-355, 2022. e-Pub 2022. PMID: 35181789.
158. Zhang H, Valiranta M, Swindles GT, Aquino-Lopez MA, Mullan D, Tan N, Amesbury M, Babeshko KV, Bao K, Bobrov A, Chernyshov V, Davies MA, Diaconu AC, Feurdean A, Finkelstein SA, Garneau M, Guo Z, Jones MC, Kay M, Klein ES, Lamentowicz M, Magnan G, Marcisz K, Mazei N, Mazei Y, Payne R, Pelletier N, Piilo SR, Pratte S, Roland T, Saldaev D, Shotyk W, Sim TG, Sloan TJ, Slowinski M, Talbot J, Taylor L, Tsyganov AN, Wetterich S, Xing W, Zhao Y. Recent climate change has driven divergent hydrological shifts in high-latitude peatlands. Nat Commun 13(1):4959, 2022. e-Pub 2022. PMID: 36002465.
159. Alvarez-Breckenridge C, Markson SC, Stocking JH, Nayyar N, Lastrapes M, Strickland MR, Kim AE, de Sauvage M, Dahal A, Larson JM, Mora JL, Navia AW, Klein RH, Kuter BM, Gill CM, Bertalan M, Shaw B, Kaplan A, Subramanian M, Jain A, Kumar S, Danish H, White M, Shahid O, Pauken KE, Miller BC, Frederick DT, Hebert C, Shaw M, Martinez-Lage M, Frosch M, Wang N, Gerstner E, Nahed BV, Curry WT, Carter B, Cahill DP, Boland GM, Izar B, Davies MA, Sharpe AH, Suvà ML, Sullivan RJ, Brastianos PK, Carter SL. Microenvironmental landscape of human melanoma brain metastases in response to immune checkpoint inhibition. Cancer Immunol Res 10(8):996-1012, 2022. e-Pub 2022. PMID: 35706413.
160. Dankner M, Wang Y, Fazelzad R, Johnson B, Nebhan CA, Dagogo-Jack I, Myall NJ, Richtig G, Bracht JWP, Gerlinger M, Shinozaki E, Yoshino T, Kotani D, Fangusaro JR, Gautschi O, Mazieres J, Sosman JA, Kopetz S, Subbiah V, Davies MA, Groover AL, Sullivan RJ, Flaherty KT, Johnson DB, Benedetti A, Cescon DW, Spreafico A, Zogopoulos G, Rose AAN. Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors. JCO Precis Oncol 6:e2200107, 2022. e-Pub 2022. PMID: 35977349.
161. Davies MA, Bennett DB. Parenting Stress in Non-Offending Caregivers of Sexually Abused Children. J Child Sex Abus 31(6):633-648, 2022. e-Pub 2022. PMID: 34606740.
162. Davies MA, Morden E, Rosseau P, Arendse J, Bam JL, Boloko L, Cloete K, Cohen C, Chetty N, Dane P, Heekes A, Hsiao NY, Hunter M, Hussey H, Jacobs T, Jassat W, Kariem S, Kassanjee R, Laenen I, Le Roux S, Lessells R, Mahomed H, Maughan D, Meintjes G, Mendelson M, Mnguni A, Moodley M, Murie K, Naude J, Ntusi NAB, Paleker M, Parker A, Pienaar D, Preiser W, Prozesky H, Raubenheimer P, Rossouw L, Schrueder N, Smith B, Smith M, Solomon W, Symons G, Taljaard J, Wasserman S, Wilkinson RJ, Wolmarans M, Wolter N, Boulle A. Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa. medRxiv, 2022. e-Pub 2022. PMID: 35794899.
163. Hickman A, Koetsier J, Kurtanich T, Nielsen MC, Winn G, Wang Y, Bentebibel SE, Shi L, Punt S, Williams L, Haymaker C, Chesson CB, Fa'ak F, Dominguez AL, Jones R, Kuiatse I, Caivano AR, Khounlo S, Warier ND, Marathi U, Market RV, Biediger RJ, Craft JW, Hwu P, Davies MA, Woodside DG, Vanderslice P, Diab A, Overwijk WW, Hailemichael Y. LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade. J Clin Invest 132(13), 2022. e-Pub 2022. PMID: 35552271.
164. Andrews MC, Oba J, Wu CJ, Zhu H, Karpinets T, Creasy CA, Forget MA, Yu X, Song X, Mao X, Robertson AG, Romano G, Li P, Burton EM, Lu Y, Sloane RS, Wani KM, Rai K, Lazar AJ, Haydu LE, Bustos MA, Shen J, Chen Y, Morgan MB, Wargo JA, Kwong LN, Haymaker CL, Grimm EA, Hwu P, Hoon DSB, Zhang J, Gershenwald JE, Davies MA, Futreal PA, Bernatchez C, Woodman SE. Multi-modal molecular programs regulate melanoma cell state. Nat Commun 13(1):4000, 2022. e-Pub 2022. PMID: 35810190.
165. Biermann J, Melms JC, Amin AD, Wang Y, Caprio LA, Karz A, Tagore S, Barrera I, Ibarra-Arellano MA, Andreatta M, Fullerton BT, Gretarsson KH, Sahu V, Mangipudy VS, Nguyen TTT, Nair A, Rogava M, Ho P, Koch PD, Banu M, Humala N, Mahajan A, Walsh ZH, Shah SB, Vaccaro DH, Caldwell B, Mu M, Wünnemann F, Chazotte M, Berhe S, Luoma AM, Driver J, Ingham M, Khan SA, Rapisuwon S, Slingluff CL, Eigentler T, Röcken M, Carvajal R, Atkins MB, Davies MA, Agustinus A, Bakhoum SF, Azizi E, Siegelin M, Lu C, Carmona SJ, Hibshoosh H, Ribas A, Canoll P, Bruce JN, Bi WL, Agrawal P, Schapiro D, Hernando E, Macosko EZ, Chen F, Schwartz GK, Izar B. Dissecting the treatment-naive ecosystem of human melanoma brain metastasis. Cell 185(14):2591-2608.e30, 2022. e-Pub 2022. PMID: 35803246.
166. Kalk E, Heekes A, Slogrove AL, Phelanyane F, Davies MA, Myer L, Euvrard J, Kroon M, Petro G, Fieggen K, Stewart C, Rhoda N, Gebhardt S, Osman A, Anderson K, Boulle A, Mehta U. Cohort profile: the Western Cape Pregnancy Exposure Registry (WCPER). BMJ Open 12(6):e060205, 2022. e-Pub 2022. PMID: 35768089.
167. Wettstein A, Tlali M, Joska JA, Cornell M, Skrivankova VW, Seedat S, Mouton JP, van den Heuvel LL, Maxwell N, Davies MA, Maartens G, Egger M, Haas AD. The effect of the COVID-19 lockdown on mental health care use in South Africa: an interrupted time-series analysis. Epidemiol Psychiatr Sci 31:e43, 2022. e-Pub 2022. PMID: 35703078.
168. Feikin DR, Abu-Raddad LJ, Andrews N, Davies MA, Higdon MM, Orenstein WA, Patel MK. Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization. Vaccine 40(26):3516-3527, 2022. e-Pub 2022. PMID: 35595662.
169. Davies MA, Kassanjee R, Rousseau P, Morden E, Johnson L, Solomon W, Hsiao NY, Hussey H, Meintjes G, Paleker M, Jacobs T, Raubenheimer P, Heekes A, Dane P, Bam JL, Smith M, Preiser W, Pienaar D, Mendelson M, Naude J, Schrueder N, Mnguni A, Le Roux S, Murie K, Prozesky H, Mahomed H, Rossouw L, Wasserman S, Maughan D, Boloko L, Smith B, Taljaard J, Symons G, Ntusi NAB, Parker A, Wolter N, Jassat W, Cohen C, Lessells R, Wilkinson RJ, Arendse J, Kariem S, Moodley M, Wolmarans M, Cloete K, Boulle A. Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa. Trop Med Int Health 27(6):564-573, 2022. e-Pub 2022. PMID: 35411997.
170. Koc S, Lloyd MW, Grover JW, Xiao N, Seepo S, Subramanian SL, Ray M, Frech C, DiGiovanna J, Webster P, Neuhauser S, Srivastava A, Woo XY, Sanderson BJ, White B, Lott P, Dobrolecki LE, Dowst H, Consortium P, Evrard YA, Wallace TA, Moscow JA, Doroshow JH, Mitsiades N, Kaochar S, Pan CX, Chen MS, Carvajal-Carmona L, Welm AL, Welm BE, Lewis MT, Govindan R, Ding L, Li S, Herlyn M, Davies MA, Roth J, Meric-Bernstam F, Robinson PN, Bult CJ, Davis-Dusenbery B, Dean DA, Chuang JH. PDXNet portal: patient-derived Xenograft model, data, workflow and tool discovery. NAR Cancer 4(2):zcac014, 2022. e-Pub 2022. PMID: 35475145.
171. Vellano CP, White MG, Andrews MC, Chelvanambi M, Witt RG, Daniele JR, Titus M, McQuade JL, Conforti F, Burton EM, Lastrapes MJ, Ologun G, Cogdill AP, Morad G, Prieto P, Lazar AJ, Chu Y, Han G, Khan MAW, Helmink B, Davies MA, Amaria RN, Kovacs JJ, Woodman SE, Patel S, Hwu P, Peoples M, Lee JE, Cooper ZA, Zhu H, Gao G, Banerjee H, Lau M, Gershenwald JE, Lucci A, Keung EZ, Ross MI, Pala L, Pagan E, Segura RL, Liu Q, Borthwick MS, Lau E, Yates MS, Westin SN, Wani K, Tetzlaff MT, Haydu LE, Mahendra M, Ma X, Logothetis C, Kulstad Z, Johnson S, Hudgens CW, Feng N, Federico L, Long GV, Futreal PA, Arur S, Tawbi HA, Moran AE, Wang L, Heffernan TP, Marszalek JR, Wargo JA. Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy. Nature 606(7915):797-803, 2022. e-Pub 2022. PMID: 35705814.
172. Shanmugam P, Lambropoulos JC, Davies MA. Grinding of silicon carbide for optical surface fabrication, Part 1: surface analysis. Appl Opt 61(15):4579-4590, 2022. e-Pub 2022. PMID: 36256301.
173. Hussey H, Davies MA, Heekes A, Williamson C, Valley-Omar Z, Hardie D, Korsman S, Doolabh D, Preiser W, Maponga T, Iranzadeh A, Wasserman S, Boloko L, Symons G, Raubenheimer P, Parker A, Schrueder N, Solomon W, Rousseau P, Wolter N, Jassat W, Cohen C, Lessells R, Wilkinson RJ, Boulle A, Hsiao NY. Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections - a survival analysis. Int J Infect Dis 118:150-154, 2022. e-Pub 2022. PMID: 35235826.
174. Creasy CA, Meng YJ, Forget MA, Karpinets T, Tomczak K, Stewart C, Torres-Cabala CA, Pilon-Thomas S, Sarnaik AA, Mulé JJ, Garraway L, Bustos M, Zhang J, Patel SP, Diab A, Glitza IC, Yee C, Tawbi H, Wong MK, McQuade J, Hoon DSB, Davies MA, Hwu P, Amaria RN, Haymaker C, Beroukhim R, Bernatchez C. Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma. Clin Cancer Res 28(9):1911-1924, 2022. e-Pub 2022. PMID: 35190823.
175. Hailemichael Y, Johnson DH, Abdel-Wahab N, Foo WC, Bentebibel SE, Daher M, Haymaker C, Wani K, Saberian C, Ogata D, Kim ST, Nurieva R, Lazar AJ, Abu-Sbeih H, Fa'ak F, Mathew A, Wang Y, Falohun A, Trinh V, Zobniw C, Spillson C, Burks JK, Awiwi M, Elsayes K, Soto LS, Melendez BD, Davies MA, Wargo J, Curry J, Yee C, Lizee G, Singh S, Sharma P, Allison JP, Hwu P, Ekmekcioglu S, Diab A. Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity. Cancer Cell 40(5):509-523.e6, 2022. e-Pub 2022. PMID: 35537412.
176. Davies C, Johnson L, Sawry S, Chimbetete C, Eley B, Vinikoor M, Technau KG, Ehmer J, Rabie H, Phiri S, Tanser F, Malisita K, Fatti G, Osler M, Wood R, Newton S, Haas A, Davies MA. Effect of antiretroviral therapy care interruptions on mortality in children living with HIV. AIDS 36(5):729-737, 2022. e-Pub 2022. PMID: 35152225.
177. Kim ST, Chu Y, Misoi M, Suarez-Almazor ME, Tayar JH, Lu H, Buni M, Kramer J, Rodriguez E, Hussain Z, Neelapu SS, Wang J, Shah AY, Tannir NM, Campbell MT, Gibbons DL, Cascone T, Lu C, Blumenschein GR, Altan M, Lim B, Valero V, Loghin ME, Tu J, Westin SN, Naing A, Garcia-Manero G, Abdel-Wahab N, Tawbi HA, Hwu P, Oliva ICG, Davies MA, Patel SP, Zou J, Futreal A, Diab A, Wang L, Nurieva R. Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy. Nat Commun 13(1):1970, 2022. e-Pub 2022. PMID: 35413951.
178. Pires da Silva I, Ahmed T, McQuade JL, Nebhan CA, Park JJ, Versluis JM, Serra-Bellver P, Khan Y, Slattery T, Oberoi HK, Ugurel S, Haydu LE, Herbst R, Utikal J, Pföhler C, Terheyden P, Weichenthal M, Gutzmer R, Mohr P, Rai R, Smith JL, Scolyer RA, Arance AM, Pickering L, Larkin J, Lorigan P, Blank CU, Schadendorf D, Davies MA, Carlino MS, Johnson DB, Long GV, Lo SN, Menzies AM. Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma. J Clin Oncol 40(10):JCO2101701, 2022. e-Pub 2022. PMID: 35143285.
179. Valley-Omar Z, Marais G, Iranzadeh A, Naidoo M, Korsman S, Maponga T, Hussey H, Davies MA, Boulle A, Doolabh D, Laubscher M, Wojno J, Deetlefs JD, Maritz J, Scott L, Msomi N, Naicker C, Tegally H, de Oliveira T, Bhiman J, Williamson C, Preiser W, Hardie D, Hsiao NY. Reduced amplification efficiency of the RNA-dependent-RNA-polymerase target enables tracking of the Delta SARS-CoV-2 variant using routine diagnostic tests. J Virol Methods 302:114471, 2022. e-Pub 2022. PMID: 35051442.
180. Bekker LG, Garrett N, Goga A, Fairall L, Reddy T, Yende-Zuma N, Kassanjee R, Collie S, Sanne I, Boulle A, Seocharan I, Engelbrecht I, Davies MA, Champion J, Chen T, Bennett S, Mametja S, Semenya M, Moultrie H, de Oliveira T, Lessells RJ, Cohen C, Jassat W, Groome M, Von Gottberg A, Le Roux E, Khuto K, Barouch D, Mahomed H, Wolmarans M, Rousseau P, Bradshaw D, Mulder M, Opie J, Louw V, Jacobson B, Rowji P, Peter JG, Takalani A, Odhiambo J, Mayat F, Takuva S, Corey L, Gray GE. Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study. Lancet 399(10330):1141-1153, 2022. e-Pub 2022. PMID: 35305740.
181. Patel AB, Farooq S, Welborn M, Amaria RN, Chon SY, Diab A, Glitza Oliva IC, Huen AO, Li SQ, Nelson KC, Pacha O, Patel SP, Rapini RP, Tawbi HA, Wong MK, McQuade J, Davies MA, Haydu LE. Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit. Cancer 128(5):975-983, 2022. e-Pub 2022. PMID: 34724197.
182. Jesson J, Crichton S, Quartagno M, Yotebieng M, Abrams EJ, Chokephaibulkit K, Le Coeur S, Ake-Assi MH, Patel K, Pinto J, Paul M, Vreeman R, Davies MA, Ben-Farhat J, Van Dyke R, Judd A, Mofenson L, Vicari M, Seage G 3rd, Bekker LG, Essajee S, Gibb D, Penazzato M, Collins IJ, Wools-Kaloustian K, Slogrove A, Powis K, Williams P, Matshaba M, Thahane L, Nyasulu P, Lukhele B, Mwita L, Kekitiinwa-Rukyalekere A, Wanless S, Goetghebuer T, Thorne C, Warszawski J, Galli L, van Rossum AMC, Giaquinto C, Marczynska M, Marques L, Prata F, Ene L, Okhonskaya L, Navarro M, Frick A, Naver L, Kahlert C, Volokha A, Chappell E, Pape JW, Rouzier V, Marcelin A, Succi R, Sohn AH, Kariminia A, Edmonds A, Lelo P, Lyamuya R, Ogalo EA, Odhiambo FA, Haas AD, Bolton C, Muhairwe J, Tweya H, Sylla M, D'Almeida M, Renner L, Abzug MJ, Oleske J, Purswani M, Teasdale C, Nuwagaba-Biribonwoha H, Goodall R, Leroy V. Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis. J Int AIDS Soc 25(3):e25871, 2022. e-Pub 2022. PMID: 35255197.
183. Goldinger SM, Buder-Bakhaya K, Lo SN, Forschner A, McKean M, Zimmer L, Khoo C, Dummer R, Eroglu Z, Buchbinder EI, Ascierto PA, Gutzmer R, Rozeman EA, Hoeller C, Johnson DB, Gesierich A, Kölblinger P, Bennannoune N, Cohen JV, Kähler KC, Wilson MA, Cebon J, Atkinson V, Smith JL, Michielin O, Long GV, Hassel JC, Weide B, Haydu LE, Schadendorf D, McArthur G, Ott PA, Blank C, Robert C, Sullivan R, Hauschild A, Carlino MS, Garbe C, Davies MA, Menzies AM. Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. Eur J Cancer 162:22-33, 2022. e-Pub 2022. PMID: 34952480.
184. Davies MAM, Spincer M, Klein A, Walters S, Wright P, Hurley A, Stokes K, Hill J. "Pilot" spectator events in British horseracing during COVID-19: post-event SMS COVID-19 reporting. Scand J Med Sci Sports 32(2):372-380, 2022. e-Pub 2022. PMID: 34655255.
185. Wolter N, Jassat W, Walaza S, Welch R, Moultrie H, Groome M, Amoako DG, Everatt J, Bhiman JN, Scheepers C, Tebeila N, Chiwandire N, du Plessis M, Govender N, Ismail A, Glass A, Mlisana K, Stevens W, Treurnicht FK, Makatini Z, Hsiao NY, Parboosing R, Wadula J, Hussey H, Davies MA, Boulle A, von Gottberg A, Cohen C. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet 399(10323):437-446, 2022. e-Pub 2022. PMID: 35065011.
186. Davies MA, Kassanjee R, Rosseau P, Morden E, Johnson L, Solomon W, Hsiao NY, Hussey H, Meintjes G, Paleker M, Jacobs T, Raubenheimer P, Heekes A, Dane P, Bam JL, Smith M, Preiser W, Pienaar D, Mendelson M, Naude J, Schrueder N, Mnguni A, Roux SL, Murie K, Prozesky H, Mahomed H, Rossouw L, Wasserman S, Maughan D, Boloko L, Smith B, Taljaard J, Symons G, Ntusi N, Parker A, Wolter N, Jassat W, Cohen C, Lessells R, Wilkinson RJ, Arendse J, Kariem S, Moodley M, Vallabhjee K, Wolmarans M, Cloete K, Boulle A. Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa. medRxiv, 2022. e-Pub 2022. PMID: 35043121.
187. Nyemba DC, Kalk E, Vinikoor MJ, Madlala HP, Mubiana-Mbewe M, Mzumara M, Moore CB, Slogrove AL, Boulle A, Davies MA, Myer L, Powis K. Growth patterns of infants with in- utero HIV and ARV exposure in Cape Town, South Africa and Lusaka, Zambia. BMC Public Health 22(1):55, 2022. e-Pub 2022. PMID: 35000577.
188. Nyakato P, Schomaker M, Fatti G, Tanser F, Euvrard J, Sipambo N, Fox MP, Haas AD, Yiannoutsos CT, Davies MA, Cornell M. Virologic non-suppression and early loss to follow up among pregnant and non-pregnant adolescents aged 15-19 years initiating antiretroviral therapy in South Africa: a retrospective cohort study. J Int AIDS Soc 25(1):e25870, 2022. e-Pub 2022. PMID: 35032096.
189. Sun H, Cao S, Mashl RJ, Mo CK, Zaccaria S, Wendl MC, Davies SR, Bailey MH, Primeau TM, Hoog J, Mudd JL, Dean DA, Patidar R, Chen L, Wyczalkowski MA, Jayasinghe RG, Rodrigues FM, Terekhanova NV, Li Y, Lim KH, Wang-Gillam A, Van Tine BA, Ma CX, Aft R, Fuh KC, Schwarz JK, Zevallos JP, Puram SV, Dipersio JF, Consortium NCI, Davis-Dusenbery B, Ellis MJ, Lewis MT, Davies MA, Herlyn M, Fang B, Roth JA, Welm AL, Welm BE, Meric-Bernstam F, Chen F, Fields RC, Li S, Govindan R, Doroshow JH, Moscow JA, Evrard YA, Chuang JH, Raphael BJ, Ding L. Author Correction: Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment. Nat Commun 13(1):294, 2022. e-Pub 2022. PMID: 34996889.
190. Ho J, Mattei J, Tetzlaff M, Williams MD, Davies MA, Diab A, Oliva ICG, McQuade J, Patel SP, Tawbi H, Wong MK, Fisher SB, Hanna E, Keung EZ, Ross M, Weiser R, Su SY, Frumovitz M, Meyer LA, Jazaeri A, Pettaway CA, Guadagnolo BA, Bishop AJ, Mitra D, Farooqi A, Bassett R, Faria S, Nagarajan P, Amaria RN. Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma. Front Oncol 12:1001150, 2022. e-Pub 2022. PMID: 36324592.
191. Hussey H, Davies MA, Heekes A, Williamson C, Valley-Omar Z, Hardie D, Korsman S, Doolabh D, Preiser W, Maponga T, Iranzadeh A, Engelbrecht S, Wasserman S, Schrueder N, Boloko L, Symons G, Raubenheimer P, Viljoen A, Parker A, Cohen C, Jasat W, Lessells R, Wilkinson RJ, Boulle A, Hsiao M. Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study. Gates Open Res 6:117, 2022. e-Pub 2022. PMID: 37994361.
192. Han WM, Law MG, Egger M, Wools-Kaloustian K, Moore R, McGowan C, Kumarasamy N, Desmonde S, Edmonds A, Davies MA, Yiannoutsos C, Althoff KN, Cortes CP, Mohamed TJ, Jaquet A, Anastos K, Euvrard J, Castelnuovo B, Salters K, Coelho LE, Ekouevi DK, Eley B, Diero L, Zaniewski E, Ford N, Sohn AH, Kariminia A. Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries. Lancet HIV 8(12):e766-e775, 2021. e-Pub 2021. PMID: 34856180.
193. Spencer CN, McQuade JL, Gopalakrishnan V, McCulloch JA, Vetizou M, Cogdill AP, Khan MAW, Zhang X, White MG, Peterson CB, Wong MC, Morad G, Rodgers T, Badger JH, Helmink BA, Andrews MC, Rodrigues RR, Morgun A, Kim YS, Roszik J, Hoffman KL, Zheng J, Zhou Y, Medik YB, Kahn LM, Johnson S, Hudgens CW, Wani K, Gaudreau PO, Harris AL, Jamal MA, Baruch EN, Perez-Guijarro E, Day CP, Merlino G, Pazdrak B, Lochmann BS, Szczepaniak-Sloane RA, Arora R, Anderson J, Zobniw CM, Posada E, Sirmans E, Simon J, Haydu LE, Burton EM, Wang L, Dang M, Clise-Dwyer K, Schneider S, Chapman T, Anang NAS, Duncan S, Toker J, Malke JC, Glitza IC, Amaria RN, Tawbi HA, Diab A, Wong MK, Patel SP, Woodman SE, Davies MA, Ross MI, Gershenwald JE, Lee JE, Hwu P, Jensen V, Samuels Y, Straussman R, Ajami NJ, Nelson KC, Nezi L, Petrosino JF, Futreal PA, Lazar AJ, Hu J, Jenq RR, Tetzlaff MT, Yan Y, Garrett WS, Huttenhower C, Sharma P, Watowich SS, Allison JP, Cohen L, Trinchieri G, Daniel CR, Wargo JA. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Science 374(6575):1632-1640, 2021. e-Pub 2021. PMID: 34941392.
194. Anderson K, Kalk E, Madlala HP, Nyemba DC, Kassanjee R, Jacob N, Slogrove A, Smith M, Eley BS, Cotton MF, Muloiwa R, Spittal G, Kroon M, Boulle A, Myer L, Davies MA. Increased infectious-cause hospitalization among infants who are HIV-exposed uninfected compared with HIV-unexposed. AIDS 35(14):2327-2339, 2021. e-Pub 2021. PMID: 34324450.
195. Sloane RAS, White MG, Witt RG, Banerjee A, Davies MA, Han G, Burton E, Ajami N, Simon JM, Bernatchez C, Haydu LE, Tawbi HA, Gershenwald JE, Keung E, Ross M, McQuade J, Amaria RN, Wani K, Lazar AJ, Woodman SE, Wang L, Andrews MC, Wargo JA. Identification of MicroRNA-mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes. Cancers (Basel) 13(21), 2021. e-Pub 2021. PMID: 34771465.
196. Patel RR, He K, Barsoumian HB, Chang JY, Tang C, Verma V, Comeaux N, Chun SG, Gandhi S, Truong MT, Erasmus JJ, Hong DS, Lee PP, Ning MS, Nguyen QN, Heymach JV, Altan M, Blumenschein G, Fossella FV, Sezen D, Chen D, Carter BW, Davies MA, Glitza IC, Diab A, Ferrarotto R, Cabanillas ME, Yuan Y, Shah SJ, Parra ER, Sun B, Cortez MA, Welsh JW. High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: results of a phase II trial. Radiother Oncol 162:60-67, 2021. e-Pub 2021. PMID: 34237343.
197. Nebhan CA, Johnson DB, Sullivan RJ, Amaria RN, Flaherty KT, Sosman JA, Davies MA. Efficacy and Safety of Trametinib in Non-V600 BRAF Mutant Melanoma: A Phase I Study. Oncologist 26(9):731-e1498, 2021. e-Pub 2021. PMID: 33861486.
198. Kassanjee R, Johnson LF, Zaniewski E, Ballif M, Christ B, Yiannoutsos CT, Nyakato P, Desmonde S, Edmonds A, Sudjaritruk T, Pinto J, Vreeman R, Dahourou DL, Twizere C, Kariminia A, Carlucci JG, Kasozi C, Davies MA. Global HIV mortality trends among children on antiretroviral treatment corrected for under-reported deaths: an updated analysis of the International epidemiology Databases to Evaluate AIDS collaboration. J Int AIDS Soc 24 Suppl 5(Suppl 5):e25780, 2021. e-Pub 2021. PMID: 34546646.
199. Jassat W, Mudara C, Ozougwu L, Tempia S, Blumberg L, Davies MA, Pillay Y, Carter T, Morewane R, Wolmarans M, von Gottberg A, Bhiman JN, Walaza S, Cohen C. Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study. Lancet Glob Health 9(9):e1216-e1225, 2021. e-Pub 2021. PMID: 34252381.
200. Jassat W, Cohen C, Tempia S, Masha M, Goldstein S, Kufa T, Murangandi P, Savulescu D, Walaza S, Bam JL, Davies MA, Prozesky HW, Naude J, Mnguni AT, Lawrence CA, Mathema HT, Zamparini J, Black J, Mehta R, Parker A, Chikobvu P, Dawood H, Muvhango N, Strydom R, Adelekan T, Mdlovu B, Moodley N, Namavhandu EL, Rheeder P, Venturas J, Magula N, Blumberg L. Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study. Lancet HIV 8(9):e554-e567, 2021. e-Pub 2021. PMID: 34363789.
201. Madlala HP, Steyn NP, Kalk E, Davies MA, Nyemba D, Malaba TR, Mehta U, Petro G, Boulle A, Myer L. Association between food intake and obesity in pregnant women living with and without HIV in Cape Town, South Africa: a prospective cohort study. BMC Public Health 21(1):1504, 2021. e-Pub 2021. PMID: 34348683.
202. Chihana ML, Conan N, Ellman T, Poulet E, Garone DB, Ortuno R, Wanjala S, Masiku C, Etard JF, Davies MA, Maman D. The HIV cascade of care among serodiscordant couples in four high HIV prevalence settings in sub-Saharan Africa. S Afr Med J 111(8):768-776, 2021. e-Pub 2021. PMID: 35227358.
203. Andrews MC, Duong CPM, Gopalakrishnan V, Iebba V, Chen WS, Derosa L, Khan MAW, Cogdill AP, White MG, Wong MC, Ferrere G, Fluckiger A, Roberti MP, Opolon P, Alou MT, Yonekura S, Roh W, Spencer CN, Curbelo IF, Vence L, Reuben A, Johnson S, Arora R, Morad G, Lastrapes M, Baruch EN, Little L, Gumbs C, Cooper ZA, Prieto PA, Wani K, Lazar AJ, Tetzlaff MT, Hudgens CW, Callahan MK, Adamow M, Postow MA, Ariyan CE, Gaudreau PO, Nezi L, Raoult D, Mihalcioiu C, Elkrief A, Pezo RC, Haydu LE, Simon JM, Tawbi HA, McQuade J, Hwu P, Hwu WJ, Amaria RN, Burton EM, Woodman SE, Watowich S, Diab A, Patel SP, Glitza IC, Wong MK, Zhao L, Zhang J, Ajami NJ, Petrosino J, Jenq RR, Davies MA, Gershenwald JE, Futreal PA, Sharma P, Allison JP, Routy B, Zitvogel L, Wargo JA. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade. Nat Med 27(8):1432-1441, 2021. e-Pub 2021. PMID: 34239137.
204. Haymaker C, Johnson DH, Murthy R, Bentebibel SE, Uemura MI, Hudgens CW, Safa H, James M, Andtbacka RHI, Johnson DB, Shaheen M, Davies MA, Rahimian S, Chunduru SK, Milton DR, Tetzlaff MT, Overwijk WW, Hwu P, Gabrail N, Agrawal S, Doolittle G, Puzanov I, Markowitz J, Bernatchez C, Diab A. Tilsotolimod with ipilimumab drives tumor responses in anti-PD-1 refractory melanoma. Cancer Discov 11(8):1996-2013, 2021. e-Pub 2021. PMID: 33707233.
205. Sun H, Cao S, Mashl RJ, Mo CK, Zaccaria S, Wendl MC, Davies SR, Bailey MH, Primeau TM, Hoog J, Mudd JL, Dean DA, Patidar R, Chen L, Wyczalkowski MA, Jayasinghe RG, Rodrigues FM, Terekhanova NV, Li Y, Lim KH, Wang-Gillam A, Van Tine BA, Ma CX, Aft R, Fuh KC, Schwarz JK, Zevallos JP, Puram SV, Dipersio JF, Consortium NCI, Davis-Dusenbery B, Ellis MJ, Lewis MT, Davies MA, Herlyn M, Fang B, Roth JA, Welm AL, Welm BE, Meric-Bernstam F, Chen F, Fields RC, Li S, Govindan R, Doroshow JH, Moscow JA, Evrard YA, Chuang JH, Raphael BJ, Ding L. Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment. Nat Commun 12(1):5086, 2021. e-Pub 2021. PMID: 34429404.
206. Dave JA, Tamuhla T, Tiffin N, Levitt NS, Ross IL, Toet W, Davies MA, Boulle A, Coetzee A, Raubenheimer PJ. Risk factors for COVID-19 hospitalisation and death in people living with diabetes: A virtual cohort study from the Western Cape Province, South Africa. Diabetes Res Clin Pract 177:108925, 2021. e-Pub 2021. PMID: 34166703.
207. Mitra D, Ologun G, Keung EZ, Goepfert RP, Amaria RN, Ross MI, Gershenwald JE, Lucci A, Fisher SB, Davies MA, Lee JE, Bishop AJ, Farooqi AS, Wargo J, Guadagnolo BA. Nodal Recurrence is a Primary Driver of Early Relapse for Patients with Sentinel Lymph Node-Positive Melanoma in the Modern Therapeutic Era. Ann Surg Oncol 28(7):3480-3489, 2021. e-Pub 2021. PMID: 33856603.
208. Li F, Deng L, Jackson KR, Talukder AH, Katailiha AS, Bradley SD, Zou Q, Chen C, Huo C, Chiu Y, Stair M, Feng W, Bagaev A, Kotlov N, Svekolkin V, Ataullakhanov R, Miheecheva N, Frenkel F, Wang Y, Zhang M, Hawke D, Han L, Zhou S, Zhang Y, Wang Z, Decker WK, Sonnemann HM, Roszik J, Forget MA, Davies MA, Bernatchez C, Yee C, Bassett R, Hwu P, Du X, Lizee G. Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations. J Immunother Cancer 9(7), 2021. e-Pub 2021. PMID: 34244308.
209. Paleker M, Tembo YA, Davies MA, Mahomed H, Pienaar D, Madhi SA, McCarthy K. Asymptomatic COVID-19 in South Africa - implications for the control of transmission. Public Health Action 11(2):58-60, 2021. e-Pub 2021. PMID: 34159063.
210. Iyun V, Technau KG, Vinikoor M, Yotebieng M, Vreeman R, Abuogi L, Desmonde S, Edmonds A, Amorissani-Folquet M, Davies MA. Variations in the characteristics and outcomes of children living with HIV following universal ART in sub-Saharan Africa (2006-17): a retrospective cohort study. Lancet HIV 8(6):e353-e362, 2021. e-Pub 2021. PMID: 33932330.
211. Ruffieux Y, Efthimiou O, Van den Heuvel LL, Joska JA, Cornell M, Seedat S, Mouton JP, Prozesky H, Lund C, Maxwell N, Tlali M, Orrell C, Davies MA, Maartens G, Haas AD. The treatment gap for mental disorders in adults enrolled in HIV treatment programmes in South Africa: a cohort study using linked electronic health records. Epidemiol Psychiatr Sci 30:e37, 2021. e-Pub 2021. PMID: 33993900.
212. Nyemba DC, Kalk E, Madlala HP, Malaba TR, Slogrove AL, Davies MA, Boulle A, Myer L, Powis KM. Lower birth weight-for-age and length-for-age z-scores in infants with in-utero HIV and ART exposure: a prospective study in Cape Town, South Africa. BMC Pregnancy Childbirth 21(1):354, 2021. e-Pub 2021. PMID: 33947351.
213. Nyakato P, Schomaker M, Sipambo N, Technau KG, Fatti G, Rabie H, Tanser F, Eley B, Euvrard J, Wood R, Tsondai PR, Yiannoutsos CT, Cornell M, Davies MA. Virologic response of adolescents living with perinatally acquired HIV receiving antiretroviral therapy in the period of early adolescence (10-14 years) in South Africa. AIDS 35(6):971-978, 2021. e-Pub 2021. PMID: 33492836.
214. Tsondai PR, Davies MA, Singtoroj T, Maxwell N, McGowan CC, Songtaweesin WN, Technau KG, Kariminia A, Chimbetete C, Succi RCM, Pinto J, Rouzier V, Luque MT, Sohn AH. Improving Methods to Classify Perinatal versus Nonperinatal HIV Acquisition in Young Adolescents 10-14 Years of Age. Pediatr Infect Dis J 40(5):453-456, 2021. e-Pub 2021. PMID: 33538538.
215. Anderson K, Kalk E, Madlala HP, Nyemba DC, Jacob N, Slogrove A, Smith M, Kroon M, Harrison MC, Eley BS, Boulle A, Myer L, Davies MA. Preterm birth and severe morbidity in hospitalized neonates who are HIV exposed and uninfected compared with HIV unexposed. AIDS 35(6):921-931, 2021. e-Pub 2021. PMID: 33821822.
216. Phadke MS, Chen Z, Li J, Mohamed E, Davies MA, Smalley I, Duckett D, Palve V, Czerniecki BJ, Forsyth PA, Noyes D, Adeegbe DO, Eroglu Z, Nguyen KT, Tsai KY, Rix U, Burd CE, Chen YA, Rodriguez PC, Smalley KSM. Targeted therapy given after anti-PD-1 leads to prolonged responses in mouse melanoma models through sustained antitumor immunity. Cancer Immunol Res 9(5):554-567, 2021. e-Pub 2021. PMID: 33653716.
217. Saberian C, Amaria RN, Najjar AM, Radvanyi LG, Haymaker CL, Forget MA, Bassett RL, Faria SC, Glitza IC, Alvarez E, Parshottam S, Prieto V, Lizée G, Wong MK, McQuade JL, Diab A, Yee C, Tawbi HA, Patel S, Shpall EJ, Davies MA, Hwu P, Bernatchez C. Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma. J Immunother Cancer 9(5), 2021. e-Pub 2021. PMID: 34021033.
218. Peters SM, Sheik S, Werner JL, Davies MA, Willems B. Antimicrobial stewardship in the Western Cape: A situational analysis of existing facility-level initiatives. S Afr Med J 111(5):421-425, 2021. e-Pub 2021. PMID: 34852882.
219. Ogata D, Haydu LE, Glitza IC, Patel SP, Tawbi HA, McQuade JL, Diab A, Ekmekcioglu S, Wong MK, Davies MA, Amaria RN. The efficacy of anti-programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma. Cancer Medicine 10(7):2293-2299, 2021. e-Pub 2021. PMID: 33686688.
220. Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, Doolabh D, Pillay S, San EJ, Msomi N, Mlisana K, von Gottberg A, Walaza S, Allam M, Ismail A, Mohale T, Glass AJ, Engelbrecht S, Van Zyl G, Preiser W, Petruccione F, Sigal A, Hardie D, Marais G, Hsiao NY, Korsman S, Davies MA, Tyers L, Mudau I, York D, Maslo C, Goedhals D, Abrahams S, Laguda-Akingba O, Alisoltani-Dehkordi A, Godzik A, Wibmer CK, Sewell BT, Lourenco J, Alcantara LCJ, Kosakovsky Pond SL, Weaver S, Martin D, Lessells RJ, Bhiman JN, Williamson C, de Oliveira T. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature 592(7854):438-443, 2021. e-Pub 2021. PMID: 33690265.
221. Cheng LY, Haydu LE, Song P, Nie J, Tetzlaff MT, Kwong LN, Gershenwald JE, Davies MA, Zhang DY. High sensitivity sanger sequencing detection of BRAF mutations in metastatic melanoma FFPE tissue specimens. Sci Rep 11(1):9043, 2021. e-Pub 2021. PMID: 33907234.
222. Moodley K, Blockman M, Pienaar D, Hawkridge AJ, Meintjes J, Davies MA, London L. Hard choices: Ethical challenges in phase 1 of COVID-19 vaccine roll-out in South Africa. S Afr Med J 111(6):554-558, 2021. e-Pub 2021. PMID: 34382565.
223. Desmonde S, Ciaranello AL, Malateste K, Musick B, Patten G, Vu AT, Edmonds A, Neilan AM, Duda SN, Wools-Kaloustian K, Davies MA, Leroy V. Age-specific mortality rate ratios in adolescents and youth aged 10-24 years living with perinatally versus nonperinatally acquired HIV. AIDS 35(4):625-632, 2021. e-Pub 2021. PMID: 33252479.
224. Syeda MM, Wiggins JM, Corless BC, Long GV, Flaherty KT, Schadendorf D, Nathan PD, Robert C, Ribas A, Davies MA, Grob JJ, Gasal E, Squires M, Marker M, Garrett J, Brase JC, Polsky D. Circulating tumour DNA measurements predict survival in patients with unresectable or metastatic melanoma treated with dabrafenib or dabrafenib plus trametinib. The Lancet Oncology 22(3):370-380, 2021. e-Pub 2021. PMID: 33587894.
225. Fukumura K, Malgulwar PB, Fischer GM, Hu X, Mao X, Song X, Hernandez SD, Zhang XH, Zhang J, Parra ER, Yu D, Debeb BG, Davies MA, Huse JT. Multi-omic molecular profiling reveals potentially targetable abnormalities shared across multiple histologies of brain metastasis. Acta Neuropathol 141(2):303-321, 2021. e-Pub 2021. PMID: 33394124.
226. Menzies AM, Amaria RN, Rozeman EA, Huang AC, Tetzlaff MT, van de Wiel BA, Lo S, Tarhini AA, Burton EM, Pennington TE, Saw RPM, Xu X, Karakousis GC, Ascierto PA, Spillane AJ, van Akkooi ACJ, Mitchell TC, Tawbi HA, Scolyer RA, Davies MA, Wargo JA, Long GV. Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC). Nat Med 27(2):301-309, 2021. e-Pub 2021. PMID: 33558722.
227. Ujeneza EL, Ndifon W, Sawry S, Fatti G, Riou J, Davies MA, Nieuwoudt M. A mechanistic model for long-term immunological outcomes in South African HIV-infected children and adults receiving ART. Elife 10, 2021. e-Pub 2021. PMID: 33443013.
228. Fischer GM, Guerrieri RA, Hu Q, Joon AY, Kumar S, Haydu LE, McQuade JL, Vashisht Gopal YN, Knighton B, Deng W, Hudgens CW, Lazar AJ, Tetzlaff MT, Davies MA. Clinical, molecular, metabolic, and immune features associated with oxidative phosphorylation in melanoma brain metastases. Neurooncol Adv 3(1):vdaa177, 2021. e-Pub 2021. PMID: 33575655.
229. Somasundaram R, Connelly T, Choi R, Somasundaram R, Connelly T, Choi R, Choi H, Samarkina A, Li L, Gregorio E, Chen Y, Thakur R, Abdel-Mohsen M, Beqiri M, Kiernan M, Perego M, Wang F, Xiao M, Brafford P, Yang X, Xu X, Secreto A, Danet-Desnoyers G, Traum D, Kaestner KH, Huang AC, Hristova D, Wang J, Fukunaga-Kalabis M, Krepler C, Ping-Chen F, Zhou X, Gutierrez A, Rebecca VW, Vonteddu P, Dotiwala F, Bala S, Majumdar S, Dweep H, Wickramasinghe J, Kossenkov AV, Reyes-Arbujas J, Santiago K, Nguyen T, Griss J, Keeney F, Hayden J, Gavin BJ, Weiner D, Montaner LJ, Liu Q, Peiffer L, Becker J, Burton EM, Davies MA, Tetzlaff MT, Muthumani K, Wargo JA, Gabrilovich D, Herlyn M. Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy. Nature Communications 12(1):346, 2021. e-Pub 2021. PMID: 33436641.
230. Woo XY, Giordano J, Srivastava A, Zhao ZM, Lloyd MW, de Bruijn R, Suh YS, Patidar R, Chen L, Scherer S, Bailey MH, Yang CH, Cortes-Sanchez E, Xi Y, Wang J, Wickramasinghe J, Kossenkov AV, Rebecca VW, Sun H, Mashl RJ, Davies SR, Jeon R, Frech C, Randjelovic J, Rosains J, Galimi F, Bertotti A, Lafferty A, O'Farrell AC, Modave E, Lambrechts D, Ter Brugge P, Serra V, Marangoni E, El Botty R, Kim H, Kim JI, Yang HK, Lee C, Dean DA, Davis-Dusenbery B, Evrard YA, Doroshow JH, Welm AL, Welm BE, Lewis MT, Fang B, Roth JA, Meric-Bernstam F, Herlyn M, Davies MA, Ding L, Li S, Govindan R, Isella C, Moscow JA, Trusolino L, Byrne AT, Jonkers J, Bult CJ, Medico E, Chuang JH, Consortium P, Consortium E. Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts. Nat Genet 53(1):86-99, 2021. e-Pub 2021. PMID: 33414553.
231. White MG, Szczepaniak Sloane R, Witt RG, Reuben A, Gaudreau PO, Andrews MC, Feng N, Johnson S, Class CA, Bristow C, Wani K, Hudgens C, Nezi L, Manzo T, De Macedo MP, Hu J, Davis R, Jiang H, Prieto P, Burton E, Hwu P, Tawbi H, Gershenwald J, Lazar AJ, Tetzlaff MT, Overwijk W, Woodman SE, Cooper ZA, Marszalek JR, Davies MA, Heffernan TP, Wargo JA. Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf-mutated melanoma. Oncoimmunology 10(1):1992880, 2021. e-Pub 2021. PMID: 34777916.
232. Hartley LJ, Evans S, Davies MA, Kelly S, Gregory JJ. A Daily Diagnostic Multidisciplinary Meeting to Reduce Time to Definitive Diagnosis in the Context of Primary Bone and Soft Tissue Sarcoma. J Multidiscip Healthc 14:115-123, 2021. e-Pub 2021. PMID: 33488087.
233. Hussey H, Zinyakatira N, Morden E, Ismail M, Paleker M, Bam JL, London L, Boulle A, Davies MA. Higher COVID-19 mortality in low-income communities in the City of Cape Town - a descriptive ecological study. Gates Open Res 5:90, 2021. e-Pub 2021. PMID: 34286217.
234. Cloete K, Davies MA, Kariem S, Bouille A, Vallabhjee K, Chopra M. Opportunities during COVID-19 towards achieving Universal Health Coverage. J Glob Health 11:03115, 2021. e-Pub 2021. PMID: 34956632.
235. Ding Z, Ogata D, Roszik J, Qin Y, Kim SH, Tetzlaff MT, Lazar AJ, Davies MA, Ekmekcioglu S, Grimm EA. iNOS Associates with Poor Survival in Melanoma: A Role for Nitric Oxide in the PI3K-AKT Pathway Stimulation and PTEN S-Nitrosylation. Front Oncol 11:631766, 2021. e-Pub 2021. PMID: 33643925.
236. Tsondai PR, Braithwaite K, Fatti G, Bolton Moore C, Chimbetete C, Rabie H, Phiri S, Sawry S, Eley B, Hobbins MA, Boulle A, Taghavi K, Sohn AH, Davies MA. Characteristics and outcomes of adolescents living with perinatally acquired HIV within Southern Africa. AIDS 34(15):2275-2284, 2020. e-Pub 2020. PMID: 32910063.
237. Haas AD, Technau KG, Pahad S, Braithwaite K, Madzivhandila M, Sorour G, Sawry S, Maxwell N, von Groote P, Tlali M, Davies MA, Egger M. Mental health, substance use and viral suppression in adolescents receiving ART at a paediatric HIV clinic in South Africa. J Int AIDS Soc 23(12):e25644, 2020. e-Pub 2020. PMID: 33283916.
238. Peters SM, Davies MA, Van As AB. Repeat injuries in childhood. S Afr Med J 110(12):1218-1225, 2020. e-Pub 2020. PMID: 33403969.
239. Kalk E, Heekes A, Mehta U, de Waal R, Jacob N, Cohen K, Myer L, Davies MA, Maartens G, Boulle A. Safety and Effectiveness of Isoniazid Preventive Therapy in Pregnant Women Living with Human Immunodeficiency Virus on Antiretroviral Therapy: An Observational Study Using Linked Population Data. Clin Infect Dis 71(8):e351-e358, 2020. e-Pub 2020. PMID: 31900473.
240. Nguyen MQ, Teh JLF, Purwin TJ, Chervoneva I, Davies MA, Nathanson KL, Cheng PF, Levesque MP, Dummer R, Aplin AE. Targeting PHGDH Upregulation Reduces Glutathione Levels and Resensitizes Resistant NRAS-Mutant Melanoma to MAPK Kinase Inhibition. Journal of Investigative Dermatology 140(11):2242-2252.e7, 2020. e-Pub 2020. PMID: 32389536.
241. Abdul Jalil MF, Dower A, Tawfik S, Brooks M, Davies MA, Ghahreman A. MRI predictors of revision surgery after primary lumbar discectomy. J Clin Neurosci 81:442-446, 2020. e-Pub 2020. PMID: 33222960.
242. Desmonde S, Neilan AM, Musick B, Patten G, Chokephaibulkit K, Edmonds A, Duda SN, Malateste K, Wools-Kaloustian K, Ciaranello AL, Davies MA, Leroy V. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium. J Int AIDS Soc 23(10):e25617, 2020. e-Pub 2020. PMID: 33034417.
243. Zhao W, Li J, Chen MM, Luo Y, Ju Z, Nesser NK, Johnson-Camacho K, Boniface CT, Lawrence Y, Pande NT, Davies MA, Herlyn M, Muranen T, Zervantonakis IK, von Euw E, Schultz A, Kumar SV, Korkut A, Spellman PT, Akbani R, Slamon DJ, Gray JW, Brugge JS, Lu Y, Mills GB, Liang H. Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines. Cancer Cell. e-Pub 2020. PMID: 33157050.
244. Fischer GM, Carapeto FCL, Joon AY, Haydu LE, Chen H, Wang F, Van Arnam JS, McQuade JL, Wani K, Kirkwood JM, Thompson JF, Tetzlaff MT, Lazar AJ, Tawbi HA, Gershenwald JE, Scolyer RA, Long GV, Davies MA. Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker. Cancer Med. e-Pub 2020. PMID: 33016647.
245. Das I, Chen H, Maddalo G, Tuominen R, Rebecca VW, Herlyn M, Hansson J, Davies MA, Egyházi Brage S. Inhibiting insulin and mTOR signaling by afatinib and crizotinib combination fosters broad cytotoxic effects in cutaneous malignant melanoma. Cell Death Dis 11(10):882, 2020. e-Pub 2020. PMID: 33082316.
246. Haas AD, Ruffieux Y, van den Heuvel LL, Lund C, Boulle A, Euvrard J, Orrell C, Prozesky HW, Tiffin N, Lovero KL, Tlali M, Davies MA, Wainberg ML. Excess mortality associated with mental illness in people living with HIV in Cape Town, South Africa: a cohort study using linked electronic health records. Lancet Glob Health 8(10):e1326-e1334, 2020. e-Pub 2020. PMID: 32971055.
247. Jaiswal AR, Liu AJ, Pudakalakatti S, Dutta P, Jayaprakash P, Bartkowiak T, Ager CR, Wang ZQ, Reuben A, Cooper ZA, Ivan C, Ju Z, Nwajei F, Wang J, Davies MA, Davis RE, Wargo JA, Bhattacharya PK, Hong DS, Curran MA. Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype. Cancer Immunol Res. e-Pub 2020. PMID: 32917656.
248. Johnson LF, Patrick M, Stephen C, Patten G, Dorrington RE, Maskew M, Jamieson L, Davies MA. Steep Declines in Pediatric AIDS Mortality in South Africa, Despite Poor Progress Toward Pediatric Diagnosis and Treatment Targets. Pediatr Infect Dis J 39(9):843-848, 2020. e-Pub 2020. PMID: 32433224.
249. Eriksson H, Hansson J, Krynitz B, Masucci G, Girnita A, Lapins J, Huen AO, Tawbi HA, MA D, Tetzlaff MT, Curry JL. Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma. Acta Derm Venereol. e-Pub 2020. PMID: 32985676.
250. Pundole X, Jones AL, Tetzlaff MT, Williams MD, Murphy WA, Otun A, Goepfert RP, Davies MA. Osteonecrosis of the jaw induced by treatment with anti-PD-1 immunotherapy: a case report. Immunotherapy. e-Pub 2020. PMID: 32900256.
251. Tymejczyk O, Brazier E, Wools-Kaloustian K, Davies MA, Dilorenzo M, Edmonds A, Vreeman R, Bolton C, Twizere C, Okoko N, Phiri S, Nakigozi G, Lelo P, von Groote P, Sohn AH, Nash D. Impact of Universal Antiretroviral Treatment Eligibility on Rapid Treatment Initiation Among Young Adolescents with Human Immunodeficiency Virus in Sub-Saharan Africa. J Infect Dis 222(5):755-764, 2020. e-Pub 2020. PMID: 31682261.
252. Bell-Gorrod H, Fox MP, Boulle A, Prozesky H, Wood R, Tanser F, Davies MA, Schomaker M. The Impact of Delayed Switch to Second-Line Antiretroviral Therapy on Mortality, Depending on Definition of Failure Time and CD4 Count at Failure. Am J Epidemiol 189(8):811-819, 2020. e-Pub 2020. PMID: 32219384.
253. Ramos RI, Bustos MA, Wu J, Jones P, Chang SC, Kiyohara E, Tran K, Zhang X, Stern SL, Izraely S, Sagi-Assif O, Witz IP, Davies MA, Mills GB, Kelly DF, Irie RF, Hoon DSB. Upregulation of Cell Surface GD3 Ganglioside Phenotype Associates with Human Melanoma Brain Metastasis. Mol Oncol 14(8), 2020. e-Pub 2020. PMID: 32358995.
254. Davies MA. HIV and risk of COVID-19 death: a population cohort study from the Western Cape Province, South Africa. medRxiv, 2020. e-Pub 2020. PMID: 32637972.
255. Tetzlaff MT, Adhikari C, Lo S, Rawson RV, Amaria RN, Menzies AM, Wilmott JS, Ferguson PM, Ross MI, Spillane AJ, Vu KA, Ma J, Ning J, Haydu L, Saw RPM, Wargo JA, Tawbi HA, Gershenwald JE, Long GV, Davies MA, Scolyer R.A. Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma. Ann Oncol. e-Pub 2020. PMID: 32739408.
256. Patten G, Puthanakit T, McGowan CC, Wools-Kaloustian K, Hazra R, Pinto JA, Machado D, Succi R, Sohn AH, Rabie H, Musick B, Davies MA. Raltegravir use and outcomes among children and adolescents living with HIV in the IeDEA global consortium. J Int AIDS Soc 23(7):e25580, 2020. e-Pub 2020. PMID: 32722897.
257. Zaniewski E, Dao Ostinelli CH, Chammartin F, Maxwell N, Davies MA, Euvrard J, van Dijk J, Bosomprah S, Phiri S, Tanser F, Sipambo N, Muhairwe J, Fatti G, Prozesky H, Wood R, Ford N, Fox MP, Egger M. Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern Africa. J Int AIDS Soc 23(7):e25546, 2020. e-Pub 2020. PMID: 32640106.
258. Ngo B, Kim E, Osorio-Vasquez V, Doll S, Bustraan S, Liang RJ, Luengo A, Davidson SM, Ali A, Ferraro GB, Fischer GM, Eskandari R, Kang DS, Ni J, Plasger A, Rajasekhar VK, Kastenhuber ER, Bacha S, Sriram RK, Stein BD, Bakhoum SF, Snuderl M, Cotzia P, Healey JH, Mainolfi N, Suri V, Friedman A, Manfredi M, Sabatini DM, Jones DR, Yu M, Zhao JJ, Jain RK, Keshari KR, Davies MA, Vander Heiden MG, Hernando E, Mann M, Cantley LC, Pacold ME. Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition. Cancer Discovery. e-Pub 2020. PMID: 32571778.
259. Chen D, Barsoumian H, Fischer G, Yang L, Verma V, Younes A, Hu Y, Masropour F, Klein K, Vellano C, Marszalek J, Davies MA, Cortez M, Welsh J. Combination treatment with radiotherapy and a novel oxidative phosphorylation inhibitor overcomes PD-1 resistance and enhances antitumor immunity. Journal for ImmunoTherapy of Cancer 8(1):e000289, 2020. e-Pub 2020. PMID: 32581056.
260. Jesson J, Desmonde S, Yiannoutsos CT, Patten G, Malateste K, Duda SN, Kumarasamy N, Yotebieng M, Davies MA, Musick B, Leroy V, Ciaranello A. Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium. BMC Res Notes 13(1):249, 2020. e-Pub 2020. PMID: 32448379.
261. Chammartin F, Dao Ostinelli CH, Anastos K, Jaquet A, Brazier E, Brown S, Dabis F, Davies MA, Duda SN, Malateste K, Nash D, Wools-Kaloustian K, von Groote PM, Egger M. International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012-2019. BMJ Open 10(5):e035246, 2020. e-Pub 2020. PMID: 32414825.
262. Haydu LE, Lo SN, McQuade JL, Amaria RN, Wargo J, Ross MI, Cormier JN, Lucci A, Lee JE, Ferguson SD, Saw RPM, Spillane AJ, Shannon KF, Stretch JR, Hwu P, Patel SP, Diab A, Wong MKK, Glitza Oliva IC, Tawbi H, Carlino MS, Menzies AM, Long GV, Lazar AJ, Tetzlaff MT, Scolyer RA, Gershenwald JE, Thompson JF, Davies MA. Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma. J Clin Oncol 38(13):1429-1441, 2020. e-Pub 2020. PMID: 31990608.
263. Kehoe K, Boulle A, Tsondai PR, Euvrard J, Davies MA, Cornell M. Long-term virologic responses to antiretroviral therapy among HIV-positive patients entering adherence clubs in Khayelitsha, Cape Town, South Africa: a longitudinal analysis. J Int AIDS Soc 23(5):e25476, 2020. e-Pub 2020. PMID: 32406983.
264. Teh JLF, Purwin TJ, Han A, Chua V, Patel P, Baqai U, Liao C, Bechtel N, Sato T, Davies MA, Aguirre-Ghiso J, Aplin AE. Metabolic adaptations to MEK and CDK4/6 co-targeting in uveal melanoma. Molecular Cancer Therapeutics, 2020. e-Pub 2020. PMID: 32430489.
265. Davies MJ, Davies MA, Sharpe R, Cordato D, Schwartz R. Epidural Blood Patch as a Diagnostic and Therapeutic Intervention in Spontaneous Intracranial Hypotension: A Novel Approach to Management. World Neurosurg 137:e242-e250, 2020. e-Pub 2020. PMID: 32004736.
266. Davies MAM, Lawrence T, Edwards A, Lecky F, McKay CD, Stokes KA, Williams S. Serious sports-related injury in England and Wales from 2012-2017: a study protocol. Inj Epidemiol 7(1):14, 2020. e-Pub 2020. PMID: 32336291.
267. Lucci A, Hall CS, Patel SP, Narendran B, Bauldry JB, Royal RE, Karhade M, Upshaw JR, Wargo JA, Glitza IC, Wong MKK, Amaria RN, Tawbi HA, Diab A, Davies MA, Gershenwald JE, Lee JE, Hwu P, Ross MI. Circulating tumor cells and early relapse in node-positive melanoma. Clin Cancer Res 26(8):1886-1895, 2020. e-Pub 2020. PMID: 32015020.
268. Mitra A, Andrews MC, Roh W, De Macedo MP, Hudgens CW, Carapeto F, Singh S, Reuben A, Wang F, Mao X, Song X, Wani K, Tippen S, Ng KS, Schalck A, Sakellariou-Thompson DA, Chen E, Reddy SM, Spencer CN, Wiesnoski D, Little LD, Gumbs C, Cooper ZA, Burton EM, Hwu P, Davies MA, Zhang J, Bernatchez C, Navin N, Sharma P, Allison JP, Wargo JA, Yee C, Tetzlaff MT, Hwu WJ, Lazar AJ, Futreal PA. Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma. Nat Commun 11(1):1839, 2020. e-Pub 2020. PMID: 32296058.
269. Drummond KJ, Hunn BHM, McAlpine HE, Jones JJ, Davies MA, Gull S. Challenges in the Australasian neurosurgery training program: who should be trained and where should they train?. Neurosurg Focus 48(3):E10, 2020. e-Pub 2020. PMID: 32114546.
270. Nagarajan P, Piao J, Ning J, Noordenbos LE, Curry JL, Torres-Cabala CA, Diwan AH, Ivan D, Aung PP, Ross MI, Royal RE, Wargo JA, Wang WL, Samdani R, Lazar AJ, Rashid A, Davies MA, Prieto VG, Gershenwald JE, Tetzlaff MT. Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features. Mod Pathol 33(3):496-513, 2020. e-Pub 2020. PMID: 31383963.
271. Tiago M, Capparelli C, Erkes DA, Purwin TJ, Heilman SA, Berger AC, Davies MA, Aplin AE. Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanoma. Br J Cancer 122(6):789-800, 2020. e-Pub 2020. PMID: 31932756.
272. Wang DY, McQuade JL, Rai RR, Park JJ, Zhao S, Ye F, Beckermann KE, Rubinstein SM, Johnpulle R, Long GV, Carlino MS, Menzies AM, Davies MA, Johnson DB. The Impact of Nonsteroidal Anti-Inflammatory Drugs, Beta Blockers, and Metformin on the Efficacy of Anti-PD-1 Therapy in Advanced Melanoma. Oncologist 25(3):e602-e605, 2020. e-Pub 2020. PMID: 32162820.
273. Iyun V, Technau KG, Eley B, Rabie H, Boulle A, Fatti G, Egger M, Tanser F, Wood R, Fairlie L, Cotton MF, Davies MA. Earlier Antiretroviral Therapy Initiation and Decreasing Mortality Among HIV-infected Infants Initiating Antiretroviral Therapy Within 3 Months of Age in South Africa, 2006-2017. Pediatr Infect Dis J 39(2):127-133, 2020. e-Pub 2020. PMID: 31725119.
274. Holbrook K, Lutzky J, Davies MA, Davis JM, Glitza IC, Amaria RN, Diab A, Patel SP, Amin A, Tawbi H. Intracranial Anti-Tumor Activity with Encorafenib Plus Binimetinib in Patients with Melanoma Brain Metastases: A Case Series. Cancer 126(3):523-530, 2020. e-Pub 2020. PMID: 31658370.
275. Helmink BA, Reddy SM, Gao J, Zhang S, Basar R, Thakur R, Yizhak K, Sade-Feldman M, Blando J, Han G, Gopalakrishnan V, Xi Y, Zhao H, Amaria RN, Tawbi HA, Cogdill AP, Liu W, LeBleu VS, Kugeratski FG, Patel S, Davies MA, Hwu P, Lee JE, Gershenwald JE, Lucci A, Arora R, Woodman S, Keung EZ, Gaudreau PO, Reuben A, Spencer CN, Burton EM, Haydu LE, Lazar AJ, Zapassodi R, Hudgens CW, Ledesma DA, Ong S, Bailey M, Warren S, Rao D, Krijgsman O, Rozeman EA, Peeper D, Blank CU, Schumacher TN, Butterfield LH, Zelazowska MA, McBride KM, Kalluri R, Allison J, Petitprez F, Fridman WH, Sautès-Fridman C, Hacohen N, Rezvani K, Sharma P, Tetzlaff MT, Wang L, Wargo JA. B cells and tertiary lymphoid structures promote immunotherapy response. Nature, 2020. e-Pub 2020. PMID: 31942075.
276. Davies MA. Cleansing-induced changes in skin measured by in vivo confocal raman spectroscopy. Skin Res Technol 26(1):30-38, 2020. e-Pub 2020. PMID: 31373073.
277. de Beer S, Kalk E, Kroon M, Boulle A, Osler M, Euvrard J, Timmerman V, Davies MA. A longitudinal analysis of the completeness of maternal HIV testing, including repeat testing in Cape Town, South Africa. J Int AIDS Soc 23(1):e25441, 2020. e-Pub 2020. PMID: 31997583.
278. Tsondai PR, Sohn AH, Phiri S, Sikombe K, Sawry S, Chimbetete C, Fatti G, Hobbins MA, Technau KG, Rabie H, Bernheimer J, Fox MP, Judd A, Collins IJ, Davies MA. Characterizing the double-sided cascade of care for adolescents living with HIV transitioning to adulthood across Southern Africa. J Int AIDS Soc 23(1):e25447, 2020. e-Pub 2020. PMID: 32003159.
279. Rosenbaum SR, Knecht M, Mollaee M, Zhong Z, Erkes DA, McCue PA, Chervoneva I, Berger AC, Lo JA, Fisher DE, Gershenwald JE, Davies MA, Purwin TJ, Aplin AE. FOXD3 regulates VISTA expression in melanoma. Cell Rep 30(2):510-524.e6, 2020. e-Pub 2020. PMID: 31940493.
280. Nyakato P, Davies MA, Technau KG, Fatti G, Rabie H, Tanser F, Boulle A, Wood R, Eley B, Sawry S, Giddy J, Sipambo N, Kuhn L, Fairlie L. Virologic response to efavirenz-based first-line antiretroviral therapy in children with previous exposure to antiretrovirals to prevent mother-to-child transmission. PLoS One 15(5):e0233693, 2020. e-Pub 2020. PMID: 32469985.
281. Boettiger DC, Law MG, Sohn AH, Davies MA, Wools-Kaloustian K, Leroy V, Yotebieng M, Vinikoor M, Vreeman R, Amorissani-Folquet M, Edmonds A, Fatti G, Batte J, Renner L, Adedimeji A, Kariminia A. Temporal Trends in Co-trimoxazole Use Among Children on Antiretroviral Therapy and the Impact of Co-trimoxazole on Mortality Rates in Children Without Severe Immunodeficiency. J Pediatric Infect Dis Soc 8(5):450-460, 2019. e-Pub 2019. PMID: 30215763.
282. Vashisht Gopal YN, Gammon ST, Prasad R, Knighton B, Pisaneschi F, Roszik J, Feng N, Johnson S, Pramanik S, Sudderth J, Sui D, Hudgens CW, Fischer GM, Deng W, Reuben A, Peng W, Wang J, Di Francesco ME, Marszalek JR, McQuade JL, Tetzlaff MT, Piwnica-Worms D, DeBerardinis RJ, Davies MA. A novel mitochondrial inhibitor blocks MAPK pathway and overcomes MAPK inhibitor-resistance in melanoma. Clin Cancer Res, 2019. e-Pub 2019. PMID: 31439581.
283. Safa H, Johnson DH, Trinh VA, Rodgers TE, Lin H, Suarez-Almazor ME, Fa'ak F, Saberian C, Yee C, Davies MA, Tummala S, Woodman K, Abdel-Wahab N, Diab A. Immune Checkpoint Inhibitor Related Myasthenia Gravis: Single Center Experience and Systematic Review of the Literature. J Immunother Cancer 7(1):319, 2019. e-Pub 2019. PMID: 31753014.
284. Gammon ST, Pisaneschi F, Bandi ML, Smith MG, Sun Y, Rao Y, Muller F, Wong F, De Groot J, Ackroyd J, Mawlawi O, Davies MA, Gopal YNV, Di Francesco ME, Marszalek JR, Dewhirst M, Piwnica-Worms D. Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [18F]FAZA PET In Vivo. Cells 8(12), 2019. e-Pub 2019. PMID: 31766580.
285. Jesson J, Schomaker M, Malasteste K, Wati DK, Kariminia A, Sylla M, Kouadio K, Sawry S, Mubiana-Mbewe M, Ayaya S, Vreeman R, McGowan CC, Yotebieng M, Leroy V, Davies MA. Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration. J Int AIDS Soc 22(11):e25412, 2019. e-Pub 2019. PMID: 31702088.
286. Schomaker M, Luque-Fernandez MA, Leroy V, Davies MA. Using longitudinal targeted maximum likelihood estimation in complex settings with dynamic interventions. Stat Med 38(24):4888-4911, 2019. e-Pub 2019. PMID: 31436859.
287. Davies MAM, Kerr ZY, DeFreese JD, Arden NK, Marshall SW, Guskiewicz KM, Padua DA, Pietrosimone B. Prevalence of and Risk Factors for Total Hip and Knee Replacement in Retired National Football League Athletes. Am J Sports Med 47(12):2863-2870, 2019. e-Pub 2019. PMID: 31498654.
288. Mackinnon AL, Jackson K, Kuznik K, Turner A, Hill J, Davies MAM, Jones ME, Delmestri A, Sanchez-Santos MT, Newton J. Increased Risk of Musculoskeletal Disorders and Mental Health Problems in Retired Professional Jockeys: A Cross-Sectional Study. Int J Sports Med 40(11):732-738, 2019. e-Pub 2019. PMID: 31390657.
289. Mackinnon AL, Jackson K, Kuznik K, Turner A, Hill J, Davies MAM, Jones ME, Delmestri A, Sanchez-Santos MT, Newton J. Increased Risk of Musculoskeletal Disorders and Mental Health Problems in Retired Professional Jockeys: A Cross-Sectional Study. Int J Sports Med 40(14):e5, 2019. e-Pub 2019. PMID: 31480087.
290. Sanchez IM, Purwin TJ, Chervoneva I, Erkes DA, Nguyen MQ, Davies MA, Nathanson KL, Kemper K, Peeper DS, Aplin AE. In vivo ERK1/2 reporter predictively models response and resistance to combined BRAF and MEK inhibitors in melanoma. Mol Cancer Ther, 2019. e-Pub 2019. PMID: 31270153.
291. AbuHammad S, Cullinane C, Martin C, Bacolas Z, Ward T, Chen H, Slater A, Ardley K, Kirby L, Chan KT, Brajanovski N, Smith LK, Rao AD, Lelliott EJ, Kleinschmidt M, Vergara IA, Papenfuss AT, Lau P, Ghosh P, Haupt S, Haupt Y, Sanij E, Poortinga G, Pearson RB, Falk H, Curtis DJ, Stupple P, Devlin M, Street I, Davies MA, McArthur GA, Sheppard KE. Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma. Proc Natl Acad Sci U S A, 2019. e-Pub 2019. PMID: 31439820.
292. Kircher DA, Trombetti KA, Silvis MR, Parkman GL, Fischer GM, Angel SN, Stehn CM, Strain SC, Grossmann AH, Duffy KL, Boucher KM, McMahon M, Davies MA, Mendoza MC, VanBrocklin MW, Holmen SL. AKT1E17K activates focal adhesion kinase and promotes melanoma brain metastasis. Mol Cancer Res, 2019. e-Pub 2019. PMID: 31138602.
293. Peng W, Williams LJ, Xu C, Melendez B, McKenzie JA, Chen Y, Jackson H, Voo KS, Mbofung RM, Leahey SE, Wang J, Lizee G, Tawbi HA, Davies MA, Hoos A, Smothers J, Srinivasan R, Paul EM, Yanamandra N, Hwu P. Anti-OX40 antibody directly enhances the function of tumor-reactive CD8+ T cells and synergizes with PI3Kβ inhibition in PTEN loss melanoma. Clin Cancer Res. e-Pub 2019. PMID: 31371342.
294. Jones ME, Davies MAM, Shah K, Kemp S, Peirce N, Leyland KM, Stokes KA, Judge AD, Newton JL, Furniss D, Arden NK. The prevalence of hand and wrist osteoarthritis in elite former cricket and rugby union players. J Sci Med Sport 22(8):871-875, 2019. e-Pub 2019. PMID: 30940442.
295. Schvartsman G, Ma J, Bassett RL, Haydu LE, Amaria RN, Hwu P, Wong MK, Hwu WJ, Diab A, Patel SP, Davies MA, Hamerschlak N, Tawbi HA, Glitza Oliva IC. Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma. Cancer. e-Pub 2019. PMID: 31398264.
296. Robert C, Grob JJ, Stroyakovskiy D, Karaszewska B, Hauschild A, Levchenko E, Chiarion Sileni V, Schachter J, Garbe C, Bondarenko I, Gogas H, Mandalá M, JBAG H, Lebbé C, Mackiewicz A, Rutkowski P, Nathan PD, Ribas A, Davies MA, Flaherty KT, Burgess P, Tan M, Gasal E, Voi M, Schadendorf D, Long GV. Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma. N Engl J Med, 2019. e-Pub 2019. PMID: 31166680.
297. Ascierto PA, Agarwala SS, Botti G, Budillon A, Davies MA, Dummer R, Ernstoff M, Ferrone S, Formenti S, Gajewski TF, Garbe C, Hamid O, Lo RS, Luke JJ, Michielin O, Palmieri G, Zitvogel L, Marincola FM, Masucci G, Caracò C, Thurin M, Puzanov I. Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy). J Transl Med 17(1):234, 2019. e-Pub 2019. PMID: 31331337.
298. Tymejczyk O, Brazier E, Yiannoutsos CT, Vinikoor M, van Lettow M, Nalugoda F, Urassa M, Sinayobye JD, Rebeiro PF, Wools-Kaloustian K, Davies MA, Zaniewski E, Anderegg N, Liu G, Ford N, Nash D. Changes in rapid HIV treatment initiation after national "treat all" policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis. PLoS Med 16(6):e1002822, 2019. e-Pub 2019. PMID: 31181056.
299. Msukwa MT, Keiser O, Jahn A, van Oosterhout JJ, Edmonds A, Phiri N, Manjomo R, Davies MA, Estill J. Timing of combination antiretroviral therapy (cART) initiation is not associated with stillbirth among HIV-infected pregnant women in Malawi. Trop Med Int Health 24(6):727-735, 2019. e-Pub 2019. PMID: 30891866.
300. Ferguson SD, Bindal S, Bassett RL, Haydu LE, McCutcheon IE, Heimberger AB, Li J, O'Brien BJ, Guha-Thakurta N, Tetzlaff MT, Tawbi H, Davies MA, Glitza IC. Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD). J Neurooncol 142(3):499-509, 2019. e-Pub 2019. PMID: 30847840.
301. Fischer GM, Jalali A, Kircher DA, Lee WC, McQuade JL, Haydu LE, Joon AY, Reuben A, de Macedo MP, Carapeto FCL, Yang C, Srivastava A, Ambati CR, Sreekumar A, Hudgens CW, Knighton B, Deng W, Ferguson SD, Tawbi HA, Glitza IC, Gershenwald JE, Vashisht Gopal YN, Hwu P, Huse JT, Wargo JA, Futreal PA, Putluri N, Lazar AJ, DeBerardinis RJ, Marszalek JR, Zhang J, Holmen SL, Tetzlaff MT, Davies MA. Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases. Cancer Discov 9(5):628-645, 2019. e-Pub 2019. PMID: 30787016.
302. Karz, A., Dimitrova, M, Alvarez-Breckenridge, C., Atkins, M. B., Boire, A., Bosenberg, M., Brastianos, P., Cahill, D. P., Chen, Q, Ferguson, S., Forsyth, P., Glitza Oliva, I. C., Goldberg, S. B., Najjar YG, Holmen, S. L., Knisely, J. P. S., Merlino, G., Pacold, M. E., Perez-Guijarro, E., Smalley, K. S. M., Tawbi, H. A., Wen, P. Y., Davies, M. A., Kluger, H. M., Mehnert, J. M., Davies MA, Hernando, E.. Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities. Pigment Cell Melanoma Res 32(3):458-469, 2019. e-Pub 2019. PMID: 30712316.
303. Kluger HM, Margolin KA, Davies MA, Long GV, Tawbi HA, Goldberg SB, Chiang VL. Reply to A. Shinde et al. J Clin Oncol 37(12):JCO1802463, 2019. e-Pub 2019. PMID: 30807233.
304. Patten G, Schomaker M, Davies MA, Rabie H, van Zyl G, Technau K, Eley B, Boulle A, Van Dyke RB, Patel K, Sipambo N, Wood R, Tanser F, Giddy J, Cotton M, Nuttall J, Essack G, Karalius B, Seage G, Sawry S, Egger M, Fairlie L. What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies. Pediatr Infect Dis J 38(4):400-405, 2019. e-Pub 2019. PMID: 30882732.
305. Euvrard J, Schulz T, Hilderbrand K, Bosland M, Osler M, Boulle A, Davies MA. How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 90-90-90 target in the population on antiretroviral treatment in Khayelitsha, South Africa?. S Afr Med J 109(3):174-177, 2019. e-Pub 2019. PMID: 30834874.
306. Yotebieng M, Brazier E, Addison D, Kimmel AD, Cornell M, Keiser O, Parcesepe AM, Onovo A, Lancaster KE, Castelnuovo B, Murnane PM, Cohen CR, Vreeman RC, Davies MA, Duda SN, Yiannoutsos CT, Bono RS, Agler R, Bernard C, Syvertsen JL, Sinayobye JD, Wikramanayake R, Sohn AH, von Groote PM, Wandeler G, Leroy V, Williams CF, Wools-Kaloustian K, Nash D. Research priorities to inform "Treat All" policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA). J Int AIDS Soc 22(1):e25218, 2019. e-Pub 2019. PMID: 30657644.
307. Chihana ML, Huerga H, Van Cutsem G, Ellman T, Goemaere E, Wanjala S, Masiku C, Szumilin E, Etard JF, Maman D, Davies MA. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi). Glob Health Action 12(1):1679472, 2019. e-Pub 2019. PMID: 31679482.
308. Anderson K, Muloiwa R, Davies MA. Treatment outcomes in perinatally infected HIV-positive adolescents and young adults after >/=10 years on antiretroviral therapy. S Afr Med J 109(1):27-34, 2018. e-Pub 2018. PMID: 30606301.
309. Kariminia A, Law M, Davies MA, Vinikoor M, Wools-Kaloustian K, Leroy V, Edmonds A, McGowan C, Vreeman R, Fairlie L, Ayaya S, Yotebieng M, Takassi E, Pinto J, Adedimeji A, Malateste K, Machado DM, Penazzato M, Hazra R, Sohn AH. Mortality and losses to follow-up among adolescents living with HIV in the IeDEA global cohort collaboration. J Int AIDS Soc 21(12):e25215, 2018. e-Pub 2018. PMID: 30548817.
310. Teh JLF, Cheng PF, Purwin TJ, Nikbakht N, Patel P, Chervoneva I, Ertel A, Fortina PM, Kleiber I, HooKim K, Davies MA, Kwong LN, Levesque MP, Dummer R, Aplin AE. Correction: In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms. Cancer Discov 8(12):1654, 2018. e-Pub 2018. PMID: 30510016.
311. Ferguson SD, Zheng S, Xiu J, Zhou S, Khasraw M, Brastianos PK, Kesari S, Hu J, Rudnick J, Salacz ME, Piccioni D, Huang S, Davies MA, Glitza IC, Heymach JV, Zhang J, Ibrahim NK, DeGroot JF, McCarty J, O'Brien BJ, Sawaya R, Verhaak RGW, Reddy SK, Priebe W, Gatalica Z, Spetzler D, Heimberger AB. Profiles of Brain Metastases: Prioritization of Therapeutic Targets. Int J Cancer 143(11):3019-3026, 2018. e-Pub 2018. PMID: 29923182.
312. Kalk E, Kroon M, Boulle A, Osler M, Euvrard J, Stinson K, Timmerman V, Davies MA. Neonatal and infant diagnostic HIV-PCR uptake and associations during three sequential policy periods in Cape Town, South Africa: a longitudinal analysis. J Int AIDS Soc 21(11):e25212, 2018. e-Pub 2018. PMID: 30480373.
313. Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JA. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med 24(11):1649-1654, 2018. e-Pub 2018. PMID: 30297909.
314. Kugel CH, Douglass SM, Webster MR, Kaur A, Liu Q, Yin X, Weiss SA, Darvishian F, Al-Rohil RN, Ndoye A, Behera R, Alicea GM, Ecker BL, Fane M, Allegrezza MJ, Svoronos N, Kumar V, Wang DY, Somasundaram R, Hu-Lieskovan S, Ozgun A, Herlyn M, Conejo-Garcia JR, Gabrilovich D, Stone EL, Nowicki TS, Sosman J, Rai R, Carlino MS, Long GV, Marais R, Ribas A, Eroglu Z, Davies MA, Schilling B, Schadendorf D, Xu W, Amaravadi RK, Menzies AM, McQuade JL, Johnson DB, Osman I, Weeraratna AT. Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations. Clin Cancer Res 24(21):5347-5356, 2018. e-Pub 2018. PMID: 29898988.
315. Childress MA, Himmelberg SM, Chen H, Deng W, Davies MA, Lovly CM. ALK Fusion Partners Impact Response to ALK Inhibition: Differential Effects on Sensitivity Cellular phenotypes, and Biochemical Properties. Mol Cancer Res 16(11):1724-1736, 2018. e-Pub 2018. PMID: 30002191.
316. Panayidou K, Davies MA, Anderegg N, Egger M. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation. J Int AIDS Soc 21(11):e25200, 2018. e-Pub 2018. PMID: 30614622.
317. Capparelli C, Purwin TJ, Heilman SA, Chervoneva I, McCue PA, Berger AC, Davies MA, Gershenwald JE, Krepler C, Aplin AE. ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma. Cancer Res 78(19):5680-5693, 2018. e-Pub 2018. PMID: 30115691.
318. Johnson DH, Zobniw CM, Trinh VA, Ma J, Bassett RL, Abdel-Wahab N, Anderson J, Davis JE, Joseph J, Uemura M, Noman A, Abu-Sbeih H, Yee C, Amaria R, Patel S, Tawbi H, Glitza IC, Davies MA, Wong MK, Woodman S, Hwu WJ, Hwu P, Wang Y, Diab A. Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis. J Immunother Cancer 6(1):103, 2018. e-Pub 2018. PMID: 30305177.
319. Barken R, Denton M, Sayin FK PhD candidate, Brookman C, Davies S MA, Zeytinoglu IU. The influence of autonomy on personal support workers' job satisfaction, capacity to care, and intention to stay. Home Health Care Serv Q 37(4):294-312, 2018. e-Pub 2018. PMID: 30321126.
320. Msukwa MT, Estill J, Haas AD, van Oosterhout JJ, Tenthani L, Davies MA, Tal K, Phiri N, Spoerri A, Mthiko BC, Chimbwandira F, Keiser O. Weight gain of HIV-exposed, uninfected children born before and after introduction of the 'Option B+' programme in Malawi. AIDS 32(15):2201-2208, 2018. e-Pub 2018. PMID: 30005013.
321. Woyton MM, Kluzek S, Wedatilake T, Davies MAM. Partial mid-portion Achilles tear resulting in substantial improvement in pain and function in an amateur long-distance runner. BMJ Case Rep 2018, 2018. e-Pub 2018. PMID: 30232204.
322. Brennan AT, Bor J, Davies MA, Wandeler G, Prozesky H, Fatti G, Wood R, Stinson K, Tanser F, Barnighausen T, Boulle A, Sikazwe I, Zanolini A, Fox MP. Medication Side Effects and Retention in HIV Treatment: A Regression Discontinuity Study of Tenofovir Implementation in South Africa and Zambia. Am J Epidemiol 187(9):1990-2001, 2018. e-Pub 2018. PMID: 29767681.
323. McQuade JL, Davies MA. Estrogen returns to the stage in melanoma. Pigment Cell Melanoma Res 31(5):554-555, 2018. e-Pub 2018. PMID: 29665231.
324. Bezrookove V, Nosrati M, Miller JR, De Semir D, Dar AA, Vosoughi E, Vaquero E, Sucker A, Lazar AJ, Gershenwald JE, Davies MA, Schadendorf D, Kashani-Sabet M. Role of Elevated PHIP Copy Number as a Prognostic and Progression Marker for Cutaneous Melanoma. Clin Cancer Res 24(17):4119-4125, 2018. e-Pub 2018. PMID: 29776954.
325. Forget MA, Haymaker C, Hess KR, Meng YJ, Creasy C, Karpinets T, Fulbright OJ, Roszik J, Woodman SE, Kim YU, Sakellariou-Thompson D, Bhatta A, Wahl A, Flores E, Thorsen ST, Tavera RJ, Ramachandran R, Gonzalez AM, Toth CL, Wardell S, Mansaray R, Patel V, Carpio DJ, Vaughn C, Farinas CM, Velasquez PG, Hwu WJ, Patel SP, Davies MA, Diab A, Glitza IC, Tawbi H, Wong MK, Cain S, Ross MI, Lee JE, Gershenwald JE, Lucci A, Royal R, Cormier JN, Wargo JA, Radvanyi LG, Torres-Cabala CA, Beroukhim R, Hwu P, Amaria RN, Bernatchez C. Prospective analysis of adoptive TIL therapy in patients with metastatic melanoma: response, impact of anti-CTLA4, and biomarkers to predict clinical outcome. Clin Cancer Res 24(18):4416-4428, 2018. e-Pub 2018. PMID: 29848573.
326. Vishnoi M, Boral D, Liu H, Sprouse ML, Yin W, Goswami-Sewell D, Tetzlaff MT, Davies MA, Oliva ICG, Marchetti D. Targeting USP7 identifies a metastasis-competent state within bone marrow-resident melanoma CTCs. Cancer Res 78(18):5349-5362, 2018. e-Pub 2018. PMID: 30026332.
327. Farley E, Stewart A, Davies MA, Govind M, Van den Bergh D, Boyles TH. Antibiotic use and resistance: Knowledge, attitudes and perceptions among primary care prescribers in South Africa. S Afr Med J 108(9):763-771, 2018. e-Pub 2018. PMID: 30182902.
328. Sohn AH, Judd A, Mofenson L, Vicari M, Jerene D, Leroy V, Bekker LG, Davies MA. Using Observational Data to Inform HIV Policy Change for Children and Youth. J Acquir Immune Defic Syndr 78 Suppl 1(1):S22-S26, 2018. e-Pub 2018. PMID: 29994916.
329. Tetzlaff MT, Messina JL, Stein JE, Xu X, Amaria RN, Blank CU, van de Wiel BA, Ferguson PM, Rawson RV, Ross MI, Spillane AJ, Gershenwald JE, Saw RPM, van Akkooi ACJ, van Houdt WJ, Mitchell TC, Menzies AM, Long GV, Wargo JA, Davies MA, Prieto VG, Taube JM, Scolyer RA. Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma. Ann Oncol 29(8):1861-1868, 2018. e-Pub 2018. PMID: 29945191.
330. Steinhaus N, Al-Talib M, Ive P, Boyles T, Bamford C, Davies MA, Mendelson M, Wasserman S. The management and outcomes of Staphylococcus aureus bacteraemia at a South African referral hospital: A prospective observational study. Int J Infect Dis 73:78-84, 2018. e-Pub 2018. PMID: 29908251.
331. Huang L, Malu S, McKenzie JA, Andrews MC, Talukder AH, Tieu T, Karpinets T, Haymaker C, Forget MA, Williams LJ, Wang Z, Mbofung RM, Wang ZQ, Davis RE, Lo RS, Wargo JA, Davies MA, Bernatchez C, Heffernan T, Amaria RN, Korkut A, Peng W, Roszik J, Lizée G, Woodman SE, Hwu P. The RNA-binding protein MEX3B mediates resistance to cancer immunotherapy by downregulating HLA-A expression. Clin Cancer Res 24(14):3366-3376, 2018. e-Pub 2018. PMID: 29496759.
332. Ballester LY, Glitza Oliva IC, Douse DY, Chen MM, Lan C, Haydu LE, Huse JT, Roy-Chowdhuri S, Luthra R, Wistuba II, Davies MA. Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease. J Neuropathol Exp Neurol 77(7):628-635, 2018. e-Pub 2018. PMID: 29873738.
333. Arrive E, Ayaya S, Davies MA, Chimbetete C, Edmonds A, Lelo P, Fong SM, Razali KA, Kouakou K, Duda SN, Leroy V, Vreeman RC. Models of support for disclosure of HIV status to HIV-infected children and adolescents in resource-limited settings. J Int AIDS Soc 21(7):e25157, 2018. e-Pub 2018. PMID: 29972632.
334. Ascierto PA, Puzanov I, Agarwala SS, Bifulco C, Botti G, Caracò C, Ciliberto G, Davies MA, Dummer R, Ferrone S, Gajewski TF, Garbe C, Luke JJ, Marincola FM, Masucci G, Mehnert JM, Mozzillo N, Palmieri G, Postow MA, Schoenberger SP, Wang E, Thurin M. Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy). J Transl Med 16(1):207, 2018. e-Pub 2018. PMID: 30031393.
335. Wools-Kaloustian K, Marete I, Ayaya S, Sohn AH, Van Nguyen L, Li S, Leroy V, Musick BS, Newman JE, Edmonds A, Davies MA, Eboua FT, Obama MT, Yotebieng M, Sawry S, Mofenson LM, Yiannoutsos CT. Time to First-Line ART Failure and Time to Second-Line ART Switch in the IeDEA Pediatric Cohort. J Acquir Immune Defic Syndr 78(2):221-230, 2018. e-Pub 2018. PMID: 29509590.
336. Jones ME, Davies MAM, Leyland KM, Delmestri A, Porter A, Ratcliffe J, Peirce N, Newton JL, Arden NK. Osteoarthritis and other long-term health conditions in former elite cricketers. J Sci Med Sport 21(6):558-563, 2018. e-Pub 2018. PMID: 29089246.
337. Cascone T, McKenzie JA, Mbofung RM, Punt S, Wang Z, Xu C, Williams LJ, Wang Z, Bristow CA, Carugo A, Peoples MD, Li L, Karpinets T, Huang L, Malu S, Creasy C, Leahey SE, Chen J, Chen Y, Pelicano H, Bernatchez C, Gopal YNV, Heffernan TP, Hu J, Wang J, Amaria RN, Garraway LA, Huang P, Yang P, Wistuba II, Woodman SE, Roszik J, Davis RE, Davies MA, Heymach JV, Hwu P, Peng W. Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy. Cell Metab 27(5):977-987.e4, 2018. e-Pub 2018. PMID: 29628419.
338. Romano G, Chen PL, Song P, McQuade JL, Liang RJ, Liu M, Roh W, Duose DY, Carapeto FCL, Li J, Teh JLF, Aplin AE, Chen M, Zhang J, Lazar AJ, Davies MA, Futreal PA, Amaria RN, Zhang DY, Wargo JA, Kwong LN. A pre-existing rare PIK3CAE545K subpopulation confers clinical resistance to MEK plus CDK4/6 inhibition in NRAS melanoma and is dependent on S6K1 signaling. Cancer Discov 8(5):556-567, 2018. e-Pub 2018. PMID: 29496665.
339. Teh JLF, Cheng PF, Purwin TJ, Nikbakht N, Patel P, Chervoneva I, Ertel A, Fortina PM, Kleiber I, HooKim K, Davies MA, Kwong LN, Levesque MP, Dummer R, Aplin AE. In vivo E2F reporting reveals efficacious schedules of MEK1/2-CDK4/6 targeting and mTOR-S6 resistance mechanisms. Cancer Discov 8(5):568-581, 2018. e-Pub 2018. PMID: 29496664.
340. Desmonde S, Tanser F, Vreeman R, Takassi E, Edmonds A, Lumbiganon P, Pinto J, Malateste K, McGowan C, Kariminia A, Yotebieng M, Dicko F, Yiannoutsos C, Mubiana-Mbewe M, Wools-Kaloustian K, Davies MA, Leroy V. Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study. PLoS Med 15(5):e1002565, 2018. e-Pub 2018. PMID: 29727458.
341. McQuade JL, Daniel CR, Davies MA. Body-mass index and metastatic melanoma outcomes - Authors' reply. Lancet Oncol 19(5):e227-e228, 2018. e-Pub 2018. PMID: 29726386.
342. Copelyn J, Apolles P, Davies MA, Eley B. Short-term outcomes of down-referral in provision of paediatric antiretroviral therapy at Red Cross War Memorial Children's Hospital, Cape Town, South Africa: A retrospective cohort study. S Afr Med J 108(5):432-438, 2018. e-Pub 2018. PMID: 29843859.
343. Rohr JK, Ive P, Horsburgh CR, Berhanu R, Hoffmann CJ, Wood R, Boulle A, Giddy J, Prozesky H, Vinikoor M, Mwanza MW, Wandeler G, Davies MA, Fox MP. Brief Report: Assessing the Association Between Changing NRTIs When Initiating Second-Line ART and Treatment Outcomes. J Acquir Immune Defic Syndr 77(4):413-416, 2018. e-Pub 2018. PMID: 29206723.
344. Slogrove AL, Schomaker M, Davies MA, Williams P, Balkan S, Ben-Farhat J, Calles N, Chokephaibulkit K, Duff C, Eboua TF, Kekitiinwa-Rukyalekere A, Maxwell N, Pinto J, Seage G 3rd, Teasdale CA, Wanless S, Warszawski J, Wools-Kaloustian K, Yotebieng M, Timmerman V, Collins IJ, Goodall R, Smith C, Patel K, Paul M, Gibb D, Vreeman R, Abrams EJ, Hazra R, Van Dyke R, Bekker LG, Mofenson L, Vicari M, Essajee S, Penazzato M, Anabwani G, Q Mohapi E, N Kazembe P, Hlatshwayo M, Lumumba M, Goetghebuer T, Thorne C, Galli L, van Rossum A, Giaquinto C, Marczynska M, Marques L, Prata F, Ene L, Okhonskaia L, Rojo P, Fortuny C, Naver L, Rudin C, Le Coeur S, Volokha A, Rouzier V, Succi R, Sohn A, Kariminia A, Edmonds A, Lelo P, Ayaya S, Ongwen P, Jefferys LF, Phiri S, Mubiana-Mbewe M, Sawry S, Renner L, Sylla M, Abzug MJ, Levin M, Oleske J, Chernoff M, Traite S, Purswani M, Chadwick EG, Judd A, Leroy V. The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis. PLoS Med 15(3):e1002514, 2018. e-Pub 2018. PMID: 29494593.
345. Fang P, Boehling NS, Koay EJ, Bucheit AD, Jakob JA, Settle SH, Davies MA, Robinson JP, Sulman EP. Melanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy. J Neurooncol 137(1):67-75, 2018. e-Pub 2018. PMID: 29198052.
346. McQuade JL, Daniel CR, Hess KR, Mak C, Wang DY, Rai RR, Park JJ, Haydu LE, Spencer C, Wongchenko M, Lane S, Lee DY, Kaper M, McKean M, Beckermann KE, Rubinstein SM, Rooney I, Musib L, Budha N, Hsu J, Nowicki TS, Avila A, Haas T, Puligandla M, Lee S, Fang S, Wargo JA, Gershenwald JE, Lee JE, Hwu P, Chapman PB, Sosman JA, Schadendorf D, Grob JJ, Flaherty KT, Walker D, Yan Y, McKenna E, Legos JJ, Carlino MS, Ribas A, Kirkwood JM, Long GV, Johnson DB, Menzies AM, Davies MA. Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. Lancet Oncol 19(3):310-322, 2018. e-Pub 2018. PMID: 29449192.
347. Vera-Aguilera J, Bedikian AY, Bassett RL, Hwu WJ, Kim KB, Qin Y, Cain S, Washington EW, Davies MA, Patel SM, Homsi J, Papadopoulos NE, Hwu P, Patel SP. Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the Liver. Am J Clin Oncol. e-Pub 2018. PMID: 29509591.
348. Amaria RN, Prieto PA, Tetzlaff MT, Reuben A, Andrews MC, Ross MI, Glitza IC, Cormier J, Hwu WJ, Tawbi HA, Patel SP, Lee JE, Gershenwald JE, Spencer CN, Gopalakrishnan V, Bassett R, Simpson L, Mouton R, Hudgens CW, Zhao L, Zhu H, Cooper ZA, Wani K, Lazar A, Hwu P, Diab A, Wong MK, McQuade JL, Royal R, Lucci A, Burton EM, Reddy S, Sharma P, Allison J, Futreal PA, Woodman SE, Davies MA, Wargo JA. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. Lancet Oncol 19(2):181-193, 2018. e-Pub 2018.
349. Haas AD, Zaniewski E, Anderegg N, Ford N, Fox MP, Vinikoor M, Dabis F, Nash D, Sinayobye JD, Niyongabo T, Tanon A, Poda A, Adedimeji AA, Edmonds A, Davies MA, Egger M. Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes. J Int AIDS Soc 21(2), 2018. e-Pub 2018. PMID: 29479867.
350. Amaria RN, Prieto PA, Tetzlaff MT, Reuben A, Andrews MC, Ross MI, Glitza IC, Cormier J, Hwu WJ, Tawbi HA, Patel SP, Lee JE, Gershenwald JE, Spencer CN, Gopalakrishnan V, Bassett R, Simpson L, Mouton R, Hudgens CW, Zhao L, Zhu H, Cooper ZA, Wani K, Lazar A, Hwu P, Diab A, Wong MK, McQuade JL, Royal R, Lucci A, Burton EM, Reddy S, Sharma P, Allison J, Futreal PA, Woodman SE, Davies MA, Wargo JA. Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. Lancet Oncol 19(2):181-193, 2018. e-Pub 2018. PMID: 29361468.
351. Yam C, Xu X, Davies MA, Gimotty PA, Morrissette JJ, Tetzlaff MT, Wani K, Liu S, Deng W, Buckley M, Zhao J, Amaravadi RK, Haas N, Kudchadkar RR, Pavlick A, Sosman JA, Tawbi H, Walker L, Schuchter LM, Karakousis GC, Gangadhar TC. A multicenter phase I study evaluating dual PI3K and BRAF inhibition with PX-866 and vemurafenib in patients with advanced BRAF V600 mutant solid tumors. Clin Cancer Res, 2018. e-Pub 2018. PMID: 29051322.
352. Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Sloane RS, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Sanchez EMR, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science, 2018. e-Pub 2018. PMID: 29097493.
353. Glitza IC, Rohlfs M, Guha-Thakurta N, Bassett RL, Bernatchez C, Diab A, Woodman SE, Yee C, Amaria RN, Patel SP, Tawbi H, Wong M, Hwu WJ, Hwu P, Heimberger A, McCutcheon IE, Papadopoulos N, Davies MA. Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2. ESMO Open 3(1):e000283, 2018. e-Pub 2018. PMID: 29387478.
354. Hartsough EJ, Kugel CH, Vido MJ, Berger AC, Purwin TJ, Goldberg A, Davies MA, Schiewer MJ, Knudsen KE, Bollag G, Aplin AE. Response and resistance to paradox breaking BRAF inhibitor in melanomas in vivo and ex vivo. Mol Cancer Ther 17(1):84-95, 2018. e-Pub 2018. PMID: 29133617.
355. Bédard PL, Davies MA, Kopetz S, Juric D, Shapiro GI, Luke JJ, Spreafico A, Wu B, Castell C, Gomez C, Cartot-Cotton S, Mazuir F, Dubar M, Micallef S, Demers B, Flaherty KT. First-in-Human Trial of the PI3Kβ-Selective Inhibitor SAR260301 in Patients with Advanced Solid Tumors. Cancer 124(2):315-324, 2018. e-Pub 2018. PMID: 28976556.
356. Chihana ML, Huerga H, Van Cutsem G, Ellman T, Wanjala S, Masiku C, Szumilin E, Etard JF, Davies MA, Maman D. Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries. PLoS One 13(11):e0207656, 2018. e-Pub 2018. PMID: 30475865.
357. Kwong LN, De Macedo MP, Haydu L, Joon AY, Tetzlaff MT, Calderone TL, Wu CJ, Kwong MK, Roszik J, Hess KR, Davies MA, Lazar AJ, Gershenwald JE. Biological Validation of RNA Sequencing Data From Formalin-Fixed Paraffin-Embedded Primary Melanomas. JCO Precis Oncol 2018, 2018. e-Pub 2018. PMID: 31058252.
358. Hector J, Davies MA, Dekker-Boersema J, Aly MM, Abdalad CCA, Langa EBR, Ehmer J, Hobbins MA, Jefferys LF. Acceptability and performance of a directly assisted oral HIV self-testing intervention in adolescents in rural Mozambique. PLoS One 13(4):e0195391, 2018. e-Pub 2018. PMID: 29621308.
359. de Waal R, Cohen K, Boulle A, Fox MP, Maartens G, Igumbor EU, Davies MA. Routine data underestimates the incidence of first-line antiretroviral drug discontinuations due to adverse drug reactions: Observational study in two South African cohorts. PLoS One 13(9):e0203530, 2018. e-Pub 2018. PMID: 30183766.
360. Patten G, Bernheimer J, Fairlie L, Rabie H, Sawry S, Technau K, Eley B, Davies MA. Lamivudine monotherapy as a holding regimen for HIV-positive children. PLoS One 13(10):e0205455, 2018. e-Pub 2018. PMID: 30308013.
361. Gallo V, McElvenny D, Hobbs C, Davoren D, Morris H, Crutch S, Zetterberg H, Fox NC, Kemp S, Cross M, Arden NK, Davies MAM, Malaspina A, Pearce N. BRain health and healthy AgeINg in retired rugby union players, the BRAIN Study: study protocol for an observational study in the UK. BMJ Open 7(12):e017990, 2017. e-Pub 2017. PMID: 29282262.
362. Robinson JP, Rebecca VW, Kircher DA, Silvis MR, Smalley I, Gibney GT, Lastwika KJ, Chen G, Davies MA, Grossman D, Smalley KSM, Holmen SL, VanBrocklin MW. Resistance mechanisms to genetic suppression of mutant NRAS in melanoma. Melanoma Res 27(6):545-557, 2017. e-Pub 2017. PMID: 29076949.
363. Tetzlaff MT, Jazaeri AA, Torres-Cabala CA, Korivi BR, Landon GA, Nagarajan P, Choksi A, Chen L, Uemura M, Aung PP, Diab A, Sharma P, Davies MA, Amaria R, Prieto VG, Curry JL. Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy. Report of two patients. J Cutan Pathol 44(12):1080-1086, 2017. e-Pub 2017. PMID: 28901560.
364. Johnson LF, May MT, Dorrington RE, Cornell M, Boulle A, Egger M, Davies MA. Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study. PLoS Med 14(12):e1002468, 2017. e-Pub 2017. PMID: 29232366.
365. Jiamsakul A, Kariminia A, Althoff KN, Cesar C, Cortes CP, Davies MA, Do VC, Eley B, Gill J, Kumarasamy N, Machado DM, Moore R, Prozesky H, Zaniewski E, Law M. HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy-Results From the IeDEA Collaboration. J Acquir Immune Defic Syndr 76(3):319-329, 2017. e-Pub 2017. PMID: 28708808.
366. Garman B, Anastopoulos IN, Krepler C, Brafford P, Sproesser K, Jiang Y, Wubbenhorst B, Amaravadi R, Bennett J, Beqiri M, Elder D, Flaherty KT, Frederick DT, Gangadhar TC, Guarino M, Hoon D, Karakousis G, Liu Q, Mitra N, Petrelli NJ, Schuchter L, Shannan B, Shields CL, Wargo J, Wenz B, Wilson MA, Xiao M, Xu W, Xu X, Yin X, Zhang NR, Davies MA, Herlyn M, Nathanson KL. Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines. Cell Rep 21(7):1936-1952, 2017. e-Pub 2017. PMID: 29141224.
367. Fontanals-Cirera B, Hasson D, Vardabasso C, Di Micco R, Agrawal P, Chowdhury A, Gantz M, de Pablos-Aragoneses A, Morgenstern A, Wu P, Filipescu D, Valle-Garcia D, Darvishian F, Roe JS, Davies MA, Vakoc CR, Hernando E, Bernstein E. Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene. Mol Cell 68(4):731-744.e9, 2017. e-Pub 2017. PMID: 29149598.
368. Ndoye A, Budina-Kolomets A, Kugel CH, Webster MR, Kaur A, Behera R, Rebecca VW, Li L, Brafford PA, Liu Q, Gopal YNV, Davies MA, Mills GB, Xu X, Wu H, Herlyn M, Nicastri MC, Winkler JD, Soengas MS, Amaravadi RK, Murphy ME, Weeraratna AT. ATG5 mediates a positive feedback loop between Wnt signaling and autophagy in melanoma. Cancer Res 77(21):5873-5885, 2017. e-Pub 2017. PMID: 28887323.
369. Krepler C, Sproesser K, Brafford P, Beqiri M, Garman B, Xiao M, Shannan B, Watters A, Perego M, Zhang G, Vultur A, Yin X, Liu Q, Anastopoulos IN, Wubbenhorst B, Wilson MA, Xu W, Karakousis G, Feldman M, Xu X, Amaravadi R, Gangadhar TC, Elder DE, Haydu LE, Wargo JA, Davies MA, Lu Y, Mills GB, Frederick DT, Barzily-Rokni M, Flaherty KT, Hoon DS, Guarino M, Bennett JJ, Ryan RW, Petrelli NJ, Shields CL, Terai M, Sato T, Aplin AE, Roesch A, Darr D, Angus S, Kumar R, Halilovic E, Caponigro G, Jeay S, Wuerthner J, Walter A, Ocker M, Boxer MB, Schuchter L, Nathanson KL, Herlyn M. A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma. Cell Rep 21(7):1953-1967, 2017. e-Pub 2017. PMID: 29141225.
370. Hofer CB, Egger M, Davies MA, Frota ACC, de Oliveira RH, Abreu TF, Araujo LE, Witthlin BB, Carvalho AW, Cordeiro JR, Lima GP, Keiser O. The cascade of care to prevent mother-to-child transmission in Rio de Janeiro, Brazil, 1996-2013: improving but still some way to go. Trop Med Int Health 22(10):1266-1274, 2017. e-Pub 2017. PMID: 28707345.
371. An Y, Jiang W, Kim BYS, Qian JM, Tang C, Fang P, Logan J, D'Souza NM, Haydu LE, Wang XA, Hess KR, Kluger H, Glitza IC, Mahajan A, Welsh JW, Lin SH, Yu JB, Davies MA, Hwu P, Sulman EP, Brown PD, Chiang VLS, Li J. Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control. Radiother Oncol 125(1):80-88, 2017. e-Pub 2017. PMID: 28916225.
372. Davies MAM, D Judge A, Delmestri A, P T Kemp S, Stokes KA, Arden NK, Newton JL. Health amongst former rugby union players: A cross-sectional study of morbidity and health-related quality of life. Sci Rep 7(1):11786, 2017. e-Pub 2017. PMID: 28959048.
373. Cornell M, Johnson LF, Wood R, Tanser F, Fox MP, Prozesky H, Schomaker M, Egger M, Davies MA, Boulle A. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa. J Int AIDS Soc 20(1):21902, 2017. e-Pub 2017. PMID: 28953328.
374. Haas AD, van Oosterhout JJ, Tenthani L, Jahn A, Zwahlen M, Msukwa MT, Davies MA, Tal K, Phiri N, Spoerri A, Chimbwandira F, Egger M, Keiser O. HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programme. J Int AIDS Soc 20(1):21947, 2017. e-Pub 2017. PMID: 28884524.
375. Brown SA, Abbas S, Davies MA, Bunupuradah T, Sohn AH, Technau KG, Renner L, Leroy V, Edmonds A, Yotebieng M, McGowan CC, Duda SN, Mofenson L, Musick B, Wools-Kaloustian K. Brief Report: Pediatric Cancer Burden and Treatment Resources Within the Pediatric IeDEA Consortium. J Acquir Immune Defic Syndr 76(1):60-64, 2017. e-Pub 2017. PMID: 28520616.
376. Somasundaram R, Zhang G, Fukunaga-Kalabis M, Perego M, Krepler C, Xu X, Wagner C, Hristova D, Zhang J, Tian T, Wei Z, Liu Q, Garg K, Griss J, Hards R, Maurer M, Hafner C, Mayerhöfer M, Karanikas G, Jalili A, Bauer-Pohl V, Weihsengruber F, Rappersberger K, Koller J, Lang R, Hudgens C, Chen G, Tetzlaff M, Wu L, Frederick DT, Scolyer RA, Long GV, Damle M, Ellingsworth C, Grinman L, Choi H, Gavin BJ, Dunagin M, Raj A, Scholler N, Gross L, Beqiri M, Bennett K, Watson I, Schaider H, Davies MA, Wargo J, Czerniecki BJ, Schuchter L, Herlyn D, Flaherty K, Herlyn M, Wagner SN. Tumor-associated B-cells induce tumor heterogeneity and therapy resistance. Nat Commun 8(1):607, 2017. e-Pub 2017. PMID: 28928360.
377. Schadendorf D, Long GV, Stroiakovski D, Karaszewska B, Hauschild A, Levchenko E, Chiarion-Sileni V, Schachter J, Garbe C, Dutriaux C, Gogas H, Mandalà M, JBAG H, Lebbé C, Mackiewicz A, Rutkowski P, Grob JJ, Nathan P, Ribas A, Davies MA, Zhang Y, Kaper M, Mookerjee B, Legos JJ, Flaherty KT, Robert C. Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials. Eur J Cancer 82:45-55, 2017. e-Pub 2017. PMID: 28648698.
378. Fang S, Wang Y, Dang Y, Gagel A, Ross MI, Gershenwald JE, Cormier JN, Wargo J, Haydu LE, Davies MA, McQuade JL, Sui D, Bassett RL, Reveille JD, Wei Q, Amos CI, Lee JE. Association between body mass index, C-reactive protein levels, and melanoma patient outcomes. J Invest Dermatol 137(8):1792-1795, 2017. e-Pub 2017. PMID: 28442307.
379. Eskiocak B, McMillan EA, Mendiratta S, Kollipara RK, Zhang H, Humphries CG, Wang C, Garcia-Rodriguez J, Ding M, Zaman A, Rosales TI, Eskiocak U, Smith MP, Sudderth J, Komurov K, Deberardinis RJ, Wellbrock C, Davies MA, Wargo JA, Yu Y, De Brabander JK, Williams NS, Chin L, Rizos H, Long GV, Kittler R, White MA. Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma. Cancer Discov 7(8):832-851, 2017. e-Pub 2017. PMID: 28455392.
380. A R, Macedo M PD, McQuade J, Joon A, Ren Z, Calderone T, Conner B, Wani K, Cooper ZA, Tawbi H, Tetzlaff MT, Padera RF, Durand JB, AJ L, JA W, Davies MA. Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumab. Oncoimmunology 6(12):e1361097, 2017. e-Pub 2017.
381. Iida Y, Ciechanover A, Marzese DM, Hata K, Bustos M, Ono S, Wang J, Salomon MP, Tran K, Lam S, Hsu S, Nelson N, Kravtsova-Ivantsiv Y, Mills GB, Davies MA, Hoon DSB. Epigenetic Regulation of KPC1 Ubiquitin Ligase Effects the NF-κB Pathway in Melanoma. Clin Cancer Res 23(16):4831-4842, 2017. e-Pub 2017. PMID: 28389511.
382. Long GV, Flaherty KT, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, Garbe C, Jouary T, Hauschild A, Chiarion-Sileni V, Lebbe C, Mandalà M, Millward M, Arance A, Bondarenko I, JBAG H, Hansson J, Utikal J, Ferraresi V, Mohr P, Probachai V, Schadendorf D, Nathan P, Robert C, Ribas A, Davies MA, Lane SR, Legos JJ, Mookerjee B, Grob JJ. Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study. Ann Oncol 28(7):1631-1639, 2017. e-Pub 2017. PMID: 28475671.
383. Davies MA, Saiag P, Robert C, Grob JJ, Flaherty KT, Arance A, Chiarion-Sileni V, Thomas L, Lesimple T, Mortier L, Moschos SJ, Hogg D, Márquez-Rodas I, Del Vecchio M, Lebbé C, Meyer N, Zhang Y, Huang Y, Mookerjee B, Long GV. Dabrafenib plus trametinib in patients with BRAF(V600)-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial. Lancet Oncol 18(7):863-873, 2017. e-Pub 2017. PMID: 28592387.
384. Xu D, Owen JD, Papa JC, Reimers J, Suleski TJ, Troutman JR, Davies MA, Thompson KP, Rolland JP. Design, fabrication, and testing of convex reflective diffraction gratings. Opt Express 25(13):15252-15268, 2017. e-Pub 2017. PMID: 28788954.
385. Fenner L, Atkinson A, Boulle A, Fox MP, Prozesky H, Zurcher K, Ballif M, Furrer H, Zwahlen M, Davies MA, Egger M. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies. J Int AIDS Soc 20(1):21327, 2017. e-Pub 2017. PMID: 28691438.
386. Carlucci JG, Blevins Peratikos M, Kipp AM, Lindegren ML, Du QT, Renner L, Reubenson G, Ssali J, Yotebieng M, Mandalakas AM, Davies MA, Ballif M, Fenner L, Pettit AC. Tuberculosis Treatment Outcomes Among HIV/TB-Coinfected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network. J Acquir Immune Defic Syndr 75(2):156-163, 2017. e-Pub 2017. PMID: 28234689.
387. Dahourou DL, Gautier-Lafaye C, Teasdale CA, Renner L, Yotebieng M, Desmonde S, Ayaya S, Davies MA, Leroy V. Transition from paediatric to adult care of adolescents living with HIV in sub-Saharan Africa: challenges, youth-friendly models, and outcomes. J Int AIDS Soc 20(Suppl 3):21528, 2017. e-Pub 2017. PMID: 28530039.
388. Davies MA, Tsondai P, Tiffin N, Eley B, Rabie H, Euvrard J, Orrell C, Prozesky H, Wood R, Cogill D, Haas AD, Sohn AH, Boulle A. Where do HIV-infected adolescents go after transfer? - Tracking transition/transfer of HIV-infected adolescents using linkage of cohort data to a health information system platform. J Int AIDS Soc 20(Suppl 3):21668, 2017. e-Pub 2017. PMID: 28530037.
389. Slogrove AL, Mahy M, Armstrong A, Davies MA. Living and dying to be counted: What we know about the epidemiology of the global adolescent HIV epidemic. J Int AIDS Soc 20(Suppl 3):21520, 2017. e-Pub 2017. PMID: 28530036.
390. Vinikoor MJ, Sinkala E, Chilengi R, Mulenga LB, Chi BH, Zyambo Z, Hoffmann CJ, Saag MS, Davies MA, Egger M, Wandeler G. Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia. Clin Infect Dis 64(10):1343-1349, 2017. e-Pub 2017. PMID: 28158504.
391. De Waal R, Cohen K, Fox MP, Stinson K, Maartens G, Boulle A, Igumbor EU, Davies MA. Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: a retrospective cohort study. J Int AIDS Soc 20(1):21317, 2017. e-Pub 2017. PMID: 28406595.
392. Schomaker M, Leroy V, Wolfs T, Technau KG, Renner L, Judd A, Sawry S, Amorissani-Folquet M, Noguera-Julian A, Tanser F, Eboua F, Navarro ML, Chimbetete C, Amani-Bosse C, Warszawski J, Phiri S, N'Gbeche S, Cox V, Koueta F, Giddy J, Sygnate-Sy H, Raben D, Chene G, Davies MA. Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe. Int J Epidemiol 46(2):453-465, 2017. e-Pub 2017. PMID: 27342220.
393. Nagarajan P, Curry JL, Ning J, Piao J, Torres-Cabala CA, Aung PP, Ivan D, Ross MI, Levenback CF, Frumovitz M, Gershenwald JE, Davies MA, Malpica A, Prieto VG, Tetzlaff MT. Tumor thickness and mitotic rate robustly predict melanoma-specific survival in patients with primary vulvar melanoma: A retrospective review of 100 cases. Clin Cancer Res 23(8):2093-2104, 2017. e-Pub 2017. PMID: 27864417.
394. Reuben A, Spencer CN, Prieto PA, Gopalakrishnan V, Reddy SM, Miller JP, Mao X, De Macedo MP, Chen J, Song X, Jiang H, Chen PL, Beird HC, Garber HR, Roh W, Wani K, Chen E, Haymaker C, Forget MA, Little LD, Gumbs C, Thornton RL, Hudgens CW, Chen WS, Austin-Breneman J, Sloane RS, Nezi L, Cogdill AP, Bernatchez C, Roszik J, Hwu P, Woodman SE, Chin L, Tawbi H, Davies MA, Gershenwald JE, Amaria RN, Glitza IC, Diab A, Patel SP, Hu J, Lee JE, Grimm EA, Tetzlaff MT, Lazar AJ, Wistuba II, Clise-Dwyer K, Carter BW, Zhang J, Futreal PA, Sharma P, Allison JP, Cooper ZA, Wargo JA. Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma. NPJ Genom Med 2. e-Pub 2017. PMID: 28819565.
395. Fiziev P, Akdemir KC, Miller JP, Keung EZ, Samant NS, Sharma S, Natale CA, Terranova CJ, Maitituoheti M, Amin SB, Martinez-Ledesma E, Dhamdhere M, Axelrad JB, Shah A, Cheng CS, Mahadeshwar H, Seth S, Barton MC, Protopopov A, Tsai KY, Davies MA, Garcia BA, Amit I, Chin L, Ernst J, Rai K. Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression. Cell Rep 19(4):875-889, 2017. e-Pub 2017. PMID: 28445736.
396. Kim DW, Haydu LE, Joon AY, Bassett RL, Siroy AE, Tetzlaff MT, Routbort MJ, Amaria RN, Wargo JA, McQuade JL, Kemnade J, Hwu P, Woodman SE, Roszik J, Kim KB, Gershenwald JE, Lazar AJ, Davies MA. Clinicopathological features and clinical outcomes associated with TP53 and BRAF (Non-V600) mutations in cutaneous melanoma patients. Cancer 123(8):1372-1381, 2017. e-Pub 2017. PMID: 27911979.
397. Mahy M, Penazzato M, Ciaranello A, Mofenson L, Yianoutsos CT, Davies MA, Stover J. Improving estimates of children living with HIV from the Spectrum AIDS Impact Model. AIDS 31 Suppl 1(Suppl 1):S13-S22, 2017. e-Pub 2017. PMID: 28301337.
398. Cheng H, Chua V, Liao C, Purwin TJ, Terai M, Kageyama K, Davies MA, Sato T, Aplin AE. Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma. Mol Cancer Ther 16(3):516-528, 2017. e-Pub 2017. PMID: 28138035.
399. Roh W, Chen PL, Reuben A, Spencer CN, Prieto PA, Miller JP, Gopalakrishnan V, Wang F, Cooper ZA, Reddy SM, Gumbs C, Little L, Chang Q, Chen WS, Wani K, De Macedo MP, Chen E, Austin-Breneman JL, Jiang H, Roszik J, Tetzlaff MT, Davies MA, Gershenwald JE, Tawbi H, Lazar AJ, Hwu P, Hwu WJ, Diab A, Glitza IC, Patel SP, Woodman SE, Amaria RN, Prieto VG, Hu J, Sharma P, Allison JP, Chin L, Zhang J, Wargo JA, Futreal PA. Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance. Sci Transl Med 9(379), 2017. e-Pub 2017. PMID: 28251903.
400. Shiuan E, Beckermann KE, Ozgun A, Kelly C, McKean M, McQuade J, Thompson MA, Puzanov I, Greer JP, Rapisuwon S, Postow M, Davies MA, Eroglu Z, Johnson D. Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy. J Immunother Cancer 5:8, 2017. e-Pub 2017. PMID: 28239462.
401. Brennan AT, Bor J, Davies MA, Conradie F, Maskew M, Long L, Sanne I, Fox MP. Tenofovir stock shortages have limited impact on clinic- and patient-level HIV treatment outcomes in public sector clinics in South Africa. Trop Med Int Health 22(2):241-251, 2017. e-Pub 2017. PMID: 27862762.
402. Li J, Zhao W, Akbani R, Liu W, Ju Z, Ling S, Vellano CP, Roebuck P, Yu Q, Eterovic AK, Byers LA, Davies MA, Deng W, Gopal YN, Chen G, von Euw EM, Slamon D, Conklin D, Heymach JV, Gazdar AF, Minna JD, Myers JN, Lu Y, Mills GB, Liang H. Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays. Cancer Cell 31(2):225-239, 2017. e-Pub 2017. PMID: 28196595.
403. Menzies AM, Johnson DB, Ramanujam S, Atkinson VG, Wong ANM, Park JJ, McQuade JL, Shoushtari AN, Tsai KK, Eroglu Z, Klein O, Hassel JC, Sosman JA, Guminski A, Sullivan RJ, Ribas A, Carlino MS, Davies MA, Sandhu SK, Long GV. Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab. Ann Oncol 28(2):368-376, 2017. e-Pub 2017. PMID: 27687304.
404. Brennan AT, Davies MA, Bor J, Wandeler G, Stinson K, Wood R, Prozesky H, Tanser F, Fatti G, Boulle A, Sikazwe I, Wool-Kaloustian K, Yuannoutsos C, Leroy V, de Rekeneire N, Fox MP. Has the phasing out of stavudine in accordance with changes in WHO guidelines led to a decrease in single-drug substitutions in first-line antiretroviral therapy for HIV in sub-Saharan Africa?. AIDS 31(1):147-157, 2017. e-Pub 2017. PMID: 27776039.
405. Davies MA. An in vivo confocal Raman spectroscopic investigation of salicylic acid penetration: Variation with formulation parameters. J Cosmet Sci 68(1):55-58, 2017. e-Pub 2017. PMID: 29465383.
406. Vettus E, Draper D, Davies MA. Metastatic Melanoma Responding to Combination Chemotherapy and Immunotherapy After Progression on Ipilimumab and Nivolumab Immunotherapy. Annals of Clinical Case Reports. e-Pub 2017.
407. Reuben A, Petaccia de Macedo M, McQuade J, Joon A, Ren Z, Calderone T, Conner B, Wani K, Cooper ZA, Tawbi H, Tetzlaff MT, Padera RF, Durand JB, Lazar AJ, Wargo JA, Davies MA. Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumab. Oncoimmunology 6(12):e1361097, 2017. e-Pub 2017. PMID: 29209563.
408. Davies MAM, Balai E, Adams J, Carter JH, Judge A, Newton JL, Arden NK. The consultation of rugby players in co-developing a player health study: feasibility and consequences of sports participants as research partners. Res Involv Engagem 3:8, 2017. e-Pub 2017. PMID: 29062533.
409. Fortuin-de Smidt M, de Waal R, Cohen K, Technau KG, Stinson K, Maartens G, Boulle A, Igumbor EU, Davies MA. First-line antiretroviral drug discontinuations in children. PLoS One 12(2):e0169762, 2017. e-Pub 2017. PMID: 28192529.
410. McQuade JL, Posada LP, Lecagoonporn S, Cain S, Bassett RL, Patel SP, Hwu WJ, Hwu P, Davies MA, Bedikian AY, Amaria RN. A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma. Melanoma Res 26(6):604-608, 2016. e-Pub 2016. PMID: 27540836.
411. Long GV, Grob JJ, Nathan P, Ribas A, Robert C, Schadendorf D, Lane SR, Mak C, Legenne P, Flaherty KT, Davies MA. Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials. Lancet Oncol 17(12):1621-1754, 2016. e-Pub 2016. PMID: 27864013.
412. Douis H, Davies MA, Sian P. The role of diffusion-weighted MRI (DWI) in the differentiation of benign from malignant skeletal lesions of the pelvis. Eur J Radiol 85(12):2262-2268, 2016. e-Pub 2016. PMID: 27842675.
413. Rohner E, Schmidlin K, Zwahlen M, Chakraborty R, Clifford G, Obel N, Grabar S, Verbon A, Noguera-Julian A, Collins IJ, Rojo P, Brockmeyer N, Campbell M, Chene G, Prozesky H, Eley B, Stefan DC, Davidson A, Chimbetete C, Sawry S, Davies MA, Kariminia A, Vibol U, Sohn A, Egger M, Bohlius J. Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia. Clin Infect Dis 63(9):1245-1253, 2016. e-Pub 2016. PMID: 27578823.
414. Ascierto PA, Agarwala S, Botti G, Cesano A, Ciliberto G, Davies MA, Demaria S, Dummer R, Eggermont AM, Ferrone S, Fu YX, Gajewski TF, Garbe C, Huber V, Khleif S, Krauthammer M, Lo RS, Masucci G, Palmieri G, Postow M, Puzanov I, Silk A, Spranger S, Stroncek DF, Tarhini A, Taube JM, Testori A, Wang E, Wargo JA, Yee C, Zarour H, Zitvogel L, Fox BA, Mozzillo N, Marincola FM, Thurin M. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015. J Transl Med 14(1):313, 2016. e-Pub 2016. PMID: 27846884.
415. Tripp MK, Gershenwald JE, Davies MA, Garcia J, Gritz ER, Hawk ET, Peterson SK. Assessment of Compliance With Texas Legislation Banning Indoor UV Tanning by Minors. JAMA Dermatol. e-Pub 2016. PMID: 27829081.
416. Krepler C, Xiao M, Samanta M, Vultur A, Chen HY, Brafford P, Reyes-Uribe PI, Halloran M, Chen T, He X, Hristova D, Liu Q, Samatar AA, Davies MA, Nathanson KL, Fukunaga-Kalabis M, Herlyn M, Villanueva J. Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma. Oncotarget 7(44):71211-71222, 2016. e-Pub 2016. PMID: 27655717.
417. Vinikoor MJ, Mulenga L, Siyunda A, Musukuma K, Chilengi R, Moore CB, Chi BH, Davies MA, Egger M, Wandeler G. Association between hepatitis B co-infection and elevated liver stiffness among HIV-infected adults in Lusaka, Zambia. Trop Med Int Health 21(11):1435-1441, 2016. e-Pub 2016. PMID: 27499385.
418. Johnson LF, Keiser O, Fox MP, Tanser F, Cornell M, Hoffmann CJ, Prozesky H, Boulle A, Davies MA. Life expectancy trends in adults on antiretroviral treatment in South Africa. AIDS 30(16):2545-2550, 2016. e-Pub 2016. PMID: 27428744.
419. Roszik J, Haydu LE, Hess KR, Oba J, Joon AY, Siroy AE, Karpinets TV, Stingo FC, Baladandayuthapani V, Tetzlaff MT, Wargo JA, Chen K, Forget MA, Haymaker CL, Chen JQ, Meric-Bernstam F, Eterovic AK, Shaw KR, Mills GB, Gershenwald JE, Radvanyi LG, Hwu P, Futreal PA, Gibbons DL, Lazar AJ, Bernatchez C, Davies MA, Woodman SE. Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set. BMC Med 14(1):168, 2016. e-Pub 2016. PMID: 27776519.
420. Rachlis B, Karwa R, Chema C, Pastakia S, Olsson S, Wools-Kaloustian K, Jakait B, Maina M, Yotebieng M, Kumarasamy N, Freeman A, de Rekeneire N, Duda SN, Davies MA, Braitstein P. Targeted Spontaneous Reporting: Assessing Opportunities to Conduct Routine Pharmacovigilance for Antiretroviral Treatment on an International Scale. Drug Saf 39(10):959-76, 2016. e-Pub 2016. PMID: 27282427.
421. Teh JL, Purwin TJ, Greenawalt EJ, Chervoneva I, Goldberg A, Davies MA, Aplin AE. An in vivo reporter to quantitatively and temporally analyze the effects of CDK4/6 inhibitor-based therapies in melanoma. Cancer Res 76(18):5455-66, 2016. e-Pub 2016. PMID: 27488531.
422. Davies MA, Gibb D, Turkova A. Survival of HIV-1 vertically infected children. Curr Opin HIV AIDS 11(5):455-464, 2016. e-Pub 2016. PMID: 27716730.
423. Tetzlaff MT, Singh RR, Seviour EG, Curry JL, Hudgens CW, Bell D, Wimmer DA, Ning J, Czerniak BA, Zhang L, Davies MA, Prieto VG, Broaddus RR, Ram P, Luthra R, Esmaeli B. Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma. J Pathol 240(1):84-95, 2016. e-Pub 2016. PMID: 27287813.
424. Chen G, McQuade JL, Panka DJ, Hudgens CW, Amin-Mansour A, Mu XJ, Bahl S, Jané-Valbuena J, Wani KM, Reuben A, Creasy CA, Jiang H, Cooper ZA, Roszik J, Bassett RL, Joon AY, Simpson LM, Mouton RD, Glitza IC, Patel SP, Hwu WJ, Amaria RN, Diab A, Hwu P, Lazar AJ, Wargo JA, Garraway LA, Tetzlaff MT, Sullivan RJ, Kim KB, Davies MA. Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial. JAMA Oncol 2(8):1056-64, 2016. e-Pub 2016. PMID: 27124486.
425. Chen PL, Roh W, Reuben A, Cooper ZA, Spencer CN, Prieto PA, Miller JP, Bassett RL, Gopalakrishnan V, Wani K, De Macedo MP, Austin-Breneman JL, Jiang H, Chang Q, Reddy SM, Chen WS, Tetzlaff MT, Broaddus RJ, Davies MA, Gershenwald JE, Haydu L, Lazar AJ, Patel SP, Hwu P, Hwu WJ, Diab A, Glitza IC, Woodman SE, Vence LM, Wistuba II, Amaria RN, Kwong LN, Prieto V, Davis RE, Ma W, Overwijk WW, Sharpe AH, Hu J, Futreal PA, Blando J, Sharma P, Allison JP, Chin L, Wargo JA. Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade. Cancer Discov 6(8):827-37, 2016. e-Pub 2016. PMID: 27301722.
426. Nanda VGY, Peng W, Hwu P, Davies MA, Ciliberto G, Fattore L, Malpicci D, Aurisicchio L, Ascierto PA, Croce CM, Mancini R, Spranger S, Gajewski TF, Wang Y, Ferrone S, Vanpouille-Box C, Wennerberg E, Pilones KA, Formenti SC, Demaria S, Tang H, Wang Y, Fu YX, Dummer R, Puzanov I, Tarhini A, Chauvin JM, Pagliano O, Fourcade J, Sun Z, Wang H, Sanders C, Kirkwood JM, Chen THT, Maurer M, Korman AJ, Zarour HM, Stroncek DF, Huber V, Rivoltini L, Thurin M, Rau T, Lugli A, Pages F, Camarero J, Sancho A, Jommi C, de Coana YP, Wolodarski M, Yoshimoto Y, Gentilcore G, Poschke I, Masucci GV, Hansson J, Kiessling R, Scognamiglio G, Sabbatino F, Marino FZ, Anniciello AM, Cantile M, Cerrone M, Scala S, D'alterio C, Ianaro A, Cirin G, Liguori G, Bott G, Chapman PB, Robert C, Larkin J, Haanen JB, Ribas A, Hogg D, Hamid O, Testori A, Lorigan P, Sosman JA, Flaherty KT, Yue H, Coleman S, Caro I, Hauschild A, McArthur GA, Sznol M, Callahan MK, Kluger H, Postow MA, Gordan R, Segal NH, Rizvi NA, Lesokhin A, Atkins MB, Burke MM, Ralabate A, Rivera A, Kronenberg SA, Agunwamba B, Ruisi M, Horak C, Jiang J, Wolchok J, Ascierto PA, Liszkay G, Maio M, Mandala M, Demidov L, Stoyakovskiy D, Thomas L, de la Cruz-Merino L, Atkinson V, Dutriaux C, Garbe C, Wongchenko M, Chang I, Koralek DO, Rooney I, Yan Y, Dreno B, Sullivan R, Patel M, Hodi S, Amaria R, Boasberg P, Wallin J, He X, Cha E, Richie N, Ballinger M, Smith DC, Bauer TM, Wasser JS, Luke JJ, Balmanoukian AS, Kaufman DR, Zhao Y, Maleski J, Leopold L, Gangadhar TC, Long GV, Michielin O, VanderWalde A, Andtbacka RHI, Cebon J, Fernandez E, Malvehy J, Olszanski AJ, Gause C, Chen L, Chou J, Stephen Hodi F, Brady B, Mortier L, Hassel JC, Rutkowski P, McNeil C, Kalinka-Warzocha E, Lebbe C, Ny L, Chacon M, Queirolo P, Loquai C, Cheema P, Berrocal A, Eizmendi KM, Bar-Sela G, Horak C, Hardy H, Weber JS, Grob JJ, Marquez-Rodas I, Schmidt H, Briscoe K, Baurain JF, Wolchok JD, Pinto R, De Summa S, Garrisi VM, Strippoli S, Azzariti A, Guida G, Guida M, Tommasi S, Jacquelot N, Enot D, Flament C, Pitt JM, Vimond N, Blattner C, Yamazaki T, Roberti MP, Vetizou M, Daillere R, Poirier-Colame V, la Semeraro M, Caignard A, Slingluff CL Jr, Sallusto F, Rusakiewicz S, Weide B, Marabelle A, Kohrt H, Dalle S, Cavalcanti A, Kroemer G, Di Giacomo AM, Maio M, Wong P, Yuan J, Umansky V, Eggermont A, Zitvogel L, Anna P, Marco T, Stefania S, Francesco M, Mariaelena C, Gabriele M, Antonio AP, Franco S, Roberti MP, Enot DP, Semeraro M, Jegou S, Flores C, Chen THT, Kwon BS, Anderson AC, Borg C, Aubin F, Ayyoub M, De Presbiteris AL, Cordaro FG, Camerlingo R, Fratangelo F, Mozzillo N, Pirozzi G, Patriarca EJ, Caputo E, Motti ML, Falcon R, Miceli R, Capone M, Madonna G, Mallardo D, Carrier MV, Panza E, De Cicco P, Armogida C, Ercolano G, Botti G, Cirino G, Sandru A, Blank M, Balatoni T, Olasz J, Farkas E, Szollar A, Savolt A, Godeny M, Csuka O, Horvath S, Eles K, Shoenfeld Y, Kasler M, Costantini S, Capone F, Moradi F, Berglund P, Leandersson K, Linnskog R, Andersson T, Prasad CP, Nigro CL, Lattanzio L, Wang H, Proby C, Syed N, Occelli M, Cauchi C, Merlano M, Harwood C, Thompson A, Crook T, Bifulco K, Ingangi V, Minopoli M, Ragone C, Pessi A, Mannavola F, D'Oronzo S, Felici C, Tucci M, Doronzo A, Silvestris F, Ferretta A, Guida S, Maida I, Cocco T, Passarelli A, Quaresmini D, Franzese O, Palermo B, Di Donna C, Sperduti I, Foddai M, Stabile H, Gismondi A, Santoni A, Nistico P, Sponghini AP, Platini F, Marra E, Rondonotti D, Alabiso O, Fierro MT, Savoia P, Stratica F, Quaglino P, Di Monta G, Corrado C, Di Marzo M, Ugo M, Di Cecilia ML, Nicola M, Fusciello C, Marra A, Guarrasi R, Baldi C, Russo R, Di Giulio G, Faiola V, Zeppa P, Pepe S, Gambale E, Carella C, Di Paolo A, De Tursi M, Marra L, De Murtas F, Sorrentino V, Voinea S, Panaitescu E, Bolovan M, Stanciu A, Cinca S, Botti C, Aquino G, Anniciello A, Fortes C, Mastroeni S, Caggiati A, Passarelli F, Zappala A, Capuano M, Bono R, Nudo M, Marino C, Michelozzi P, De Biasio V, Battarra VC, Formenti S, Ascierto ML, McMiller TL, Berger AE, Danilova L, Anders RA, Netto GJ, Xu H, Pritchard TS, Fan J, Cheadle C, Cope L, Drake CG, Pardoll DM, Taube JM, Topalian SL, Gnjatic S, Nataraj S, Imai N, Rahman A, Jungbluth AA, Pan L, Venhaus R, Park A, Lehmann FF, Lendvai N, Cohen AD, Cho HJ, Daniel S, Hirsh V. Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015. J Transl Med 14(1):65, 2016. e-Pub 2016. PMID: 27461275.
427. Merlino G, Herlyn M, Fisher DE, Bastian BC, Flaherty KT, Davies MA, Wargo JA, Curiel-Lewandrowski C, Weber MJ, Leachman SA, Soengas MS, McMahon M, Harbour JW, Swetter SM, Aplin AE, Atkins MB, Bosenberg MW, Dummer R, Gershenwald JE, Halpern AC, Herlyn D, Karakousis GC, Kirkwood JM, Krauthammer M, Lo RS, Long GV, McArthur G, Ribas A, Schuchter L, Sosman JA, Smalley KS, Steeg P, Thomas NE, Tsao H, Tueting T, Weeraratna A, Xu G, Lomax R, Martin A, Silverstein S, Turnham T, Ronai ZA. The State of Melanoma: Challenges and Opportunities. Pigment Cell Melanoma Res 29(4):404-16, 2016. e-Pub 2016. PMID: 27087480.
428. Bohlius J, Maxwell N, Spoerri A, Wainwright R, Sawry S, Poole J, Eley B, Prozesky H, Rabie H, Garone D, Technau KG, Maskew M, Davies MA, Davidson A, Stefan DC, Egger M. Incidence of AIDS-defining and Other Cancers in HIV-positive Children in South Africa: Record Linkage Study. Pediatr Infect Dis J 35(6):e164-70, 2016. e-Pub 2016. PMID: 26906162.
429. Goedert L, Pereira CG, Roszik J, Plaça JR, Cardoso C, Chen G, Deng W, Yennu-Nanda VG, Silva WA, Davies MA, Espreafico EM. RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma. Oncotarget 7(24):36711-36718, 2016. e-Pub 2016. PMID: 27167340.
430. Ekmekcioglu S, Davies MA, Tanese K, Roszik J, Shin-Sim M, Bassett RL, Milton DR, Woodman SE, Prieto VG, Gershenwald JE, Morton DL, Hoon DS, Grimm EA. Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and its Expression Associates with Favorable Survival for Stage III Melanoma. Clin Cancer Res 22(12):3016-24, 2016. e-Pub 2016. PMID: 26783288.
431. Zhang G, Frederick DT, Wu L, Wei Z, Krepler C, Srinivasan S, Chae YC, Xu X, Choi H, Dimwamwa E, Ope O, Shannan B, Basu D, Zhang D, Guha M, Xiao M, Randell S, Sproesser K, Xu W, Liu J, Karakousis GC, Schuchter LM, Gangadhar TC, Amaravadi RK, Gu M, Xu C, Ghosh A, Xu W, Tian T, Zhang J, Zha S, Liu Q, Brafford P, Weeraratna A, Davies MA, Wargo JA, Avadhani NG, Lu Y, Mills GB, Altieri DC, Flaherty KT, Herlyn M. Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors. J Clin Invest 126(5):1834-56, 2016. e-Pub 2016. PMID: 27043285.
432. Meric-Bernstam F, Brusco L, Daniels M, Wathoo C, Bailey AM, Strong L, Shaw K, Lu K, Qi Y, Zhao H, Lara-Guerra H, Litton J, Arun B, Eterovic AK, Aytac U, Routbort M, Subbiah V, Janku F, Davies MA, Kopetz S, Mendelsohn J, Mills GB, Chen K. Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol. Ann Oncol 27(5):795-800, 2016. e-Pub 2016. PMID: 26787237.
433. Sholl LM, Andea A, Bridge JA, Cheng L, Davies MA, Ehteshami M, Gangadhar TC, Kamel-Reid S, Lazar A, Raparia K, Siroy A, Watson KL, Reporting Committee MOCB, American Pathologists CO. Template for Reporting Results of Biomarker Testing of Specimens From Patients With Melanoma. Arch Pathol Lab Med 140(4):355-7, 2016. e-Pub 2016. PMID: 26340412.
434. De Waal R, Cohen K, Fox MP, Stinson K, Maartens G, Boulle A, Davies MA. Clinician compliance with laboratory monitoring and prescribing guidelines in HIV-1-infected patients receiving tenofovir. S Afr Med J 106(4):52-3, 2016. e-Pub 2016. PMID: 27032851.
435. Cooper ZA, Reuben A, Spencer CN, Prieto PA, Austin-Breneman JL, Jiang H, Haymaker C, Gopalakrishnan V, Tetzlaff MT, Frederick DT, Sullivan RJ, Amaria RN, Patel SP, Hwu P, Woodman SE, Glitza IC, Diab A, Vence LM, Rodriguez-Canales J, Parra ER, Wistuba II, Coussens LM, Sharpe AH, Flaherty KT, Gershenwald JE, Chin L, Davies MA, Clise-Dwyer K, Allison JP, Sharma P, Wargo JA. Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma. Oncoimmunology 5(3):e1136044, 2016. e-Pub 2016. PMID: 27141370.
436. Tsai WB, Long Y, Park JR, Chang JT, Liu H, Rodriguez-Canales J, Savaraj N, Feun LG, Davies MA, Wistuba II, Kuo MT. Gas6/Axl is the sensor of arginine-auxotrophic response in targeted chemotherapy with arginine-depleting agents. Oncogene 35(13):1632-42, 2016. e-Pub 2016. PMID: 26096933.
437. Schomaker M, Davies MA, Malateste K, Renner L, Sawry S, N'Gbeche S, Technau KG, Eboua F, Tanser F, Sygnate-Sy H, Phiri S, Amorissani-Folquet M, Cox V, Koueta F, Chimbete C, Lawson-Evi A, Giddy J, Amani-Bosse C, Wood R, Egger M, Leroy V. Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis. Epidemiology 27(2):237-46, 2016. e-Pub 2016. PMID: 26479876.
438. Vu HL, Rosenbaum S, Capparelli C, Purwin TJ, Davies MA, Berger AC, Aplin AE. MIG6 Is MEK Regulated and Affects EGF-Induced Migration in Mutant NRAS Melanoma. J Invest Dermatol 136(2):453-63, 2016. e-Pub 2016. PMID: 26967478.
439. Peng W, Chen JQ, Liu C, Malu S, Creasy C, Tetzlaff MT, Xu C, McKenzie JA, Zhang C, Liang X, Williams LJ, Deng W, Chen G, Mbofung R, Lazar AJ, Torres-Cabala CA, Cooper ZA, Chen PL, Tieu TN, Spranger S, Yu X, Bernatchez C, Forget MA, Haymaker C, Amaria R, McQuade JL, Glitza IC, Cascone T, Li HS, Kwong LN, Heffernan TP, Hu J, Bassett RL Jr, Bosenberg MW, Woodman SE, Overwijk WW, Lizee G, Roszik J, Gajewski TF, Wargo JA, Gershenwald JE, Radvanyi L, Davies MA, Hwu P. Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy. Cancer Discov 6(2):202-16, 2016. e-Pub 2016. PMID: 26645196.
440. Peng W, Chen JQ, Liu C, Malu S, Creasy C, Tetzlaff MT, Xu C, McKenzie JA, Zhang C, Liang X, Williams LJ, Deng W, Chen G, Mbofung R, Lazar AJ, Torres-Cabala CA, Cooper ZA, Chen PL, Tieu TN, Spranger S, Yu X, Bernatchez C, Forget MA, Haymaker C, Amaria R, McQuade JL, Glitza IC, Cascone T, Li HS, Kwong LN, Heffernan TP, Hu J, Bassett RL, Bosenberg MW, Woodman SE, Overwijk WW, Lizée G, Roszik J, Gajewski TF, Wargo JA, Gershenwald JE, Radvanyi L, Davies MA, Hwu P. Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy. Cancer Discov 6(2):202-16, 2016. e-Pub 2016.
441. Zand B, Previs RA, Zacharias NM, Rupaimoole R, Mitamura T, Nagaraja AS, Guindani M, Dalton HJ, Yang L, Baddour J, Achreja A, Hu W, Pecot CV, Ivan C, Wu SY, McCullough CR, Gharpure KM, Shoshan E, Pradeep S, Mangala LS, Rodriguez-Aguayo C, Wang Y, Nick AM, Davies MA, Armaiz-Pena G, Liu J, Lutgendorf SK, Baggerly KA, Eli MB, Lopez-Berestein G, Nagrath D, Bhattacharya PK, Sood AK. Role of Increased n-acetylaspartate Levels in Cancer. J Natl Cancer Inst 108(6):djv426, 2016. e-Pub 2016. PMID: 26819345.
442. Roszik J, Wu CJ, Siroy AE, Lazar AJ, Davies MA, Woodman SE, Kwong LN. Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression. Sci Rep 6:19649, 2016. e-Pub 2016. PMID: 26787600.
443. Johnson LF, Chiu C, Myer L, Davies MA, Dorrington RE, Bekker LG, Boulle A, Meyer-Rath G. Prospects for HIV control in South Africa: a model-based analysis. Glob Health Action 9:30314, 2016. e-Pub 2016. PMID: 27282146.
444. Morden E, Technau KG, Giddy J, Maxwell N, Keiser O, Davies MA. Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration. PLoS One 11(4):e0151762, 2016. e-Pub 2016. PMID: 27049853.
445. Feng Y, Pinkerton AB, Hulea L, Zhang T, Davies MA, Grotegut S, Cheli Y, Yin H, Lau E, Kim H, De SK, Barile E, Pellecchia M, Bosenberg M, Li JL, James B, Hassig CA, Brown KM, Topisirovic I, Ronai ZA. SBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation Complex. Cancer Res 75(75):5211-5218, 2015. e-Pub 2015. PMID: 26603897.
446. Davies MA, Ford N, Rabie H, Fatti G, Stinson K, Giddy J, Tanser F, Technau KG, Sawry S, Eley B, Wood R, Mofenson LM, Keiser O, Boulle A. Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression. Pediatr Infect Dis J 34(12):1361-4, 2015. e-Pub 2015. PMID: 26379169.
447. Hong D, Kurzrock R, Wheler JJ, Naing A, Falchook GS, Fu S, Kim KB, Davies MA, Nguyen LM, George GC, Xu L, Shumaker R, Ren M, Mink J, Bedell C, Andresen C, Sachdev P, O'Brien JP, Nemunaitis J. Phase I dose-escalation study of the multikinase inhibitor lenvatinib in patients with advanced solid tumors and in an expanded cohort of patients with melanoma. Clin Cancer Res 21(21):4801-10, 2015. e-Pub 2015. PMID: 26169970.
448. Cho JH, Robinson JP, Arave RA, Burnett WJ, Kircher DA, Chen G, Davies MA, Grossmann AH, VanBrocklin MW, McMahon M, Holmen SL. AKT1 Activation Promotes Development of Melanoma Metastases. Cell Rep 13(5):898-905, 2015. e-Pub 2015. PMID: 26565903.
449. Ascierto PA, Atkins M, Bifulco C, Botti G, Cochran A, Davies MA, Demaria S, Dummer R, Ferrone S, Formenti S, Gajewski TF, Garbe C, Khleif S, Kiessling R, Lo R, Lorigan P, Arthur GM, Masucci G, Melero I, Mihm M, Palmieri G, Parmiani G, Puzanov I, Romero P, Schilling B, Seliger B, Stroncek D, Taube J, Tomei S, Zarour HM, Testori A, Wang E, Galon J, Ciliberto G, Mozzillo N, Marincola FM, Thurin M. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014. J Transl Med 13(1):374, 2015. e-Pub 2015. PMID: 26619946.
450. Glitza IC, Haymaker C, Bernatchez C, Vence LM, Rohlfs ML, Richard J, Lacey C, Mansaray R, Fulbright OJ, Ramachandran R, Toth C, Wardell S, Woodman SE, Patel S, Hwu WJ, Radvanyi L, Davies MA, Papadopoulos NE, Hwu P. Intrathecal administration of tumor-infiltrating lymphocytes is well tolerated in a patient with leptomeningeal disease from metastatic melanoma: A case report. Cancer Immunol Res 3(11):1201-6, 2015. e-Pub 2015. PMID: 26216417.
451. Davies MA, Terhorst L, Zhang P, Nakonechny AJ, Nowalk MP. Pilot Study of a Computer-Based Parental Questionnaire and Visual Profile of Obesity Risk in Healthy Preschoolers. J Pediatr Nurs 30(6):e45-52, 2015. e-Pub 2015. PMID: 25813269.
452. Davies MA. Salicylic acid deposition from wash-off products: comparison of in vivo and porcine deposition models. Int J Cosmet Sci 37(5):526-31, 2015. e-Pub 2015. PMID: 25899428.
453. Keiser O, Blaser N, Davies MA, Wessa P, Eley B, Moultrie H, Rabie H, Technau KG, Ndirangu J, Garone D, Giddy J, Grimwood A, Gsponer T, Egger M. Growth in Virologically Suppressed HIV-Positive Children on Antiretroviral Therapy: Individual and Population-level References. Pediatr Infect Dis J 34(10):e254-9, 2015. e-Pub 2015. PMID: 26192393.
454. Moreno FA, Erickson RP, Garriock HA, Gelernter J, Mintz J, Oas-Terpstra J, Davies MA, Delgado PL. Association Study of Genotype by Depressive Response during Tryptophan Depletion in Subjects Recovered from Major Depression. Mol Neuropsychiatry 1(3):165-174, 2015. e-Pub 2015. PMID: 26528486.
455. Capparelli C, Rosenbaum S, Berman-Booty LD, Salhi A, Gaborit N, Zhan T, Chervoneva I, Roszik J, Woodman SE, Davies MA, Setiady YY, Osman I, Yarden Y, Aplin AE. ErbB3/ErbB2 complexes as a therapeutic target in a subset of wild-type BRAF/NRAS cutaneous melanomas. Cancer Res 75(15):3554-67, 2015. e-Pub 2015. PMID: 26206558.
456. Vu HL, Rosenbaum S, Purwin TJ, Davies MA, Aplin AE. RAC1 P29S regulates PD-L1 expression in melanoma. Pigment Cell Melanoma Res 28(5):590-8, 2015. e-Pub 2015. PMID: 26176707.
457. Meric-Bernstam F, Brusco L, Shaw K, Horombe C, Kopetz S, Davies MA, Routbort M, Piha-Paul SA, Janku F, Ueno N, Hong D, De Groot J, Ravi V, Li Y, Luthra R, Patel K, Broaddus R, Mendelsohn J, Mills GB. Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials. J Clin Oncol 33(25):2753-62, 2015. e-Pub 2015. PMID: 26014291.
458. Porter M, Davies MA, Mapani MK, Rabie H, Phiri S, Nuttall J, Fairlie L, Technau KG, Stinson K, Wood R, Wellington M, Haas AD, Giddy J, Tanser F, Eley B. Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012. J Acquir Immune Defic Syndr 69(5):593-601, 2015. e-Pub 2015. PMID: 26167620.
459. Tetzlaff MT, Pattanaprichakul P, Wargo J, Fox PS, Patel KP, Estrella JS, Broaddus RR, Williams MD, Davies MA, Routbort MJ, Lazar AJ, Woodman SE, Hwu WJ, Gershenwald JE, Prieto VG, Torres-Cabala CA, Curry JL. Utility of BRAF V600E immunohistochemical expression pattern as a surrogate of BRAF mutation status in 154 patients with advanced melanoma. Hum Pathol 46(8):1101-10, 2015. e-Pub 2015. PMID: 26058727.
460. Haas AD, Keiser O, Balestre E, Brown S, Bissagnene E, Chimbetete C, Dabis F, Davies MA, Hoffmann CJ, Oyaro P, Parkes-Ratanshi R, Reynolds SJ, Sikazwe I, Wools-Kaloustian K, Zannou DM, Wandeler G, Egger M. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis. Lancet HIV 2(7):e271-8, 2015. e-Pub 2015. PMID: 26423252.
461. Meric-Bernstam F, Johnson A, Holla V, Bailey AM, Brusco L, Chen K, Routbort M, Patel KP, Zeng J, Kopetz S, Davies MA, Piha-Paul SA, Hong DS, Eterovic AK, Tsimberidou AM, Broaddus R, Bernstam EV, Shaw KR, Mendelsohn J, Mills GB. A decision support framework for genomically informed investigational cancer therapy. J Natl Cancer Inst 107(7), 2015. e-Pub 2015. PMID: 25863335.
462. Atlas Network CG. Genomic Classification of Cutaneous Melanoma. Cell 161(7):1681-96, 2015. e-Pub 2015. PMID: 26091043.
463. Goswami RS, Patel KP, Singh RR, Meric-Bernstam F, Kopetz ES, Subbiah V, Alvarez RH, Davies MA, Jabbar KJ, Roy-Chowdhuri S, Lazar AJ, Medeiros LJ, Broaddus RR, Luthra R, Routbort MJ. Hotspot mutation panel testing reveals clonal evolution in a study of 265 paired primary and metastatic tumors. Clin Cancer Res 21(11):2644-51, 2015. e-Pub 2015. PMID: 25695693.
464. Bradley SD, Chen Z, Melendez B, Talukder A, Khalili JS, Rodriguez-Cruz T, Liu S, Whittington M, Deng W, Li F, Bernatchez C, Radvanyi LG, Davies MA, Hwu P, Lizée G. BRAF(V600E) co-opts a conserved MHC class I internalization pathway to diminish antigen presentation and CD8+ T-cell recognition of melanoma. Cancer Immunol Res 3(6):602-9, 2015. e-Pub 2015. PMID: 25795007.
465. Stockman DL, Curry JL, Torres-Cabala CA, Watson IR, Siroy AE, Bassett RL, Zou L, Patel KP, Luthra R, Davies MA, Wargo JA, Routbort MA, Broaddus RR, Prieto VG, Lazar AJ, Tetzlaff MT. Use of Clinical Next-Generation Sequencing To Identify Melanomas Harboring SMARCB1 Mutations. J Cutan Pathol 42(5):308-17, 2015. e-Pub 2015. PMID: 25754356.
466. Scortegagna M, Lau E, Zhang T, Feng Y, Sereduk C, Yin H, De SK, Meeth K, Platt JT, Langdon CG, Halaban R, Pellecchia M, Davies MA, Brown K, Stern DF, Bosenberg M, Ronai ZA. PDK1 and SGK3 contribute to the growth of BRAF mutant melanomas and are potential therapeutic targets. Cancer Res 75(7):1399-412, 2015. e-Pub 2015. PMID: 25712345.
467. Ballif M, Renner L, Claude Dusingize J, Leroy V, Ayaya S, Wools-Kaloustian K, Cortes CP, McGowan CC, Graber C, Mandalakas AM, Mofenson LM, Egger M, Kumara Wati KD, Nallusamy R, Reubenson G, Davies MA, Fenner L. Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries: Diagnosis and Screening Practices. J Pediatric Infect Dis Soc 4(1):30-8, 2015. e-Pub 2015. PMID: 26407355.
468. Pillay V, Davies MA, King S, Eley B. Short-term treatment outcomes of children starting antiretroviral therapy in the intensive care unit, general medical wards and outpatient HIV clinics at Red Cross War Memorial Children's Hospital, Cape Town, South Africa: A retrospective cohort study. S Afr Med J 105(3):220-7, 2015. e-Pub 2015. PMID: 26294831.
469. Chen K, Meric-Bernstam F, Zhao H, Zhang Q, Ezzeddine N, Tang LY, Qi Y, Mao Y, Chen T, Chong Z, Zhou W, Zheng X, Johnson A, Aldape KD, Routbort MJ, Luthra R, Kopetz S, Davies MA, de Groot J, Moulder S, Vinod R, Farhangfar CJ, Shaw KM, Mendelsohn J, Mills GB, Eterovic AK. Clinical actionability enhanced through deep targeted sequencing of solid tumors. Clin Chem 61(3):544-53, 2015. e-Pub 2015. PMID: 25626406.
470. Ju Z, Liu W, Roebuck PL, Siwak DR, Zhang N, Lu Y, Davies MA, Akbani R, Weinstein JN, Mills GB, Coombes KR. Development of a robust classifier for quality control of reverse-phase protein arrays. Bioinformatics 31(6):912-8, 2015. e-Pub 2015. PMID: 25380958.
471. Siroy AE, Boland GM, Milton DR, Roszik J, Frankian S, Malke J, Haydu L, Prieto VG, Tetzlaff M, Ivan D, Wang WL, Torres-Cabala C, Curry J, Roy-Chowdhuri S, Broaddus R, Rashid A, Stewart J, Gershenwald JE, Amaria RN, Patel SP, Papadopoulos NE, Bedikian A, Hwu WJ, Hwu P, Diab A, Woodman SE, Aldape KD, Luthra R, Patel KP, Shaw KR, Mills GB, Mendelsohn J, Meric-Bernstam F, Kim KB, Routbort MJ, Lazar AJ, Davies MA. Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma. J Invest Dermatol 135(2):508-15, 2015. e-Pub 2015. PMID: 25148578.
472. Turley RS, Tokuhisa Y, Toshimitsu H, Lidsky ME, Padussis JC, Fontanella A, Deng W, Augustine CK, Beasley GM, Davies MA, Dewhirst MW, Tyler DS. Targeting N-cadherin Increases Vascular Permeability and Differentially Activates AKT in Melanoma. Ann Surg 261(2):368-77, 2015. e-Pub 2015. PMID: 24646553.
473. Geng EH, Neilands TB, Thiebaut R, Bwana MB, Nash D, Moore RD, Wood R, Zannou DM, Althoff KN, Lim PL, Nachega JB, Easterbrook PJ, Kambugu A, Little F, Nakigozi G, Nakanjako D, Kiggundu V, Ki Li PC, Bangsberg DR, Fox MP, Prozesky H, Hunt PW, Davies MA, Reynolds SJ, Egger M, Yiannoutsos CT, Vittinghoff EV, Deeks SG, Martin JN. CD41 T cell recovery during suppression of HIV replication: an international comparison of the immunological efficacy of antiretroviral therapy in North America, Asia and Africa. Int J Epidemiol 44(1):251-63, 2015. e-Pub 2015. PMID: 25859596.
474. Yotebieng M, Meyers T, Behets F, Davies MA, Keiser O, Ngonyani KZ, Lyamuya RE, Kariminia A, Hansudewechakul R, Leroy V, Koumakpai S, Newman J, Van Rie A. Age-specific and sex-specific weight gain norms to monitor antiretroviral therapy in children in low-income and middle-income countries. AIDS 29(1):101-9, 2015. e-Pub 2015. PMID: 25562494.
475. Koller M, Patel K, Chi BH, Wools-Kaloustian K, Dicko F, Chokephaibulkit K, Chimbetete C, Avila D, Hazra R, Ayaya S, Leroy V, Truong HK, Egger M, Davies MA. Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr 68(1):62-72, 2015. e-Pub 2015. PMID: 25501345.
476. Damsky W, Micevic G, Meeth K, Muthusamy V, Curley DP, Santhanakrishnan M, Erdelyi I, Platt JT, Huang L, Theodosakis N, Zaidi MR, Tighe S, Davies MA, Dankort D, McMahon M, Merlino G, Bardeesy N, Bosenberg M. mTORC1 activation blocks Braf V600E - induced growth arrest, but is insufficient for melanoma formation. Cancer Cell 27(1):41-56, 2015. e-Pub 2015. PMID: 25584893.
477. Johnson LF, Dorrington RE, Laubscher R, Hoffmann CJ, Wood R, Fox MP, Cornell M, Schomaker M, Prozesky H, Tanser F, Davies MA, Boulle A. A comparison of death recording by health centres and civil registration in South Africans receiving antiretroviral treatment. J Int AIDS Soc 18(1):20628, 2015. e-Pub 2015. PMID: 26685125.
478. Davies MA, Pinto J, Bras M. Getting to 90-90-90 in paediatric HIV: What is needed?. J Int AIDS Soc 18(7Suppl 6):20770, 2015. e-Pub 2015. PMID: 28326130.
479. Davies MA. Abstracts of the Melanoma Bridge Meeting 2014, December 3-6, 2014, Naples, Italy. J Transl Med 13 Suppl 1(Suppl 1):K1-P16, 2015. e-Pub 2015. PMID: 26056689.
480. Davies MA. Research gaps in neonatal HIV-related care. South Afr J HIV Med 16(1):375, 2015. e-Pub 2015. PMID: 29568592.
481. Johnson LF, Estill J, Keiser O, Cornell M, Moolla H, Schomaker M, Grimsrud A, Davies MA, Boulle A. Do increasing rates of loss to follow-up in antiretroviral treatment programs imply deteriorating patient retention?. Am J Epidemiol 180(12):1208-12, 2014. e-Pub 2014. PMID: 25399412.
482. Bohlius J, Valeri F, Maskew M, Prozesky H, Garone D, Sengayi M, Fox MP, Davies MA, Egger M. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era. Int J Cancer 135(11):2644-52, 2014. e-Pub 2014. PMID: 24729433.
483. Gopal YN, Rizos H, Chen G, Deng W, Frederick DT, Cooper ZA, Scolyer RA, Pupo G, Komurov K, Sehgal V, Zhang J, Patel L, Pereira CG, Broom BM, Mills GB, Ram P, Smith PD, Wargo JA, Long GV, Davies MA. Inhibition of mTORC1/2 overcomes PGC1a and OxPhos-mediated resistance. Cancer Res 74(23):7037-47, 2014. e-Pub 2014. PMID: 25297634.
484. Chen G, Chakravarti N, Aardalen K, Lazar AJ, Tetzlaff MT, Wubbenhorst B, Kim SB, Kopetz S, Ledoux AA, Gopal YN, Pereira CG, Deng W, Lee JS, Nathanson KL, Aldape KD, Prieto VG, Stuart D, Davies MA. Molecular Profiling of Patient-Matched Brain and Extracranial Melanoma Metastases Implicates the PI3K Pathway as a Therapeutic Target. Clin Cancer Res 20(21):5537-46, 2014. e-Pub 2014. PMID: 24803579.
485. Bucheit AD, Chen G, Siroy A, Tetzlaff M, Broaddus R, Milton D, Fox P, Bassett R, Hwu P, Gershenwald JE, Lazar AJ, Davies MA. Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB/C melanoma patients with BRAFV600 mutations. Clin Cancer Res 20(21):5527-36, 2014. e-Pub 2014. PMID: 25165098.
486. Salazar-Vizcaya L, Keiser O, Karl Technau, Davies MA, Haas AD, Blaser N, Cox V, Eley B, Rabie H, Moultrie H, Giddy J, Wood R, Egger M, Estill J. Viral load versus CD4(+) monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study. AIDS 28(16):2451-60, 2014. e-Pub 2014. PMID: 25392857.
487. Davies MA, Terhorst L, Nakonechny AJ, Skukla N, El Saadawi G. The development and effectiveness of a health information website designed to improve parents' self-efficacy in managing risk for obesity in preschoolers. J Spec Pediatr Nurs 19(4):316-30, 2014. e-Pub 2014. PMID: 25160030.
488. Ford N, Stinson K, Davies MA, Cox V, Patten G, Cragg C, Van Cutsem G, Boulle A. Is it safe to drop CD4+ monitoring among virologically suppressed patients: a cohort evaluation from Khayelitsha, South Africa. AIDS 28(14):2003-5, 2014. e-Pub 2014. PMID: 25102088.
489. Watson IR, Li L, Cabeceiras PK, Mahdavi M, Gutschner T, Genovese G, Wang G, Fang Z, Tepper JM, Stemke-Hale K, Tsai KY, Davies MA, Mills GB, Chin L. The RAC1 P29S Hotspot Mutation in Melanoma Confers Resistance to Pharmacological Inhibition of RAF. Cancer Res 74(17):4845-4852, 2014. e-Pub 2014. PMID: 25056119.
490. Kugel CH, Hartsough EJ, Davies MA, Setiady YY, Aplin AE. Function-Blocking ERBB3 Antibody Inhibits the Adaptive Response to RAF Inhibitor. Cancer Res 74(15):4122-32, 2014. e-Pub 2014. PMID: 25035390.
491. Alrwas A, Papadopoulos NE, Cain S, Patel SP, Kim KB, Deburr TL, Bassett R, Hwu WJ, Bedikian AY, Davies MA, Woodman SE, Hwu P. Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic melanoma. Melanoma Res 24(4):342-8, 2014. e-Pub 2014. PMID: 24743052.
492. Davies MA, May M, Bolton-Moore C, Chimbetete C, Eley B, Garone D, Giddy J, Moultrie H, Ndirangu J, Phiri S, Rabie H, Technau KG, Wood R, Boulle A, Egger M, Keiser O. Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programs. Pediatr Infect Dis J 33(6):608-16, 2014. e-Pub 2014. PMID: 24378936.
493. Technau KG, Schomaker M, Kuhn L, Moultrie H, Coovadia A, Eley B, Rabie H, Wood R, Cox V, Vizcaya LS, Muchiri E, Davies MA. Virologic response in children treated with abacavir-compared with stavudine-based antiretroviral treatment: a South African multi-cohort analysis. Pediatr Infect Dis J 33(6):617-22, 2014. e-Pub 2014. PMID: 24378944.
494. Dutton-Regester K, Gartner JJ, Emmanuel R, Qutob N, Davies MA, Gershenwald JE, Robinson W, Robinson S, Rosenberg SA, Scolyer RA, Mann GJ, Thompson JF, Hayward NK, Samuels Y. A highly recurrent RPS27 5'UTR mutation in melanoma. Oncotarget 5(10):2912-7, 2014. e-Pub 2014. PMID: 24913145.
495. Davies MA, Kalk E. Provider-initiated HIV testing and counselling for children. PLoS Med 11(5):e1001650, 2014. e-Pub 2014. PMID: 24866364.
496. Mulenga L, Musonda P, Mwango A, Vinikoor MJ, Davies MA, Mweemba A, Calmy A, Stringer JS, Keiser O, Chi BH, Wandeler G. Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia. Clin Infect Dis 58(10):1473-80, 2014. e-Pub 2014. PMID: 24585558.
497. Penazzato M, Davies MA, Apollo T, Negussie E, Ford N. Task shifting for the delivery of pediatric antiretroviral treatment: a systematic review. J Acquir Immune Defic Syndr 65(4):414-22, 2014. e-Pub 2014. PMID: 24583614.
498. Ma XH, Piao SF, Dey S, McAfee Q, Karakousis G, Villanueva J, Hart LS, Levi S, Hu J, Zhang G, Lazova R, Klump V, Pawelek JM, Xu X, Xu W, Schuchter LM, Davies MA, Herlyn M, Winkler J, Koumenis C, Amaravadi RK. Targeting ER stress induced-autophagy overcomes resistance to BRAF inhibition in melanoma. J Clin Invest 124(3):1406-17, 2014. e-Pub 2014. PMID: 24569374.
499. Lopez-Rivera E, Jayaraman P, Parikh F, Davies MA, Ekmekcioglu S, Izadmehr S, Milton DR, Chipuk JE, Grimm EA, Estrada Y, Aguirre-Ghiso J, Sikora AG. Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2. Cancer Res 74(4):1067-78, 2014. e-Pub 2014. PMID: 24398473.
500. Prickett TD, Zerlanko B, Gartner JJ, Parker SC, Dutton-Regester K, Lin JC, Teer JK, Wei X, Jiang J, Sequencing Program NC, Chen G, Davies MA, Gershenwald JE, Robinson W, Robinson S, Hayward NK, Rosenberg SA, Margulies EH, Samuels Y. Somatic Mutations in MAP3K5 Attenuate Its Proapoptotic Function in Melanoma through Increased Binding to Thioredoxin. J Invest Dermatol 134(2):452-60, 2014. e-Pub 2014. PMID: 24008424.
501. Avila D, Althoff KN, Mugglin C, Wools-Kaloustian K, Koller M, Dabis F, Nash D, Gsponer T, Sungkanuparph S, McGowan C, May M, Cooper D, Chimbetete C, Wolff M, Collier A, McManus H, Davies MA, Costagliola D, Crabtree-Ramirez B, Chaiwarith R, Cescon A, Cornell M, Diero L, Phanuphak P, Sawadogo A, Ehmer J, Eholie SP, Li PC, Fox MP, Gandhi NR, Gonzalez E, Lee CK, Hoffmann CJ, Kambugu A, Keiser O, Ditangco R, Prozesky H, Lampe F, Kumarasamy N, Kitahata M, Lugina E, Lyamuya R, Vonthanak S, Fink V, d'Arminio Monforte A, Luz PM, Chen YM, Minga A, Casabona J, Mwango A, Choi JY, Newell ML, Bukusi EA, Ngonyani K, Merati TP, Otieno J, Bosco MB, Phiri S, Ng OT, Anastos K, Rockstroh J, Santos I, Oka S, Somi G, Stephan C, Teira R, Wabwire D, Wandeler G, Boulle A, Reiss P, Wood R, Chi BH, Williams C, Sterne JA, Egger M. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr 65(1):e8-16, 2014. e-Pub 2014. PMID: 24419071.
502. Baladandayuthapani V, Talluri R, Ji Y, Coombes KR, Lu Y, Hennessy BT, Davies MA, Mallick BK. BAYESIAN SPARSE GRAPHICAL MODELS FOR CLASSIFICATION WITH APPLICATION TO PROTEIN EXPRESSION DATA. Ann Appl Stat 8(3):1443-1468, 2014. e-Pub 2014. PMID: 26246866.
503. Curry JL, Davies MA, Calderone TL, Nathanson K, Prieto VG, Gershenwald JE. Tissue resources for clinical use and marker studies in melanoma. Methods Mol Biol 1102:679-95, 2014. e-Pub 2014. PMID: 24259006.
504. Frederick DT, Salas Fragomeni RA, Schalck A, Ferreiro-Neira I, Hoff T, Cooper ZA, Haq R, Panka DJ, Kwong LN, Davies MA, Cusack JC, Flaherty KT, Fisher DE, Mier JW, Wargo JA, Sullivan RJ. Clinical profiling of BCL-2 family members in the setting of BRAF inhibition offers a rationale for targeting de novo resistance using BH3 mimetics. PLoS One 9(7):e101286, 2014. e-Pub 2014. PMID: 24983357.
505. Hayes AR, O'Sullivan AJ, Davies MA. A case of pituitary apoplexy in pregnancy. Endocrinol Diabetes Metab Case Rep 2014:140043, 2014. e-Pub 2014. PMID: 25031837.
506. Green A, de Azevedo V, Patten G, Davies MA, Ibeto M, Cox V. Clinical mentorship of nurse initiated antiretroviral therapy in Khayelitsha, South Africa: a quality of care assessment. PLoS One 9(6):e98389, 2014. e-Pub 2014. PMID: 24887260.
507. Labhardt ND, Keiser O, Sello M, Lejone TI, Pfeiffer K, Davies MA, Egger M, Ehmer J, Wandeler G. Outcomes of antiretroviral treatment programmes in rural Lesotho: health centres and hospitals compared. J Int AIDS Soc 16(1):18616, 2013. e-Pub 2013. PMID: 24267671.
508. Bucheit AD, Syklawer E, Jakob JA, Bassett RL Jr, Curry JL, Gershenwald JE, Kim KB, Hwu P, Lazar AJ, Davies MA. Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma. Cancer 119(21):3821-9, 2013. e-Pub 2013. PMID: 23922205.
509. Schomaker M, Egger M, Ndirangu J, Phiri S, Moultrie H, Technau K, Cox V, Giddy J, Chimbetete C, Wood R, Gsponer T, Bolton Moore C, Rabie H, Eley B, Muhe L, Penazzato M, Essajee S, Keiser O, Davies MA. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa. PLoS Med 10(11):e1001555, 2013. e-Pub 2013. PMID: 24260029.
510. Siegfried N, Davies MA, Penazzato M, Muhe LM, Egger M. Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old. Cochrane Database Syst Rev 2013(10):CD010309, 2013. e-Pub 2013. PMID: 24114324.
511. Wandeler G, Gsponer T, Mulenga L, Garone D, Wood R, Maskew M, Prozesky H, Hoffmann C, Ehmer J, Dickinson D, Davies MA, Egger M, Keiser O. Zidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern Africa. AIDS 27(14):2225-32, 2013. e-Pub 2013. PMID: 23660577.
512. Nathanson KL, Martin AM, Wubbenhorst B, Greshock J, Letrero R, D'Andrea K, O'Day S, Infante JR, Falchook GS, Arkenau HT, Millward M, Brown MP, Pavlick A, Davies MA, Ma B, Gagnon R, Curtis M, Lebowitz PF, Kefford R, Long GV. Tumor genetic analyses of patients with metastatic melanoma treated with the BRAF inhibitor dabrafenib (GSK2118436). Clin Cancer Res 19(17):4868-78, 2013. e-Pub 2013. PMID: 23833299.
513. Gartner JJ, Parker SC, Prickett TD, Dutton-Regester K, Stitzel ML, Lin JC, Davis S, Simhadri VL, Jha S, Katagiri N, Gotea V, Teer JK, Wei X, Morken MA, Bhanot UK, Chen G, Elnitski LL, Davies MA, Gershenwald JE, Carter H, Karchin R, Robinson W, Robinson S, Rosenberg SA, Collins FS, Parmigiani G, Komar AA, Kimchi-Sarfaty C, Hayward NK, Margulies EH, Samuels Y. Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma. Proc Natl Acad Sci U S A 110(33):13481-6, 2013. e-Pub 2013. PMID: 23901115.
514. Technau KG, Lazarus E, Kuhn L, Abrams EJ, Sorour G, Strehlau R, Reubenson G, Davies MA, Coovadia A. Poor early virologic performance and durability of abacavir-based first-line regimens for HIV-infected children. Pediatr Infect Dis J 32(8):851-5, 2013. e-Pub 2013. PMID: 23860481.
515. Greaves WO, Verma S, Patel KP, Davies MA, Barkoh BA, Galbincea JM, Yao H, Lazar AJ, Aldape KD, Medeiros LJ, Luthra R. Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanoma. J Mol Diagn 15(2):220-6, 2013. e-Pub 2013. PMID: 23273605.
516. Patel SP, Lazar AJ, Papadopoulos NE, Liu P, Infante JR, Glass MR, Vaughn CS, LoRusso PM, Cohen RB, Davies MA, Kim KB. Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma. Cancer 119(4):799-805, 2013. e-Pub 2013. PMID: 22972589.
517. Leroy V, Malateste K, Rabie H, Lumbiganon P, Ayaya S, Dicko F, Davies MA, Kariminia A, Wools-Kaloustian K, Aka E, Phiri S, Aurpibul L, Yiannoutsos C, Signate-Sy H, Mofenson L, Dabis F. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration. J Acquir Immune Defic Syndr 62(2):208-19, 2013. e-Pub 2013. PMID: 23187940.
518. Mao M, Tian F, Mariadason JM, Tsao CC, Lemos R Jr, Dayyani F, Gopal YN, Jiang ZQ, Wistuba II, Tang XM, Bornman WG, Bollag G, Mills GB, Powis G, Desai J, Gallick GE, Davies MA, Kopetz S. Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents. Clin Cancer Res 19(3):657-67, 2013. e-Pub 2013. PMID: 23251002.
519. Bokhari AR, Davies MA, Diamond T. Endoscopic transsphenoidal pituitary surgery: a single surgeon experience and the learning curve. Br J Neurosurg 27(1):44-9, 2013. e-Pub 2013. PMID: 22900510.
520. Liu C, Peng W, Xu C, Lou Y, Zhang M, Wargo JA, Chen JQ, Li HS, Watowich SS, Yang Y, Tompers Frederick D, Cooper ZA, Mbofung RM, Whittington M, Flaherty KT, Woodman SE, Davies MA, Radvanyi LG, Overwijk WW, Lizee G, Hwu P. BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in mice. Clin Cancer Res 19(2):393-403, 2013. e-Pub 2013. PMID: 23204132.
521. Davies MA, Phiri S, Wood R, Wellington M, Cox V, Bolton-Moore C, Timmerman V, Moultrie H, Ndirangu J, Rabie H, Technau K, Giddy J, Maxwell N, Boulle A, Keiser O, Egger M, Eley B. Temporal trends in the characteristics of children at antiretroviral therapy initiation in southern Africa: the IeDEA-SA Collaboration. PLoS One 8(12):e81037, 2013. e-Pub 2013. PMID: 24363808.
522. Estill J, Egger M, Johnson LF, Gsponer T, Wandeler G, Davies MA, Boulle A, Wood R, Garone D, Stringer JS, Hallett TB, Keiser O. Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling study. PLoS One 8(2):e57611, 2013. e-Pub 2013. PMID: 23469035.
523. Radvanyi LG, Bernatchez C, Zhang M, Fox PS, Miller P, Chacon J, Wu R, Lizee G, Mahoney S, Alvarado G, Glass M, Johnson VE, McMannis JD, Shpall E, Prieto V, Papadopoulos N, Kim K, Homsi J, Bedikian A, Hwu WJ, Patel S, Ross MI, Lee JE, Gershenwald JE, Lucci A, Royal R, Cormier JN, Davies MA, Mansaray R, Fulbright OJ, Toth C, Ramachandran R, Wardell S, Gonzalez A, Hwu P. Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients. Clin Cancer Res 18(24):6758-70, 2012. e-Pub 2012. PMID: 23032743.
524. Davies MA, Boulle A, Technau K, Eley B, Moultrie H, Rabie H, Garone D, Giddy J, Wood R, Egger M, Keiser O. The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure. Trop Med Int Health 17(11):1386-90, 2012. e-Pub 2012. PMID: 22974345.
525. Joseph RW, Eckel-Passow JE, Sharma R, Liu P, Parker A, Jakob J, Buchbinder E, Bassett RL, Davies MA, Hwu P, Atkins MB, Sullivan RJ. Characterizing the clinical benefit of ipilimumab in patients who progressed on high-dose IL-2. J Immunother 35(9):711-5, 2012. e-Pub 2012. PMID: 23090080.
526. Long GV, Trefzer U, Davies MA, Kefford RF, Ascierto PA, Chapman PB, Puzanov I, Hauschild A, Robert C, Algazi A, Mortier L, Tawbi H, Wilhelm T, Zimmer L, Switzky J, Swann S, Martin AM, Guckert M, Goodman V, Streit M, Kirkwood JM, Schadendorf D. Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial. Lancet Oncol 13(11):1087-95, 2012. e-Pub 2012. PMID: 23051966.
527. Beasley GM, Coleman AP, Raymond A, Sanders G, Selim MA, Peterson BL, Brady MS, Davies MA, Augustine C, Tyler DS. A phase I multi-institutional study of systemic sorafenib in conjunction with regional melphalan for in-transit melanoma of the extremity. Ann Surg Oncol 19(12):3896-3905, 2012. e-Pub 2012. PMID: 22549288.
528. Khalili JS, Liu S, Rodriguez-Cruz TG, Whittington M, Wardell S, Liu C, Zhang M, Cooper ZA, Frederick DT, Li Y, Zhang M, Joseph RW, Bernatchez C, Ekmekcioglu S, Grimm E, Radvanyi LG, Davis RE, Davies MA, Wargo JA, Hwu P, Lizee G. Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma. Clin Cancer Res 18(19):5329-40, 2012. e-Pub 2012. PMID: 22850568.
529. Gsponer T, Weigel R, Davies MA, Bolton C, Moultrie H, Vaz P, Rabie H, Technau K, Ndirangu J, Eley B, Garone D, Wellington M, Giddy J, Ehmer J, Egger M, Keiser O. Variability of growth in children starting antiretroviral treatment in southern Africa. Pediatrics 130(4):e966-77, 2012. e-Pub 2012. PMID: 22987878.
530. Kim J, Lazar AJ, Davies MA, Homsi J, Papadopoulos NE, Hwu WJ, Bedikian AY, Woodman SE, Patel SP, Hwu P, Kim KB. BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma. J Cutan Pathol 39(9):821-5, 2012. e-Pub 2012. PMID: 22809251.
531. Khalili JS, Yu X, Wang J, Hayes BC, Davies MA, Lizee G, Esmaeli B, Woodman SE. Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Clin Cancer Res 18(16):4345-55, 2012. e-Pub 2012. PMID: 22733540.
532. Jakob JA, Bassett RL Jr, Ng CS, Curry JL, Joseph RW, Alvarado GC, Rohlfs ML, Richard J, Gershenwald JE, Kim KB, Lazar AJ, Hwu P, Davies MA. NRAS mutation status is an independent prognostic factor in metastatic melanoma. Cancer 118(16):4014-23, 2012. e-Pub 2012. PMID: 22180178.
533. Alvarado G, Noor R, Bassett R, Papadopoulos NE, Kim KB, Hwu WJ, Bedikian A, Patel S, Hwu P, Davies MA. Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases. Melanoma Res 22(4):310-5, 2012. e-Pub 2012. PMID: 22584956.
534. Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP, Nickerson E, Auclair D, Li L, Place C, Dicara D, Ramos AH, Lawrence MS, Cibulskis K, Sivachenko A, Voet D, Saksena G, Stransky N, Onofrio RC, Winckler W, Ardlie K, Wagle N, Wargo J, Chong K, Morton DL, Stemke-Hale K, Chen G, Noble M, Meyerson M, Ladbury JE, Davies MA, Gershenwald JE, Wagner SN, Hoon DS, Schadendorf D, Lander ES, Gabriel SB, Getz G, Garraway LA, Chin L. A landscape of driver mutations in melanoma. Cell 150(2):251-63, 2012. e-Pub 2012. PMID: 22817889.
535. Estill J, Aubriere C, Egger M, Johnson L, Wood R, Garone D, Gsponer T, Wandeler G, Boulle A, Davies MA, Hallett TB, Keiser O. Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis. AIDS 26(11):1403-13, 2012. e-Pub 2012. PMID: 22421243.
536. Chattopadhyay C, Ellerhorst JA, Ekmekcioglu S, Greene VR, Davies MA, Grimm EA. Association of activated c-Met with NRAS-mutated human melanomas. Int J Cancer 131(2):E56-65, 2012. e-Pub 2012. PMID: 22020736.
537. Hatiboglu MA, Kong LY, Wei J, Wang Y, McEnery KA, Fuller GN, Qiao W, Davies MA, Priebe W, Heimberger AB. The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models. Int J Cancer 131(1):8-17, 2012. e-Pub 2012. PMID: 21792892.
538. Mu H, Calderone TL, Davies MA, Prieto VG, Wang H, Mills GB, Bar-Eli M, Gershenwald JE. Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells. Am J Pathol 180(5):2170-81, 2012. e-Pub 2012. PMID: 22465753.
539. Al-Zaid T, Ditelberg JS, Prieto VG, Lev D, Luthra R, Davies MA, Diwan AH, Wang WL, Lazar AJ. Trichilemmomas show loss of PTEN in Cowden syndrome but only rarely in sporadic tumors. J Cutan Pathol 39(5):493-9, 2012. e-Pub 2012. PMID: 22486434.
540. Johnson LF, Davies MA, Moultrie H, Sherman GG, Bland RM, Rehle TM, Dorrington RE, Newell ML. The effect of early initiation of antiretroviral treatment in infants on pediatric AIDS mortality in South Africa: a model-based analysis. Pediatr Infect Dis J 31(5):474-80, 2012. e-Pub 2012. PMID: 22189531.
541. Johnson LF, Stinson K, Newell ML, Bland RM, Moultrie H, Davies MA, Rehle TM, Dorrington RE, Sherman GG. The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV. J Acquir Immune Defic Syndr 59(4):417-25, 2012. e-Pub 2012. PMID: 22193774.
542. Douis H, James SL, Grimer RJ, Davies MA. Is bone scintigraphy necessary in the initial surgical staging of chondrosarcoma of bone?. Skeletal Radiol 41(4):429-36, 2012. e-Pub 2012. PMID: 21892729.
543. Deng W, Gopal YN, Scott A, Chen G, Woodman SE, Davies MA. Role and therapeutic potential of PI3K-mTOR signaling in de novo resistance to BRAF inhibition. Pigment Cell Melanoma Res 25(2):248-58, 2012. e-Pub 2012. PMID: 22171948.
544. Davies MA, Fox PS, Papadopoulos NE, Bedikian AY, Hwu WJ, Lazar AJ, Prieto VG, Culotta KS, Madden TL, Xu Q, Huang S, Deng W, Ng CS, Gupta S, Liu W, Dancey JE, Wright JJ, Bassett RL, Hwu P, Kim KB. Phase I study of the combination of sorafenib and temsirolimus in patients with metastatic melanoma. Clin Cancer Res 18(4):1120-8, 2012. e-Pub 2012. PMID: 22223528.
545. Springer BD, Habet NA, Griffin WL, Nanson CJ, Davies MA. Deformation of 1-piece metal acetabular components. J Arthroplasty 27(1):48-54, 2012. e-Pub 2012. PMID: 21641760.
546. Joseph RW, Sullivan RJ, Harrell R, Stemke-Hale K, Panka D, Manoukian G, Percy A, Bassett RL, Ng CS, Radvanyi L, Hwu P, Atkins MB, Davies MA. Correlation of NRAS mutations with clinical response to high-dose IL-2 in patients with advanced melanoma. J Immunother 35(1):66-72, 2012. e-Pub 2012. PMID: 22130161.
547. Davies MA. Regulation, role, and targeting of Akt in cancer. J Clin Oncol 29(35):4715-7, 2011. e-Pub 2011. PMID: 22025159.
548. Davies MA, Boulle A, Eley B, Moultrie H, Technau K, Rabie H, van Cutsem G, Giddy J, Wood R, Egger M, Keiser O. Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy - the IeDEA Southern Africa Collaboration. Trop Med Int Health 16(11):1367-71, 2011. e-Pub 2011. PMID: 21834797.
549. Prickett TD, Wei X, Cardenas-Navia I, Teer JK, Lin JC, Walia V, Gartner J, Jiang J, Cherukuri PF, Molinolo A, Davies MA, Gershenwald JE, Stemke-Hale K, Rosenberg SA, Margulies EH, Samuels Y. Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma. Nat Genet 43(11):1119-26, 2011. e-Pub 2011. PMID: 21946352.
550. Wei X, Walia V, Lin JC, Teer JK, Prickett TD, Gartner J, Davis S, Stemke-Hale K, Davies MA, Gershenwald JE, Robinson W, Robinson S, Rosenberg SA, Samuels Y. Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet 43(5):442-6, 2011. e-Pub 2011. PMID: 21499247.
551. Davies MA, Liu P, McIntyre S, Kim KB, Papadopoulos N, Hwu WJ, Hwu P, Bedikian A. Prognostic factors for survival in melanoma patients with brain metastases. Cancer 117(8):1687-96, 2011. e-Pub 2011. PMID: 20960525.
552. Davies MA, Moultrie H, Eley B, Rabie H, Van Cutsem G, Giddy J, Wood R, Technau K, Keiser O, Egger M, Boulle A. Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaboration. J Acquir Immune Defic Syndr 56(3):270-8, 2011. e-Pub 2011. PMID: 21107266.
553. Davies MA, Conley Y, Roth BL. Functional SNPs in genes encoding the 5-HT2A receptor modify the affinity and potency of several atypical antipsychotic drugs. Biol Res Nurs 13(1):55-60, 2011. e-Pub 2011. PMID: 20097665.
554. Hennessy BT, Lu Y, Gonzalez-Angulo AM, Carey MS, Myhre S, Ju Z, Davies MA, Liu W, Coombes K, Meric-Bernstam F, Bedrosian I, McGahren M, Agarwal R, Zhang F, Overgaard J, Alsner J, Neve RM, Kuo WL, Gray JW, Borresen-Dale AL, Mills GB. A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers. Clin Proteomics 6(4):129-51, 2010. e-Pub 2010. PMID: 21691416.
555. Gopal YN, Deng W, Woodman SE, Komurov K, Ram P, Smith PD, Davies MA. Basal and treatment-induced activation of AKT mediates resistance to cell death by AZD6244 (ARRY-142886) in Braf-mutant human cutaneous melanoma cells. Cancer Res 70(21):8736-47, 2010. e-Pub 2010. PMID: 20959481.
556. Wei X, Prickett TD, Viloria CG, Molinolo A, Lin JC, Cardenas-Navia I, Cruz P, Rosenberg SA, Davies MA, Gershenwald JE, Lopez-Otin C, Samuels Y. Mutational and functional analysis reveals ADAMTS18 metalloproteinase as a novel driver in melanoma. Mol Cancer Res 8(11):1513-25, 2010. e-Pub 2010. PMID: 21047771.
557. Griffin WL, Nanson CJ, Springer BD, Davies MA, Fehring TK. Reduced articular surface of one-piece cups: a cause of runaway wear and early failure. Clin Orthop Relat Res 468(9):2328-32, 2010. e-Pub 2010. PMID: 20480405.
558. Fenner L, Brinkhof MW, Keiser O, Weigel R, Cornell M, Moultrie H, Prozesky H, Technau K, Eley B, Vaz P, Pascoe M, Giddy J, Van Cutsem G, Wood R, Egger M, Davies MA. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. J Acquir Immune Defic Syndr 54(5):524-32, 2010. e-Pub 2010. PMID: 20588185.
559. Altman MK, Gopal V, Jia W, Yu S, Hall H, Mills GB, McGinnis AC, Bartlett MG, Jiang G, Madan D, Prestwich GD, Xu Y, Davies MA, Murph MM. Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid. Mol Cancer 9:140, 2010. e-Pub 2010. PMID: 20529378.
560. Gray D, Nuttall J, Lombard C, Davies MA, Workman L, Apolles P, Eley B, Cotton M, Zar HJ. Low rates of hepatotoxicity in HIV-infected children on anti-retroviral therapy with and without isoniazid prophylaxis. J Trop Pediatr 56(3):159-65, 2010. e-Pub 2010. PMID: 19710246.
561. Connell TG, Davies MA, Johannisen C, Wood K, Pienaar S, Wilkinson KA, Wilkinson RJ, Zar HJ, Beatty D, Nicol MP, Curtis N, Eley B. Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children. BMC Infect Dis 10:138, 2010. e-Pub 2010. PMID: 20507549.
562. Davies MA, Conley Y, Puskar K. Incorporating evidence from pharmacologic and pharmacogenetic studies of atypical antipsychotic drugs into advanced psychiatric nursing practice. Perspect Psychiatr Care 46(2):98-107, 2010. e-Pub 2010. PMID: 20377797.
563. Ding Z, Liang J, Li J, Lu Y, Ariyaratna V, Lu Z, Davies MA, Westwick JK, Mills GB. Physical association of PDK1 with AKT1 is sufficient for pathway activation independent of membrane localization and phosphatidylinositol 3 kinase. PLoS One 5(3):e9910, 2010. e-Pub 2010. PMID: 20361045.
564. Sikora AG, Gelbard A, Davies MA, Sano D, Ekmekcioglu S, Kwon J, Hailemichael Y, Jayaraman P, Myers JN, Grimm EA, Overwijk WW. Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy. Clin Cancer Res 16(6):1834-44, 2010. e-Pub 2010. PMID: 20215556.
565. Park ES, Rabinovsky R, Carey M, Hennessy BT, Agarwal R, Liu W, Ju Z, Deng W, Lu Y, Woo HG, Kim SB, Cheong JH, Garraway LA, Weinstein JN, Mills GB, Lee JS, Davies MA. Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set. Mol Cancer Ther 9(2):257-67, 2010. e-Pub 2010. PMID: 20124458.
566. Davies MA, Stemke-Hale K, Lin E, Tellez C, Deng W, Gopal YN, Woodman SE, Calderone TC, Ju Z, Lazar AJ, Prieto VG, Aldape K, Mills GB, Gershenwald JE. Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma. Clin Cancer Res 15(24):7538-7546, 2009. e-Pub 2009. PMID: 19996208.
567. Davies MA, Egger M, Keiser O, Boulle A. Paediatric antiretroviral treatment programmes in sub-Saharan Africa: a review of published clinical studies. Afr J AIDS Res 8(3):329-338, 2009. e-Pub 2009. PMID: 21124759.
568. Davies MA, Keiser O, Technau K, Eley B, Rabie H, van Cutsem G, Giddy J, Wood R, Boulle A, Egger M, Moultrie H. Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration. S Afr Med J 99(10):730-7, 2009. e-Pub 2009. PMID: 20128272.
569. Davies MA, Meintjes G. Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programs. Clin Infect Dis 49(6):973-5, 2009. e-Pub 2009. PMID: 19673616.
570. Cornell M, Technau K, Fairall L, Wood R, Moultrie H, van Cutsem G, Giddy J, Mohapi L, Eley B, MacPhail P, Prozesky H, Rabie H, Davies MA, Maxwell N, Boulle A. Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration. S Afr Med J 99(9):653-60, 2009. e-Pub 2009. PMID: 20073292.
571. Sajatovic M, Davies MA, Ganocy SJ, Bauer MS, Cassidy KA, Hays RW, Safavi R, Blow FC, Calabrese JR. A comparison of the life goals program and treatment as usual for individuals with bipolar disorder. Psychiatr Serv 60(9):1182-9, 2009. e-Pub 2009. PMID: 19723732.
572. Woodman SE, Trent JC, Stemke-Hale K, Lazar AJ, Pricl S, Pavan GM, Fermeglia M, Gopal YN, Yang D, Podoloff DA, Ivan D, Kim KB, Papadopoulos N, Hwu P, Mills GB, Davies MA. Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates. Mol Cancer Ther 8(8):2079-85, 2009. e-Pub 2009. PMID: 19671763.
573. Vasudevan KM, Barbie DA, Davies MA, Rabinovsky R, McNear CJ, Kim JJ, Hennessy BT, Tseng H, Pochanard P, Kim SY, Dunn IF, Schinzel AC, Sandy P, Hoersch S, Sheng Q, Gupta PB, Boehm JS, Reiling JH, Silver S, Lu Y, Stemke-Hale K, Dutta B, Joy C, Sahin AA, Gonzalez-Angulo AM, Lluch A, Rameh LE, Jacks T, Root DE, Lander ES, Mills GB, Hahn WC, Sellers WR, Garraway LA. AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell 16(1):21-32, 2009. e-Pub 2009. PMID: 19573809.
574. Davies MA, Connell T, Johannisen C, Wood K, Pienaar S, Wilkinson KA, Wilkinson RJ, Zar HJ, Eley B, Beatty D, Curtis N, Nicol MP. Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay. AIDS 23(8):961-969, 2009. e-Pub 2009. PMID: 19287300.
575. O'Reilly KE, Warycha M, Davies MA, Rodrik V, Zhou XK, Yee H, Polsky D, Pavlick AC, Rosen N, Bhardwaj N, Mills G, Osman I. Phosphorylated 4E-BP1 is associated with poor survival in melanoma. Clin Cancer Res 15(8):2872-8, 2009. e-Pub 2009. PMID: 19336517.
576. Nicol MP, Davies MA, Wood K, Hatherill M, Workman L, Hawkridge A, Eley B, Wilkinson KA, Wilkinson RJ, Hanekom WA, Beatty D, Hussey G. Comparison of T-SPOT.TB assay and tuberculin skin test for the evaluation of young children at high risk for tuberculosis in a community setting. Pediatrics 123(1):38-43, 2009. e-Pub 2009. PMID: 19117858.
577. Nuttall JJ, Davies MA, Hussey GD, Eley BS. Bacillus Calmette-Guerin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy. Int J Infect Dis 12(6):e99-105, 2008. e-Pub 2008. PMID: 18799339.
578. Davies MA, Stemke-Hale K, Tellez C, Calderone TL, Deng W, Prieto VG, Lazar AJ, Gershenwald JE, Mills GB. A novel AKT3 mutation in melanoma tumours and cell lines. Br J Cancer 99(8):1265-8, 2008. e-Pub 2008. PMID: 18813315.
579. Davies MA, McBride L, Sajatovic M. The collaborative care practice model in the long-term care of individuals with bipolar disorder: a case study. J Psychiatr Ment Health Nurs 15(8):649-53, 2008. e-Pub 2008. PMID: 18803739.
580. Davies MA, Boulle A, Fakir T, Nuttall J, Eley B. Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatr 8:34, 2008. e-Pub 2008. PMID: 18771599.
581. Eley B, Davies MA, Apolles P, Cowburn C, Buys H, Zampoli M, Finlayson H, King S, Nuttall J. Antiretroviral treatment for children. S Afr Med J 96(9 Pt 2):988-93, 2006. e-Pub 2006. PMID: 17077930.
582. Davies MA, Bryant SC, Larsen SP, Murrey DB, Nussman DS, Laxer EB, Darden BV. Comparison of cervical disk implants and cervical disk fusion treatments in human cadaveric models. J Biomech Eng 128(4):481-6, 2006. e-Pub 2006. PMID: 16813439.
583. Davies MA, Spence Laschinger HK, Andrusyszyn MA. Clinical educators' empowerment, job tension, and job satisfaction: A test of Kanter's Theory. J Nurses Staff Dev 22(2):78-86, 2006. e-Pub 2006. PMID: 16603905.
584. Davies MA, Setola V, Strachan RT, Sheffler DJ, Salay E, Hufeisen SJ, Roth BL. Pharmacologic analysis of non-synonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies. Pharmacogenomics J 6(1):42-51, 2006. e-Pub 2006. PMID: 16314884.
585. Laxer EB, Darden BV, Murrey DB, Milam RA, Rhyne AL, Claytor B, Nussman DS, Powers TW, Davies MA, Bryant SC, Larsen SP, Bhatt M, Brodziak J, Polic J. Adjacent segment disc pressures following two-level cervical disc replacement versus simulated anterior cervical fusion. Stud Health Technol Inform 123:488-92, 2006. e-Pub 2006. PMID: 17108473.
586. Davies MA, Compton-Toth BA, Hufeisen SJ, Meltzer HY, Roth BL. The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions?. Psychopharmacology (Berl) 178(4):451-60, 2005. e-Pub 2005. PMID: 15765260.
587. Davies MA, Tales H. Enhancing patient safety through a standardized model of physiologic monitoring. Healthc Q 8 Spec No:49-52, 2005. e-Pub 2005. PMID: 16334072.
588. Cordato DJ, Davies MA, Masters LT, Cremer PD, Schwartz RS, Sorby W, Becvarovski Z. Positional vomiting due to a thoracic spinal dural arteriovenous fistula. Case report. J Neurosurg Spine 1(2):219-22, 2004. e-Pub 2004. PMID: 15347009.
589. Eley B, Nuttall J, Davies MA, Smith L, Cowburn C, Buys H, Hussey G. Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents. S Afr Med J 94(8):643-6, 2004. e-Pub 2004. PMID: 15352588.
590. Hunter PR, Bickerstaff K, Davies MA. Potential sources of bias in the use of individual's recall of the frequency of exposure to air pollution for use in exposure assessment in epidemiological studies: a cross-sectional survey. Environ Health 3(1):3, 2004. e-Pub 2004. PMID: 15056391.
591. Hunter PR, Davies MA, Hill H, Whittaker M, Sufi F. The prevalence of self-reported symptoms of respiratory disease and community belief about the severity of pollution from various sources. Int J Environ Health Res 13(3):227-38, 2003. e-Pub 2003. PMID: 12909554.
592. Calabrese JR, Hirschfeld RM, Reed M, Davies MA, Frye MA, Keck PE, Lewis L, McElroy SL, McNulty JP, Wagner KD. Impact of bipolar disorder on a U.S. community sample. J Clin Psychiatry 64(4):425-32, 2003. e-Pub 2003. PMID: 12716245.
593. Hirschfeld RM, Calabrese JR, Weissman MM, Reed M, Davies MA, Frye MA, Keck PE Jr, Lewis L, McElroy SL, McNulty JP, Wagner KD. Screening for bipolar disorder in the community. J Clin Psychiatry 64(1):53-9, 2003. e-Pub 2003. PMID: 12590624.
594. Davies MA, Kim SJ, Parikh NU, Dong Z, Bucana CD, Gallick GE. Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells. Clin Cancer Res 8(6):1904-14, 2002. e-Pub 2002. PMID: 12060635.
595. Koul D, Jasser SA, Lu Y, Davies MA, Shen R, Shi Y, Mills GB, Yung WK. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity. Oncogene 21(15):2357-64, 2002. e-Pub 2002. PMID: 11948419.
596. Beresford SA, Davies MA, Gallick GE, Donato NJ. Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PCc-3 prostate cancer cells. J Interferon Cytokine Res 21(5):313-22, 2001. e-Pub 2001. PMID: 11429162.
597. Tanaka M, Koul D, Davies MA, Liebert M, Steck PA, Grossman HB. MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells. Oncogene 19(47):5406-12, 2000. e-Pub 2000. PMID: 11103942.
598. Lu Y, Lin YZ, LaPushin R, Cuevas B, Fang X, Yu SX, Davies MA, Khan H, Furui T, Mao M, Zinner R, Hung MC, Steck P, Siminovitch K, Mills GB. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene 18(50):7034-45, 1999. e-Pub 1999. PMID: 10597304.
599. Davies MA, Koul D, Dhesi H, Berman R, McDonnell TJ, McConkey D, Yung WK, Steck PA. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res 59(11):2551-6, 1999. e-Pub 1999. PMID: 10363971.
600. Davies MA, Lu Y, Sano T, Fang X, Tang P, LaPushin R, Koul D, Bookstein R, Stokoe D, Yung WK, Mills GB, Steck PA. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res 58(23):5285-90, 1998. e-Pub 1998. PMID: 9850049.
601. Davies MA, Ter Brugge K, Willinsky R, Wallace MC. The natural history and management of intracranial dural arteriovenous fistulae. Part 2: aggressive lesions. Interv Neuroradiol 3(4):303-11, 1997. e-Pub 1997. PMID: 20678361.
602. Davies MA, Saleh J, Ter Brugge K, Willinsky R, Wallace MC. The natural history and management of intracranial dural arteriovenous fistulae. Part 1: benign lesions. Interv Neuroradiol 3(4):295-302, 1997. e-Pub 1997. PMID: 20678360.
603. Milross CG, Davies MA, Fisher R, Mameghan J, Mameghan H. The efficacy of treatment for malignant epidural spinal cord compression. Australas Radiol 41(2):137-42, 1997. e-Pub 1997. PMID: 9153809.
604. Davies MA, TerBrugge K, Willinsky R, Coyne T, Saleh J, Wallace MC. The validity of classification for the clinical presentation of intracranial dural arteriovenous fistulas. J Neurosurg 85(5):830-7, 1996. e-Pub 1996. PMID: 8893721.
605. Davies MA, Turner J, Bentivoglio P. Spinal and basilar extraparenchymal neurocysticercosis. J Clin Neurosci 3(2):174-7, 1996. e-Pub 1996. PMID: 18638863.
606. Davies MA, Pell MF, Brew BJ. Stereotactic biopsy of cerebral lesions in acquired immunodeficiency syndrome. J Clin Neurosci 2(1):40-4, 1995. e-Pub 1995. PMID: 18638782.
607. Meltzer HY, Cola P, Way L, Thompson PA, Bastani B, Davies MA, Snitz B. Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia. Am J Psychiatry 150(11):1630-8, 1993. e-Pub 1993. PMID: 8105705.
608. Matheson JM, Truskett P, Davies MA, Vonau M. Hemispherectomy: a further modification using omentum vascularized free flaps. Aust N Z J Surg 63(8):646-50, 1993. e-Pub 1993. PMID: 8338485.
609. Davies MA, Moon FC. 3-D spatial chaos in the elastica and the spinning top: Kirchhoff analogy. Chaos 3(1):93-99, 1993. e-Pub 1993. PMID: 12780018.
610. Davies MA, Hubner W, Blume A, Mendelsohn R. Acyl chain conformational ordering in 1,2 dipalmitoylphosphatidylethanolamine. Integration of FT-IR and 2H NMR results. Biophys J 63(4):1059-62, 1992. e-Pub 1992. PMID: 1420924.
611. Kahn EM, Munetz MR, Davies MA, Schulz SC. Akathisia: clinical phenomenology and relationship to tardive dyskinesia. Compr Psychiatry 33(4):233-6, 1992. e-Pub 1992. PMID: 1353716.
612. Davies MA, Vonau M, Blum PW, Kwok BC, Matheson JM, Stening WA. Results of ulnar neuropathy at the elbow treated by decompression or anterior transposition. Aust N Z J Surg 61(12):929-34, 1991. e-Pub 1991. PMID: 1661575.
613. Mendelsohn R, Davies MA, Schuster HF, Xu ZC, Bittman R. CD2 rocking modes as quantitative infrared probes of one-, two-, and three-bond conformational disorder in dipalmitoylphosphatidylcholine and dipalmitoylphosphatidylcholine/cholesterol mixtures. Biochemistry 30(35):8558-63, 1991. e-Pub 1991. PMID: 1888722.
614. Davies MA, Conley RR, Schulz SC, Bell-Delaney J. One-year follow-up of 24 patients in a clinical trial of clozapine. Hosp Community Psychiatry 42(6):628-9, 1991. e-Pub 1991. PMID: 1864575.
615. Davies MA, Schuster HF, Brauner JW, Mendelsohn R. Effects of cholesterol on conformational disorder in dipalmitoylphosphatidylcholine bilayers. A quantitative IR study of the depth dependence. Biochemistry 29(18):4368-73, 1990. e-Pub 1990. PMID: 2350543.
616. Davies MA, Brauner JW, Schuster HF, Mendelsohn R. A quantitative infrared determination of acyl chain conformation in gramicidin/dipalmitoylphosphatidylcholine mixtures. Biochem Biophys Res Commun 168(1):85-90, 1990. e-Pub 1990. PMID: 1691641.
617. Mendelsohn R, Davies MA, Brauner JW, Schuster HF, Dluhy RA. Quantitative determination of conformational disorder in the acyl chains of phospholipid bilayers by infrared spectroscopy. Biochemistry 28(22):8934-9, 1989. e-Pub 1989. PMID: 2605234.
618. Davies MA, Bromet EJ, Schulz SC, Dunn LO, Morgenstern M. Community adjustment of chronic schizophrenic patients in urban and rural settings. Hosp Community Psychiatry 40(8):824-30, 1989. e-Pub 1989. PMID: 2759573.
619. Davies MA, Munetz MR, Schulz SC, Bromet EJ. Assessing mental illness in SRO shelter residents. Hosp Community Psychiatry 38(10):1114-6, 1987. e-Pub 1987. PMID: 3666704.
620. Chantler JK, Davies MA. The effect of antibody on rubella virus infection in human lymphoid cells. J Gen Virol 68 ( Pt 5):1277-88, 1987. e-Pub 1987. PMID: 3572365.
621. Traber J, Davies MA, Dompert WU, Glaser T, Schuurman T, Seidel PR. Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821. Brain Res Bull 12(6):741-4, 1984. e-Pub 1984. PMID: 6541079.
622. Noble J, Jones AG, Davies MA, Sledge CB, Kramer RI, Livni E. Leakage of radioactive particle systems from a synovial joint studied with a gamma camera. Its application to radiation synovectomy. J Bone Joint Surg Am 65(3):381-9, 1983. e-Pub 1983. PMID: 6826601.
623. Kyes JJ, Davies MA. Pseudocommunication is the nurse-patient game. Nurs Life 2(1):50-54, 1982. e-Pub 1982. PMID: 6976538.
624. Davies MA. Postsynaptic pharmacology of psychoactive substances in Aplysia californica. Brain Res Bull 6(6):495-502, 1981. e-Pub 1981. PMID: 6113882.
625. Davies MA. Continuing care unit: a model of services for chronic psychiatric patients. J Psychiatr Nurs Ment Health Serv 19(2):42-5, 1981. e-Pub 1981. PMID: 6259346.
626. Hipp FX, Gielen W, Davies MA, Hinzen DH. Blocking action of intracellularly injected neuraminidase on central synapses in vivo. Pflugers Arch 385(1):45-50, 1980. e-Pub 1980. PMID: 6251424.
627. Davies MA, Hinzen DH. Is there an intracellular presynaptic effect of curare on neurotransmission?. Brain Res 169(1):199-207, 1979. e-Pub 1979. PMID: 222397.
628. Davies MA, Hinzen DH. Is there a presynaptic action of curare on chemical transmission? [proceedings]. J Physiol 287:29P-30P, 1979. e-Pub 1979. PMID: 219183.
629. Hinzen DH, Davies MA. Synaptic connexions and related postsynaptic pharmacology studied in the cerebral ganglion of Aplysia. Brain Res 144(1):49-62, 1978. e-Pub 1978. PMID: 25121.
630. Davies MA, Gale J, Clarke WD. Audiotape and booklet self-instructional materials in physiology: an evaluation of their effectiveness and acceptability in the pre-clinical curriculum. Med Educ 11(6):370-3, 1977. e-Pub 1977. PMID: 74008.
631. Davies MA, Hinzen DH. Synaptic properties of identified neurones in the cerebral ganglion of Aplysia [proceedings]. J Physiol 263(2):244P-245P, 1976. e-Pub 1976. PMID: 1018241.
632. Bergner-Rabinowitz S, Ofek I, Davies MA, Rabinowitz K. Type-specific streptococcal antibodies in pyodermal nephritis. J Infect Dis 124(5):488-93, 1971. e-Pub 1971. PMID: 5115672.
633. Davies HE, Davies MA, Gould CT. Sodium content of rat renal medulla during water diuresis. J Physiol 213(2):72P-73P, 1971. e-Pub 1971. PMID: 5574870.
634. Freundlich E, Sterk VV, Hampel N, Davies MA. [Infant mortality in Western Galilee]. Harefuah 78(3):109-12, 1970. e-Pub 1970. PMID: 5535697.
635. COLTER JS, DAVIES MA, CAMPBELL JB. STUDIES OF THREE VARIANTS OF MENGO ENCEPHALOMYELITIS VIRUS. II. INHIBITION OF INTERACTION WITH L CELLS BY AN AGAR INHIBITOR AND BY PROTAMINE. Virology 24:578-85, 1964. e-Pub 1964. PMID: 14240405.
636. COLTER JS, DAVIES MA, CAMPBELL JB. STUDIES OF THREE VARIANTS OF MENGO ENCEPHALOMYELITIS VIRUS. I. RATE OF ATTACHMENT TO L CELLS, AND EFFECT OF PH ON INFECTIVITY. Virology 24:474-80, 1964. e-Pub 1964. PMID: 14227050.

Invited Articles

1. Saberian C, Davies MA. Re-thinking therapeutic development for CNS metastatic disease. Exp Dermatol 31(1):74-81, 2022. e-Pub 2022. PMID: 34152638.
2. Brastianos P, Davies MA, Margolin K, Yu HA. Modern Management of Central Nervous System Metastases in the Era of Targeted Therapy and Immune Oncology. Am Soc Clin Oncol Educ Book 39:e59-e69, 2019. e-Pub 2019. PMID: 31099629.
3. Davies MA, Flaherty KT. Melanoma in 2017: Moving treatments earlier to move further forwards. Nat Rev Clin Oncol 15(2):75-76, 2018. e-Pub 2018. PMID: 29182162.
4. Davies MA, Saiag P, Long GV. Primary medical therapy for BRAFV600E-mutant melanoma brain metastases—is this good enough?. The Lancet Oncology 18(9):1137-1284, 2017. e-Pub 2017.
5. Glitza Oliva I, Tawbi H, Davies MA. Melanoma brain metastases: current areas of investigation and future directions. Cancer J 23(1):68-74, 2017. e-Pub 2017. PMID: 28114258.
6. Loghavi S, Routbort MJ, Patel KP, Luthra R, Wang WL, Broaddus RR, Davies MA, Lazar AJ. How Do We Make Clinical Molecular Testing for Cancer Standard of Care for Pathology Departments?. J Natl Compr Canc Netw 14(6):787-92, 2016. e-Pub 2016. PMID: 27283170.
7. Davies MA. Role and complexity of next-generation sequencing in melanoma. Cancer Cytopathol 123(6):329-30, 2015. e-Pub 2015. PMID: 25877344.
8. McQuade J, Davies MA. Converting biology into clinical benefit: lessons learned from BRAF inhibitors. Melanoma Manag 2(3):241-254, 2015. e-Pub 2015. PMID: 26594316.

Review Articles

1. Hajjar J, Stephen B, Aaroe AE, Aiche MM, Al-Zubidi N, Ameri M, Aragon KE, Carabenciov ID, Chambers MS, Chaudhry AL, Connors JM, Davies MA, Debnath KC, Faiz SA, Fuller CD, Goepfert RP, Gombos DS, Gupta S, Hadfield M, Hutcheson KA, Islam S, Jalal A, Jayasekera M, Jazieh KA, Khine A, Kim P, Lai SY, Lei YL, Li YJ, Markovic SN, McMillan H, Moreno AC, Muhaj F, Nader ME, Otun A, Pacha O, Palaskas NL, Patel AB, Patel N, Quandt Z, Sagiv O, Sharon E, Shatila M, Sheshadri A, Suarez-Almazor ME, Thomas AS, Wang Y, Won A, Zhang HC, Naing A. The Immune Checkpoint Inhibitors Journey: From Early Promise to Lasting Impact. J Immunother Precis Oncol 9(4):153-245, 2026. e-Pub 2026. PMID: 42820064.
2. Flaherty KT, Aplin AE, Davies MA, Hacohen N, Herlyn M, Hoon D, Hwu P, Lotem M, Mule J, Wargo JA, Fisher DE. Facts & Hopes: towards the next quantum leap in melanoma. Clin Cancer Res 31(14):2882-2889, 2025. e-Pub 2025. PMID: 40407722.
3. Hasanov M, Acikgoz Y, Davies MA. Melanoma Brain Metastasis: Biology and Therapeutic Advances. Hematol Oncol Clin North Am 38(5):1027-1043, 2024. e-Pub 2024. PMID: 38845301.
4. Hunter M, Peters S, Khumalo N, Davies MA. Analysis of patient flow and barriers to timely discharge from general medical wards at a tertiary academic hospital in Cape Town, South Africa. BMC Health Serv Res 24(1):287, 2024. e-Pub 2024. PMID: 38448938.
5. Smalley I, Boire A, Brastianos P, Kluger HM, Hernando-Monge E, Forsyth PA, Ahmed KA, Smalley KSM, Ferguson S, Davies MA, Glitza Oliva IC. Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care. Pigment Cell Melanoma Res 37(1):51-67, 2024. e-Pub 2023. PMID: 37622466.
6. Karz A, Dimitrova M, Kleffman K, Alvarez-Breckenridge C, Atkins MB, Boire A, Bosenberg M, Brastianos P, Cahill DP, Chen Q, Ferguson S, Forsyth P, Glitza Oliva IC, Goldberg SB, Holmen SL, Knisely JPS, Merlino G, Nguyen DX, Pacold ME, Perez-Guijarro E, Smalley KSM, Tawbi HA, Wen PY, Davies MA, Kluger HM, Mehnert JM, Hernando E. Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities. Pigment Cell Melanoma Res 35(6):554-572, 2022. e-Pub 2022. PMID: 35912544.
7. Maskew M, Technau K, Davies MA, Vreeman R, Fox MP. Adolescent retention in HIV care within differentiated service-delivery models in sub-Saharan Africa. Lancet HIV 9(10):e726-e734, 2022. e-Pub 2022. PMID: 36088915.
8. Saberian C, Sperduto P, Davies MA. Targeted therapy strategies for melanoma brain metastasis. Neurooncol Adv 3(Suppl 5):v75-v85, 2021. e-Pub 2021. PMID: 34859235.
9. Ambrosioni J, Blanco JL, Reyes-Uruena JM, Davies MA, Sued O, Marcos MA, Martinez E, Bertagnolio S, Alcami J, Miro JM. Overview of SARS-CoV-2 infection in adults living with HIV. Lancet HIV 8(5):e294-e305, 2021. e-Pub 2021. PMID: 33915101.
10. Glitza IC, Smalley KSM, Brastianos PK, Davies MA, McCutcheon I, Liu JKC, Ahmed KA, Arrington JA, Evernden BR, Smalley I, Eroglu Z, Khushalani N, Margolin K, Kluger H, Atkins MB, Tawbi H, Boire A, Forsyth P. Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions. Pigment Cell Melanoma Res 33(4):527-541, 2020. e-Pub 2020. PMID: 31916400.
11. Anderson K, Muloiwa R, Davies MA. Long-term outcomes in perinatally HIV-infected adolescents and young adults on antiretroviral therapy: a review of South African and global literature. Afr J AIDS Res 19(1):1-12, 2020. e-Pub 2020. PMID: 32122278.
12. Gray DM, Davies MA, Githinji L, Levin M, Mapani M, Nowalaza Z, Washaya N, Yassin A, Zampoli M, Zar HJ, Vanker A. COVID-19 and Pediatric Lung Disease: A South African Tertiary Center Experience. Front Pediatr 8:614076, 2020. e-Pub 2020. PMID: 33553073.
13. Stover J, Glaubius R, Mofenson L, Dugdale CM, Davies MA, Patten G, Yiannoutsos C. Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels. AIDS 33 Suppl 3(Suppl 3):S227-S234, 2019. e-Pub 2019. PMID: 31805028.
14. Dower A, Davies MA, Ghahreman A. Pathologic Basis of Lumbar Radicular Pain. World Neurosurg 128:114-121, 2019. e-Pub 2019. PMID: 31028982.
15. Amaria RN, Menzies AM, Burton EM, Scolyer RA, Tetzlaff MT, Antdbacka R, Ariyan C, Bassett R, Carter B, Daud A, Faries M, Fecher LA, Flaherty KT, Gershenwald JE, Hamid O, Hong A, Kirkwood JM, Lo S, Margolin K, Messina J, Postow MA, Rizos H, Ross MI, Rozeman EA, Saw RPM, Sondak V, Sullivan RJ, Taube JM, Thompson JF, van de Wiel BA, Eggermont AM, Davies MA, Consortium members INM, Ascierto PA, Spillane AJ, van Akkooi ACJ, Wargo JA, Blank CU, Tawbi HA, Long GV. Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium. Lancet Oncol 20(7):e378-e389, 2019. e-Pub 2019. PMID: 31267972.
16. Judd A, Davies MA. Adolescent transition among young people with perinatal HIV in high-income and low-income settings. Curr Opin HIV AIDS 13(3):236-248, 2018. e-Pub 2018. PMID: 29528851.
17. Fischer GM, Vashisht Gopal YN, McQuade JL, Peng W, DeBerardinis RJ, Davies MA. Metabolic Strategies of Melanoma Cells: Mechanisms, Interactions with the Tumor Microenvironment, and Therapeutic Implications. Pigment Cell Melanoma Res 31(1):11-30, 2018. e-Pub 2018. PMID: 29049843.
18. Barlow-Mosha L, Musiime V, Davies MA, Prendergast AJ, Musoke P, Siberry G, Penazzato M. Universal antiretroviral therapy for HIV-infected children: a review of the benefits and risks to consider during implementation. J Int AIDS Soc 20(1):21552, 2017. e-Pub 2017. PMID: 28691434.
19. Singh E, Naidu G, Davies MA, Bohlius J. HIV-associated malignancies in children. Curr Opin HIV AIDS 12(1):77-83, 2017. e-Pub 2017. PMID: 27685986.
20. Cohen JV, Tawbi H, Margolin KA, Amravadi R, Bosenberg M, Brastianos PK, Chiang VL, de Groot J, Glitza IC, Herlyn M, Holmen SL, Jilaveanu LB, Lassman A, Moschos S, Postow MA, Thomas R, Tsiouris JA, Wen P, White RM, Turnham T, Davies MA, HM K. Melanoma Central Nervous System Metastases: Current Approaches, Challenges, and Opportunities. Pigment Cell Melanoma Res 29(6):627-642, 2016. e-Pub 2016.
21. Cohen JV, Tawbi H, Margolin KA, Amravadi R, Bosenberg M, Brastianos PK, Chiang VL, de Groot J, Glitza IC, Herlyn M, Holmen SL, Jilaveanu LB, Lassman A, Moschos S, Postow MA, Thomas R, Tsiouris JA, Wen P, White RM, Turnham T, Davies MA, Kluger HM. Melanoma central nervous system metastases: current approaches, challenges, and opportunities. Pigment Cell Melanoma Res 29(6):627-642, 2016. e-Pub 2016. PMID: 27615400.
22. Davies MA. Molecular Approaches to Tumor Inhibition in Melanoma. Clinical Advances in Hematology & Oncology 13(12), 2015. e-Pub 2015. PMID: 27058849.
23. Ford N, Meintjes G, Pozniak A, Bygrave H, Hill A, Peter T, Davies MA, Grinsztejn B, Calmy A, Kumarasamy N, Phanuphak P, deBeaudrap P, Vitoria M, Doherty M, Stevens W, Siberry GK. The future role of CD4 cell count for monitoring antiretroviral therapy. Lancet Infect Dis 15(2):241-7, 2015. e-Pub 2015. PMID: 25467647.
24. Glitza IC, Davies MA. Genotyping of Cutaneous Melanoma. Chin Clin Oncol 3(3):27, 2014. e-Pub 2014. PMID: 25632386.
25. Chen G, Davies MA. Targeted Therapy Resistance Mechanisms and Therapeutic Implications in Melanoma. Hematology/Oncology Clinics of North America 28(3):523-536, 2014. e-Pub 2014. PMID: 24880945.
26. Shtivelman E, Davies MA, Hwu P, Yang J, Lotem M, Oren M, Flaherty KT, Fisher DE. Pathways and therapeutic targets in melanoma. Oncotarget 5(7):1701-52, 2014. e-Pub 2014. PMID: 24743024.
27. Davies MA. Targeted Therapy for Cutaneous Melanoma: Beyond BRAF. J Patient-Centered Res Rev 1(1):12-20, 2014. e-Pub 2014.
28. Bucheit AD, Davies MA. Emerging insights into resistance to BRAF inhibitors in melanoma. Biochem Pharmacol 87(3):381-9, 2014. e-Pub 2014. PMID: 24291778.
29. Kwong LN, Davies MA. Targeted therapy for melanoma: rational combinatorial approaches. Oncogene 33(1):1-9, 2014. e-Pub 2014. PMID: 23416974.
30. Kwong LN, Davies MA. Navigating the therapeutic complexity of PI3K pathway inhibition in melanoma. Clin Cancer Res 19(19):5310-9, 2013. e-Pub 2013. PMID: 24089444.
31. Schutte DL, Davies MA, Goris ED. The implications of genomics on the nursing care of adults with neuropsychiatric conditions. J Nurs Scholarsh 45(1):79-88, 2013. e-Pub 2013. PMID: 23368536.
32. Woodman SE, Lazar AJ, Aldape KD, Davies MA. New strategies in melanoma: molecular testing in advanced disease. Clin Cancer Res 18(5):1195-200, 2012. e-Pub 2012. PMID: 22275506.
33. Davies MA. The role of the PI3K-AKT pathway in melanoma. Cancer J 18(2):142-7, 2012. e-Pub 2012. PMID: 22453015.
34. Chen G, Davies MA. Emerging insights into the molecular biology of brain metastases. Biochem Pharmacol 83(3):305-14, 2012. e-Pub 2012. PMID: 21946085.
35. Davies MA. Targeted therapy for brain metastases. Adv Pharmacol 65:109-42, 2012. e-Pub 2012. PMID: 22959025.
36. Davies MA, Gershenwald JE. Targeted therapy for melanoma: a primer. Surg Oncol Clin N Am 20(1):165-80, 2011. e-Pub 2011. PMID: 21111965.
37. Davies MA, Samuels Y. Analysis of the genome to personalize therapy for melanoma. Oncogene 29(41):5545-55, 2010. e-Pub 2010. PMID: 20697348.
38. Woodman SE, Davies MA. Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics. Biochem Pharmacol 80(5):568-74, 2010. e-Pub 2010. PMID: 20457136.
39. Davies MA, Sheffler DJ, Roth BL. Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology. CNS Drug Rev 10(4):317-36, 2004. e-Pub 2004. PMID: 15592581.
40. Mobbs RJ, Vonau M, Davies MA. Death after late failure of endoscopic third ventriculostomy: a potential solution. Neurosurgery 53(2):384-5; discussion 385-6, 2003. e-Pub 2003. PMID: 12925256.
41. Davies MA, Teo C. Management of traumatic cerebrospinal fluid fistula. J Craniomaxillofac Trauma 1(2):9-17, 1995. e-Pub 1995. PMID: 11951463.

Professional Educational Materials

1. Davies, MA, Lipson E. Metastatic Melanoma: Incorporating LAG3 Inhibitors Into the Treatment Paradigm. Medscape Oncology, 2023.
2. Davies MA, Ariyan C. SMR/Medscape Video Series titled, “A New Era of Progress for Melanoma: Leveling-Up with Immunotherapy”. Immune Checkpoint and BRAF/MEK Inhibitor-directed Therapies for Advanced Melanoma, 2022.

Other Articles

1. Herb J, Bassett RL, Torres-Cabala CA, Prieto VG, Patel SP, Holder AM, Fisher SB, Lucci A, Wargo J, Amaria RN, Davies MA, Glitza Oliva IC, Tawbi HA, McQuade J, Ikeguchi AP, Wong MK, Diab AK, Gershenwald JE, Ross MI, Weiser R Correction: Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal Dissection. Ann Surg Oncol 33(7):6758-6759, 2026. PMID: 42032252.
2. Nagarajan, P, Piao, J, Ning, J, Noordenbos, LE, Curry, JL, Torres Cabala, CA, Diwan, AH, Ivan, D, Aung, PP, Ross, MI, Royal, RE, Wargo, J, Wang, W, Samdani, RT, Lazar, A, Rashid, A, Davies, MA, Prieto, V, Gershenwald, JE, Tetzlaff, M Corrigendum to “Prognostic Model for Patient Survival in Primary Anorectal Mucosal Melanoma. Modern Pathology 38(8), 2025. PMID: 40541156.
3. Koul, D, Parthasarathy, R, Shen, R, Davies, MA, Jasser, SA, Chintala, SK, Rao, JS, Sun, Y, Benvenisite, EN, Liu, TJ, Yung, WA Retraction Note. Oncogene 44(17):1211, 2025. PMID: 40200095.
4. Hussey H, Vreede H, Davies MA, Heekes A, Kalk E, Hardie D, van Zyl G, Naidoo M, Morden E, Bam JL, Zinyakatira N, Centner CM, Maritz J, Opie J, Chapanduka Z, Mahomed H, Smith M, Cois A, Pienaar D, Redd AD, Preiser W, Wilkinson R, Boulle A, Hsiao NY Correction: SARS-CoV-2 seroepidemiology in Cape Town, South Africa, and implications for future outbreaks in low-income communities. PLOS Glob Public Health 5(6):e0004804, 2025. PMID: 40504816.
5. Kim, ST, Chu, Y, Misoi, MW, Suarez-Almazor, M, Tayar, JH, Lu, H, Buni, M, Kramer, J, Rodriguez, E, Hussain, Z, Neelapu, SS, Wang, RJ, Shah, AY, Tannir, NM, Campbell, M, Gibbons, DL, Cascone, T, Lu, C, Blumenschein, GR, Altan, M, Lim, B, Valero, V, Loghin, ME, Tu, J, Westin, SN, Naing, A, Garcia-Manero, G, Hassan, NA, Tawbi, H, Hwu, P, Oliva, IC, Davies, MA, Patel, SP, Zou, J, Futreal, A, Diab, A, Wang, L, Nurieva, R Author Correction. Nature communications 15(1), 2024. PMID: 38965214.
6. Glitza, IC, Ferguson, SD, Bassett Jr, R, Foster, AP, John, I, Hennegan, TD, Rohlfs, ML, Richard, J, Iqbal, M, Dett, TK, Lacey, C, Jackson, N, Rodgers, TE, Phillips, S, Duncan, S, Haydu, LE, Lin, R, Amaria, RN, Wong, MK, Diab, A, Yee, C, Patel, SP, McQuade, JL, Fischer, G, McCutcheon, IE, O'Brien, BJ, Tummala, S, Debnam, M, Guha-Thakurta, N, Wargo, J, Carapeto, F, Hudgens, CW, Huse, J, Tetzlaff, M, Burton, EM, Tawbi, H, Davies, MA Author Correction. Nature medicine 30(6):1787, 2024. PMID: 38649781.
7. Ford N, Patten G, Rangaraj A, Davies MA, Meintjes G, Ellman T Outcomes of people living with HIV after hospital discharge: a systematic review and meta-analysis. Lancet HIV 9(3):e150-e159, 2022. PMID: 35245507.
8. Woo, XY, Giordano, J, Srivastava, A, Zhao, ZM, Lloyd, M, de Bruijn, R, Suh, YS, Patidar, R, Chen, L, Scherer, S, Bailey, M, Yang, CH, Cortes-Sanchez, E, Xi, Y, Wang, J, Wickramasinghe, JM, Kossenkov, AV, Rebecca, VW, Sun, H, Mashl, RJ, Davies, S, Jeon, R, Frech, C, Randjelovic, J, Rosains, J, Galimi, F, Bertotti, A, Lafferty, A, O’Farrell, AC, Modave, E, Fang, B, Roth, JA, Meric-Bernstam, F, Davies, MA, Zheng, X, Zhang, X, Akcakanat, A, Yap, TA, Ha, MJ, Chen, H, Kopetz, S, Menter, DG, Westin, SN, Kim, M, Dai, B, Gibbons, DL, Tapia, C, Jensen, VB, Yennu Nanda, VG, Mælandsmo, GM Author Correction. Nature Genetics 53(5):761, 2021. PMID: 33608693.
9. Long GV, Flaherty KT, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, Garbe C, Jouary T, Hauschild A, Chiarion-Sileni V, Lebbe C, Mandala M, Millward M, Arance A, Bondarenko I, Haanen JBAG, Hansson J, Utikal J, Ferraresi V, Mohr P, Probachai V, Schadendorf D, Nathan P, Robert C, Ribas A, Davies MA, Lane SR, Legos JJ, Mookerjee B, Grob JJ Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study. Ann Oncol 30(11):1848, 2019. PMID: 31406976.
10. Johnson DH, Zobniw CM, Trinh VA, Ma J, Bassett RL Jr, Abdel-Wahab N, Anderson J, Davis JE, Joseph J, Uemura M, Noman A, Abu-Sbeih H, Yee C, Amaria R, Patel S, Tawbi H, Glitza IC, Davies MA, Wong MK, Woodman S, Hwu WJ, Hwu P, Wang Y, Diab A Correction to: Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis. J Immunother Cancer 7(1):107, 2019. PMID: 30995944.
11. Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JA Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med 24(12):1941, 2018. PMID: 30361510.
12. Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JA Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med 24(12):1942, 2018. PMID: 30361511.
13. Ford N, Shubber Z, Meintjes G, Grinsztejn B, Eholie S, Mills EJ, Davies MA, Vitoria M, Penazzato M, Nsanzimana S, Frigati L, O'Brien D, Ellman T, Ajose O, Calmy A, Doherty M Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis. Lancet HIV 2(10):e438-44, 2015. PMID: 26423651.
14. Mbeye NM, ter Kuile FO, Davies MA, Phiri KS, Egger M, Wandeler G Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health 19(9):1057-67, 2014. PMID: 25039469.
15. Mugglin C, Wandeler G, Estill J, Egger M, Bender N, Davies MA, Keiser O Retention in care of HIV-infected children from HIV test to start of antiretroviral therapy: systematic review. PLoS One 8(2):e56446, 2013. PMID: 23437135.
16. Wettstein C, Mugglin C, Egger M, Blaser N, Vizcaya LS, Estill J, Bender N, Davies MA, Wandeler G, Keiser O Missed opportunities to prevent mother-to-child-transmission: systematic review and meta-analysis. AIDS 26(18):2361-73, 2012. PMID: 22948267.
17. Koul D, Parthasarathy R, Shen R, Davies MA, Jasser SA, Chintala SK, Rao JS, Sun Y, Benvenisite EN, Liu TJ, Yung WK Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN. Oncogene 20(46):6669-78, 2001. PMID: 11709701.

Editorials

1. Mendelsohn AS, De Sa A, Morden E, Botha B, Boulle A, Paleker M, Davies MA. COVID-19 wave 4 in Western Cape Province, South Africa: Fewer hospitalisations, but new challenges for a depleted workforce. S Afr Med J 112(2):13496, 2022. PMID: 35139985.
2. Davies MA. Is It Safe to Stop Anti-PD-1 Immunotherapy in Patients With Metastatic Melanoma Who Achieve a Complete Response?. J Clin Oncol 38(15):1645-1647, 2020. PMID: 32097093.
3. Ford N, Penazzato M, Vitoria M, Doherty M, Davies MA, Zaniewski E, Tymejczyk O, Egger M, Nash D. The contribution of observational studies in supporting the WHO 'treat all' recommendation for HIV/AIDS. J Virus Erad 4(Suppl 2):5-8, 2018. PMID: 30515308.
4. Enane LA, Davies MA, Leroy V, Edmonds A, Apondi E, Adedimeji A, Vreeman RC. Traversing the cascade: urgent research priorities for implementing the 'treat all' strategy for children and adolescents living with HIV in sub-Saharan Africa. J Virus Erad 4(Suppl 2):40-46, 2018. PMID: 30515313.
5. de Waal R, Lessells R, Hauser A, Kouyos R, Davies MA, Egger M, Wandeler G. HIV drug resistance in sub-Saharan Africa: public health questions and the potential role of real-world data and mathematical modelling. J Virus Erad 4(Suppl 2):55-58, 2018. PMID: 30515315.
6. McQuade JL, Daniel CR, Hess KR, Davies MA. Sex as a predictor of response to cancer immunotherapy. Lancet Oncology 19(8):376, 2018. PMID: 30102226.
7. Davies MA, Hamlyn E. HIV and adolescents: challenges and opportunities. Curr Opin HIV AIDS 13(3):167-169, 2018. PMID: 29517500.
8. Davies MA. BRAF in early stage melanoma: rationale for testing and treatment?. Br J Dermatol 173(1):9-10, 2015. PMID: 26174638.
9. Davies MA, Pinto J. Targeting 90-90-90--don't leave children and adolescents behind. J Int AIDS Soc 18(Suppl 6):20745, 2015. PMID: 26639121.
10. Davies MA. Finding the Right Balance of BRAF Inhibition in Melanoma. Cancer Discov 4(5):510-2, 2014. PMID: 24795008.
11. Davies MA, Kopetz S. Overcoming resistance to MAPK pathway inhibitors. J Natl Cancer Inst 105(1):9-10, 2013. PMID: 23250957.
12. Davies MA. Special issue on melanoma. Cancer J 18(2):115-6, 2012. PMID: 22453010.

Abstracts

1. Burton E, Honaker V, Milton D, Glitza IC, Amaria R, Patel S, Diab A, Wong M, Mcquade J, Chung C, Wefel JS, Li J, Davies MA, Tawbi HA. Atezolizumab, bevacizumab, and cobimetinib (TACo) in patients (pts) with PD1 refractory melanoma brain metastases (MBM). 2023 ESMO Congress 34(S2):S652-S653, 2023. e-Pub 2023.
2. Glitza IC, Phillips S, John I, Bassett RL, Lin R, Rohlfs ML, Richard J, Iqbal M, Hennegan T, McCutcheon IE, Ferguson S, O'Brien B, Tummala S, Guha-Thakurta N, Debnam M, Tawbi HA, Burton E, Davies MA. Concurrent intrathecal (IT) and intravenous (IV) nivolumab (N) for melanoma (MM) patients (pts) with leptomeningeal disease (LMD). 2023 ESMO Congress 34(SUPPLEMENT 2):S652, 2023. e-Pub 2023.
3. Eroglu Z, Mehnert JM, Giobbie-Hurder A, Kendra KL, Kim In G, Salama AKS, Doolittle GC, Sosman JA, Valerin JB, Medina TM, Lutzky J, Moschos SJ, Khushalani NI, Markowitz J, Takebe N, Chen HX, Knight LW, Davies MA, Sullivan RJ. Randomized phase II trial of dabrafenib and trametinib with or without navitoclax in patients (pts) with BRAF-mutant (MT) metastatic melanoma (MM) (CTEP P9466). 2023 ASCO Annual Meeting, 2023. e-Pub 2023.
4. Glitza IC, John I, Phillips S, See L, Bassett RL, Lin R, Rohlfs ML, Richard J, Iqbal M, Hennegan T, McCutcheon IE, Ferguson SD, Morad G, O'Brien JO, Tummala S, Guha-Thakurta N, Debnam M, Tawbi HA, Burton EM, Davies MA. Safety and preliminary efficacy of intrathecal (IT) and intravenous (IV) nivolumab (N) for patients (pts) with leptomeningeal disease (LMD). 2023 ASCO Annual Meeting, 2023. e-Pub 2023.
5. Hennegan T, Burton EM, Simpson L, Prieto VG, Ross MI, Glitza IC, Beal LG, Gershenwald JE, Tawbi HA, Wong M KK, Wang Z, Bassett RL, Lucci A, Lee JE, Fisher SB, Patel SP, McQuade JL, Davies MA, Wargo JA, Amaria RN. Expanded cohort and extended follow-up of neoadjuvant plus adjuvant (neo + adj) dabrafenib (D) and trametinib (T) in patients (pts) with surgically resectable stage (stg) III/IV melanoma. 2023 ASCO Annual Meeting, 2023. e-Pub 2023.
6. Cass S, Tobin J, Seo YD, Gener-Ricos G, Keung E ZY, Burton EM, Walsh DM, Davies MA, McQuade JL, Lazar AJ, Hampel PJ, Wargo JA, Ferrajoli A. Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma (AM) in patients with concomitant chronic lymphocytic leukemia (CLL). 2023 ASCO Annual Meeting, 2023. e-Pub 2023.
7. Phillips S, Burton EM, Kreidieh FY, Glitza IC, McQuade JL, Amaria RN, Diab A, Patel SP, Wong M KK, Li J, Chung C, Milton DR, Malke J, Simon J, Wefei JS, Davies MA, Tawbi HA. Phase II study of nivolumab (nivo) in combination with relatlimab (rela) in patients (pts) with active melanoma brain metastases (MBM). 2023 ASCO Annual Meeting, 2023. e-Pub 2023.
8. Morad G, Yang Y, Duncan S, Ferguson SD, Wargo JA, Burton EM, Tawbi HA, Davies MA, Liang H, Glitza IC. Longitudinal single-cell (sc) immune profiling of cerebrospinal fluid (CSF) from melanoma patients (pts) with leptomeningeal disease (LMD) treated with intrathecal (IT) and intravenous (IV) nivolumab (N). 2023 ASCO Annual Meeting, 2023. e-Pub 2023.
9. Patel SP, Forget MA, Kreidieh FY, Pelster M, Davies MA, Amaria RN, Gombos DS, Bernatchez C. Tumor infiltrating lymphocyte (TIL) harvest and ex vivo expansion from primary and metastatic (met) uveal melanoma (UM) tumors. 2023 ASCO Annual Meeting, 2023. e-Pub 2023.
10. Hasanov M, Milton DR, Lo SN, Gershenwald JE, Simon J, Long GV, Scolyer RA, Davies MA. External validation and nomogram for risk factors of CNS metastasis in patients with clinically localized melanoma. 2023 ASCO Annual Meeting, 2023. e-Pub 2023.
11. Kumar S, Pelster MS, Hasanov M, Milton DR, Guerrieri RA, Hudgens C, Ledesma D, Wang F, Fischer G, Haydu LE, Yennu Nanda V, McQuade J, Kwong L, Huse J, Lazar AJ, Tetzlaff MT, Gershenwald JE, Joon AY, Chen K, Ram PT, Ferguson SD, Davies MA. Multivariate (MV) analysis of clinical, molecular and immune features associated with overall survival (OS) in patients (pts) with melanoma brain metastases (MBMs). The 19th International Congress of the Society for Melanoma Research, 2022. e-Pub 2022.
12. Hasanov M, Milton D, Davies AB, Sirmans E, Saberian C, Posada EL, Osusunju S, Gershenwald JE, Torres-Cabala CA, Burton EM, Colen R, Huse J, Glitza Oliva IC, Chung C, McAleer MF, McGovern SL, Yeboa DN, Kim BY, Prabhu SS, McCutcheon IE, Weinberg JS, Lang FF, Tawbi HT, Li J, Haydu LE, Ferguson SD, Davies MA. Changes in Overall Survival and Prognostic Factors in Melanoma Brain Metastasis (MBM) Patients. The 19th International Congress of the Society for Melanoma Research, 2022. e-Pub 2022.
13. Wilmott JS, Tawbi HT, Engh JA, Amankulor N, Shivalingam B, Banerjee H, Vergara IA, Lee H, Johansson PA, Ferguson PM, Saiag P, Robert C, Grob JJ, Butterfield LH, Scolyer RA, Kirkwood JM, Long GV, Davies MA. Clinical features associated with outcomes and biomarker analysis of dabrafenib plus trametinib (DT) in patients (pts) with BRAF-mutant melanoma brain metastases (MBMs). The 19th International Congress of the Society for Melanoma Research, 2022. e-Pub 2022.
14. de Groot E, Guerrieri RA, Knighton B, Wubbenhorst B, D'Andrea K, Xiao M, Baxter K, Kossenkov A, Herlyn M, Nathanson K, Davies MA, Roszik J, Yennu Nanda VG. Anti-melanoma activity of the PARP inhibitor (PARPi) Talazoparib combined with anti-PD1 in patient-derived xenografts (PDX) in a humanized mouse model. The 19th International Congress of the Society for Melanoma Research, 2022. e-Pub 2022.
15. Guerrieri RA, Fischer G, Kircher D, Ledesma D, Joon AY, Cortez JR, Knighton BG, Hudgens C, Hu Q, Yennu Nanda VG, Deng W, Haydu LE, Gershenwald JE, Lazar AJ, Tetzlaff MT, Holmen S, Davies MA. The Role of Oxidative Phosphorylation (OXPHOS) in Metastatic Melanoma (MM) Formation and Growth. The 19th International Congress of the Society for Melanoma Research, 2022. e-Pub 2022.
16. White MG, Vellano CP, Andrews MC, Witt RG, Chelvanambi M, McQuade JL, Burton EM, Chu Y, Lastrapes MJ, Lau M, Banerjee H, Lazar AJ, Davies MA, Woodman SE, Wang L, Moran AE, Long GV, Heffernan TP, Marszalek JR, Wargo JA. Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy. 2022 ASCO Annual Meeting, 2022. e-Pub 2022.
17. Abdel-Wahab N, Kus T, Bentebibel S, McQuade J, Glitza IC, Amaria R, Patel S, Wong MK, Tawbi H, Davies MA, Peterson S, Shete S, Yee C, Kavelaars A, Suarez-Almazor M, Diab A. Immune-Related Adverse Events and Symptom Burden in Melanoma Patients Receiving Adjuvant Immune Checkpoint Inhibitor. 2022 ASCO Annual Meeting, 2022. e-Pub 2022.
18. Wilmott JS, Banerjee H, Saiag P, Robert C, Grob J, Long GV, Davies MA. Baseline treatment with corticosteroids is associated with worse outcomes with dabrafenib and trametinib (DT) treatment in patients (pts) with BRAF-mutant melanoma brain metastases (MBMs) in COMBI-MB. 2022 ASCO Annual Meeting, 2022. e-Pub 2022.
19. Abdel-Wahab N, Montazari EJ, Spillson CA, Bentebibel S, Awiwi MO, Elsayes KM, Gao J, Altan M, Wong M, Glitza IC, Amaria R, McQuade J, Patel S, Tawbi H, Davies MA, Yee C, Sharma P, Allison J, Ekmekcioglu S, Diab A. Tocilizumab in Combination with Ipilimumab and Nivolumab in Solid Tumors. 2022 ASCO Annual Meeting, 2022. e-Pub 2022.
20. Wilmott JS, Banerjee H, Saiag P, Robert C, Grob J, Long GV, Davies MA. Association of baseline corticosteroid treatment with outcomes for patients (pts) with BRAF-mutant melanoma brain metastases (MBMs) in COMBI-MB treated with dabrafenib and trametinib (DT). 2022 ASCO Annual Meeting, 2022. e-Pub 2022.
21. Schadendorf D, Hauschild A, Mandalà M, Kirkwood JM, Robert C, Grob J, Nathan PD, Davies MA, Banerjee H, Shah R, Lau MR, Dummer R, Long GV. Adjuvant dabrafenib + trametinib (D + T) vs placebo in patients with resected stage III BRAFV600-mutant melanoma: updated 5-year distant metastases-free survival (DMFS) analysis of COMBI-AD. 2022 ASCO Annual Meeting, 2022. e-Pub 2022.
22. Fischer GM, Guerrieri RA, Hu Q, Carapeto FC, Joon AY, Gopal VY, Knighton B, Deng W, Haydu LE, Gershenwald JE, Lazar AJ, Tetzlaff MT, Davies MA. The role of oxidative phosphorylation (OXPHOS) in melanoma brain metastasis (MBM) formation and growth. AACR Virtual Annual Meeting 2021, 2021. e-Pub 2021.
23. Hahn A, Xu M, Li J, Haydu LE, Wadud Khan MA, Gide TN, Menzies AM, Hudgens CW, Nowicki TS, Gershenwald JE, Ribas A, Tetzlaff MT, Lazar AJ, Willmont J, Wargo J, Futreal A, Zhang J, Davies MA, McQuade JL. Obesity is associated with lower tumor oxidative phosphorylation (OXPHOS) in metastatic melanoma (MM). AACR Virtual Annual Meeting 2021, 2021. e-Pub 2021.
24. Pattipaka T, Davies MA, Sullivan R, Lang C, Lau M. Real-World Characterization of Pyrexia in Melanoma Patients Treated with Dabrafebib and Trametinib. 10th World Congress of Melanoma/17th EADO Congress 2021, 2021. e-Pub 2021.
25. Colen RR, Ologun GO, Zinn P, AK M, Arora R, Burton EM, Glitza IC, Tawbi H, Patel SP, Diab A, Wong MK, McQuade JL, Ross MI, Ahmed S, Elshafeey N, Gershenwald JE, Davies MA, Tetzlaff MT, Amaria RN, Wargo JA. Radiomic signatures to predict response to targeted therapy and immune checkpoint blockade in melanoma patients (pts) on neoadjuvant therapy. 2020 ASCO Virtual Scientific Program, 2020. e-Pub 2020.
26. Glitza IC, Phillips S, Brown C, Haymaker CL, Bassett RL, Lee JJ, Rohlfs ML, Richard J, Iqbal M, John I, McCutcheon IE, Ferguson SD, Heimberger AB, O'Brien BJ, Tummala S, Guha-Thakurta N, Debnam M, Burton EM, Tawbi H, Davies MA. Single-center phase I/Ib study of concurrent intrathecal (IT) and intravenous (IV) nivolumab (N) for metastatic melanoma (MM) patients (pts) with leptomeningeal disease (LMD). 2020 ASCO Virtual Scientific Program, 2020. e-Pub 2020.
27. Guerra V, Ologun GO, Haydu LE, Keung E, Burton EM, Tawbi H, Wierda WG, Davies MA, Wargo JA, Ferrajoli A. Efficacy of immune checkpoint inhibitors for the treatment of metastatic melanoma (MM) in patients with concurrent chronic lymphocytic leukemia (CLL). 2020 ASCO Virtual Scientific Program, 2020. e-Pub 2020.
28. Tawbi H, Peng W, Phillips S, Milton DR, Amaria RN, Diab A, Glitza IC, Patel SP, Wong MK, Yee C, McQuade JL, Tetzlaff MT, Lazar AJ, Shepherd M, Cain S, Burton EM, Hwu P, Davies MA. Safety results from phase I/II study of the PI3Kβ inhibitor GSK2636771 (G) in combination with pembrolizumab (P) in patients (pts) with PD-1 refractory metastatic melanoma (MM) and PTEN loss. 2020 ASCO Virtual Scientific Program, 2020. e-Pub 2020.
29. Ogata D, Haydu L, Glitza IC, Patel SP, Tawbi H, McQuade J, Diab A, Ekmekcioglu S, Wong M, Amaria R, Davies MA. The efficacy of anti-PD-1 in metastatic acral and mucosal melanoma patients (pts). 2019 SMR Congress, 2019. e-Pub 2019.
30. Rosenbaum S, Knecht M, Mollaee M, Zhong Z, Erkes DA, McCue P, Berger AC, Lo JA, Fisher DE, Gershenwald JE, Davies MA, Purwin TJ, Aplin A. FOXD3 regulates VISTA expression in melanoma. 2019 SMR Congress, 2019. e-Pub 2019.
31. Robert C, Grob JJ, Stroyakovskiy D, Karaszewska B, Hauschild A, Levchenko E, Sileni VC, Schachter J, Garbe C, Bondarenko I, Nathan P, Ribas A, Davies MA, Flaherty K, Burgess P, Tan M, Gasal E, Schadendorf D, Long GV. Characteristics of patients (pts) with a complete response (CR) treated with dabrafenib plus trametinib (D+T) combination therapy: findings from COMBI-d and COMBI-v 5-year analysis. 2019 SMR Congress, 2019. e-Pub 2019.
32. Rebecca VW, Xiao M, Fingerman D, Martorella A, Alicea G, Kossenkov A, Liu Q, Gopal V, Davies MA, Herlyn M. Drug repurposing screen using BTAFi/MEKi- and immunotherapy-resistant PDX identifies salvage strategies. 2019 SMR Congress, 2019. e-Pub 2019.
33. Capparelli C, Tiago M, Purwin T, Rosenbaum S, Cai W, Richard Z, Kumar G, Snook A, Rortina P, Cukierman E, Davies MA, Aplin A. Loss of SOX10 induces a transition to an invasive/dormant-like phenotype in Melanoma. 2019 SMR Congress, 2019. e-Pub 2019.
34. Pelster M, Haydu L, Gruschkus S, Gombos DS, Davies MA, Hwu P, Wong M, Amaria R, Diab A, Glitza IC, Tawbi H, McQuade J, Patel SP. CNS metastases in uveal melanoma. 2019 SMR Congress, 2019. e-Pub 2019.
35. Kircher DA, Parkman GL, Fischer GM, Stehn C, Grossmann AH, Boucher K, McMahon M, Davies MA, Mendoza MC, VanBrocklin MW, Holmen S. AKT1 E17K activates focal adhesion kinase and promotes melanoma brain metastasis. 2019 SMR Congress, 2019. e-Pub 2019.
36. Holbrook K, Lutzky J, Davies MA, Davis J, Glitza IC, Amaria R, Diab A, Patel SP, Amin A, Tawbi H. Intracranial Anti-Tumor Activity with Encorafenib Plus Binimetinib in Patients with Melanoma Brain Metastases: A Case Series. 2019 SMR Congress, 2019. e-Pub 2019.
37. Fischer GM, Carapeto F, Tetzlaff M, Hudgens C, Huse J, Davies MA, Ferguson S. Preclinical modeling of leptomeningeal disease (LMD) from melanoma to facilitate therapeutic development. 2019 SMR Congress, 2019. e-Pub 2019.
38. Davies MA, Weber JS, Flaherty K, McArthur G, Hamid O, Reddy M, Golden A, Culbertson J, Thomas C, Tawbi H, Long GV. A Phase 2, open-label, randomized, multicenter trial of Encorafenib + Binimetinib evaluating a standard-dose and a high-dose regimen in patients with BRAFV600-mutant melanoma brain metastasis (MBM) (POLARIS). 2019 SMR Congress, 2019. e-Pub 2019.
39. Syeda MM, Wiggins J, Davies MA, Robert C, Long GV, Grob JJ, Flaherty K, Gasal E, Squires M, Garrett J, Brase J, Polsky D. Circulating tumor DNA (ctDNA) kinetics and survival outcomes in patients (pts) with metastatic melanoma (MM) and brain metastases (BM) treated with dabrafenib (D)+ trametinib (T) in the COMBI-MB trial. 2019 SMR Congress, 2019. e-Pub 2019.
40. Saberian C, Ludford K, Roszik J, Gruschkus S, Johnson DH, Bernatchez C, Davies MA, Haymaker C, Diab A. Analysis of tumor mutation burden (TMB), PD-L1 status and clinical outcomes with checkpoint inhibitors (CPI) in acral melanoma (AM). 2019 SMR Congress, 2019. e-Pub 2019.
41. Menzies AM, Rozeman EA, Amaria RN, Huang AC, Scolyer RA, Tetzlaff MT, Van de Wiel BA, Lo S, Tarhini A, Tawbi H, Burton EM, Karakousis G, Ascierto PA, Spillane A, Davies MA, Van Akkooi AC, Mitchell TC, Long GV, Wargo JA, Blank CU. Pathological response and survival with neoadjuvant therapy in melanoma: A pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC). 2019 ASCO Annual Meeting, 2019. e-Pub 2019.
42. Amaria RN, Haymaker CL, Forget M, Bassett R, Cormier JN, Davies MA, Diab A, Gershenwald JE, Glitza IC, Lee JE, Lucci A, McQuade JL, Patel SP, Royal RE, Ross M, Tawbi H, Wargo J, Wong MK, Bernatchez C, Hwu P. Lymphodepletion (LD), tumor-infiltrating lymphocytes (TIL) and high (HD-IL2) versus low-dose (LD-IL2) IL-2 followed by pembrolizumab (pembro) in patients (pts) with metastatic melanoma (MM). 2019 ASCO Annual Meeting, 2019. e-Pub 2019.
43. Jones AL, Joon A, Haydu LE, Lazar AJ, Tetzlaff MT, Ravi V, Davies MA. Outcomes of melanoma soft parts/clear cell sarcoma (MSP/CCS) patients (pts) with immune and targeted therapies. 2019 ASCO Annual Meeting, 2019. e-Pub 2019.
44. Syeda MM, Wiggins J, Corless B, Long GV, Flaherty K, Schadendorf D, Nathan PD, Robert C, Ribas A, Davies MA, Grob JJ, Gasal E, Squires M, Marker M, Brase JC, Polsky D. Circulating tumor DNA (ctDNA) kinetics to predict survival in patients (pts) with unresectable or metastatic melanoma treated with dabrafenib (D) or D + trametinib (T). 2019 ASCO Annual Meeting, 2019. e-Pub 2019.
45. Nathan PD, Robert C, Grob JJ, Stroyakovskiy D, Karaszewska B, Hauschild A, Levchenko E, Sileni VC, Schachter J, Garbe C, Bondarenko I, Davies MA, Ribas A, Flaherty K, Burgess P, Tan M, Gasal E, Schadendorf D, Long GV. Five-year analysis on the long-term effects of dabrafenib plus trametinib (D + T) in patients with BRAF V600–mutant unresectable or metastatic melanoma. 2019 ASCO Annual Meeting, 2019. e-Pub 2019.
46. Burton EM, Woody T, Glitza IC, Amaria RN, Keung E, Diab A, Patel SP, Wong MK, Yee C, Hwu P, McQuade JL, Woodman SE, Tetzlaff MT, Davies MA, Wargo JA, Rai K, Tawbi H. A phase II study of oral azacitidine (CC-486) in combination with pembrolizumab (PEMBRO) in patients (pts) with metastatic melanoma (MM). 2019 ASCO Annual Meeting, 2019. e-Pub 2019.
47. Yennu Nanda VG, Gammon S, Prasad R, Knighton B, Pisaneschi F, Feng N, Williams L, Pramanik S, Sudderth J, Sui D, Fischer GM, Deng W, Peng W, Wang J, McQuade JL, Tetzlaff M, Di Francesco ME, Marszalek J, Piwnica-Worms D, DeBerardinis RJ, Davies MA. A novel mitochondrial inhibitor overcomes resistance to BRAF and MEK inhibition in melanoma. 2019 Melanoma Research Alliance 11th Annual Scientific Retreat, 2019. e-Pub 2019.
48. Carapeto FCL, Fischer GM, Joon AY, Chen H, Haydu L, Lee S, Saul M, Appana S, Thompson JF, Mann GJ, McQuade JL, Lazar AJ, Kirkwood J, Scolyer RA, Long GV, Davies MA. Analysis of molecular and immune features that correlate with serum lactate dehydrogenase (LDH) levels in patients (pts) with metastatic melanoma. AACR Special Conference on Melanoma: From Biology to Target, 2019. e-Pub 2019.
49. Fischer GM, Kotrotsou A, Ahmed S, O'Neal P, Sahnoune I, Yennu-Nanda VG, Hudgens C, Knighton B, Colen R, Tetzlaff MT, Davies MA. Molecular, immunological, metabolic, and radiomic associations of oxidative phosphorylation (OXPHOS) in melanoma brain metastases (MBMs). AACR Special Conference on Melanoma: From Biology to Target, 2019. e-Pub 2019.
50. Nagarajan P, Piao J, Ning J, Noordenbos LE, Curry JL, Torres-Cabala CA, Diwan AH, Aung PA, Ivan D, Ross MI, Royal RE, Wargo JA, Wang WL, Samdani R, Lazar AJ, Rashid A, Davies MA, Prieto VG, Gershenwald JE. Prognostic Model for Disease Specific Survival in Anorectal Melanoma. AACR Special Conference on Melanoma: From Biology to Target, 2019. e-Pub 2019.
51. Davies MA. Will Targeted Therapy Replace Radiation for Melanoma Brain Metastases?. 2019 ASCO Annual Meeting, 2019. e-Pub 2019.
52. Tiago M, Capparelli C, Erkes D, Purwin TD, Davies MA, Aplin AE. BET proteins inhibition to optimize BRAFi/MEKi therapy for mutant BRAF melanoma. 2018 SMR Congress International Meeting, 2018. e-Pub 2018.
53. Glitza IC, Rohlfs ML, Iqbal M, Ricahrd J, Burton E, Duncan S, Brown C, Anderson J, Hwu P, Hwu WJ, Yee C, Patel S, Woodman S, Amaria R, Diab A, Tawbi H, Davies MA. A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) For melanoma patients (pts) with leptomeningeal disease (LMD). ESMO 2018 Congress International, 2018. e-Pub 2018.
54. Andrews MC, Chen S, Prieto P, Marszalek J, Hudgens C, Tetzlaff MT, Amaria R, Gershenwald J, Davies MA, Arur S, Heffernan TP, Wargo J. Sexual dimorphism in response to BRAF mut melanoma target therapy. 2018 SMR International Congress Meeting, 2018. e-Pub 2018.
55. Fischer GM, Yennu-Nanda VG, Tetzlaff MT, Lazar AJ, Carapeto F, de Macedo MP, Hudgens C, Holmen SL, Kircher DA, Knighton B, Davies MA. Oxidative Phosphorylation (OXPHOS): A Feature, Driver, and Therapeutic Target in Melanoma Brain Metastases (MBMs). 2018 SMR International Congress Meeting, 2018. e-Pub 2018.
56. McQuade JL, Gopalakrishnan V, Spencer C, Andrews MC, Helmink B, Cogdill AP, Sirmans E, Haydu LE, Posada E, Burton E, Glitza I, Amaria R, Patel S, Diab A, Wong M, Tawbi HA, Hwu WJ, Davies MA, Hwu P, Jenq R, Nelson K, Daniel CR, Cohen L, Wargo J. The gut microbiome of melanoma patients is distinct from that of healthy individuals and is impacted by probiotic and antibiotic use. 2018 SMR International Congress Meeting, 2018. e-Pub 2018.
57. Reddy S Helmink B, Zhang S, Blando J, Han G, Amaria R, Tawbi HA, Davies MA, Hwu P, Lee J, Gershenwald J, Burton E, Hudgens C, Keung E, Gaudreau P, Gopalakrishnan V, Reuben A, Andrews MC, Spencer C, Allison J, Sharma P, Tetzlaff MT, Wang L, Wargo J. B cell signature predicts survival in melanoma and response to immune checkpoint blockade (ICB). 2018 SMR International Congress Meeting, 2018. e-Pub 2018.
58. Johnson DH, Bentebibel SE, Lecagoonporn S, Bernatchez C, Haymaker CL, Murthy R, Tam A, Yee C, Amaria RN, Patel SP, Tawbi H, Glitza IC, Davies MA, Hwu WJ, Hwu P, Overwijk WW, Diab A. Phase I/II dose escalation and expansion cohort safety and efficacy study of image guided intratumoral CD40 agonistic monoclonal antibody APX005M in combination with systemic pembrolizumab for treatment naive metastatic melanoma. 2018 ASCO Annual Meeting, 2018. e-Pub 2018.
59. McQuade JL, Betof Warner A, Li M, Chon J, Haydu LE, Carrie D, Hess KR, Johnson DB, Menzies AM, Davies MA, Shoushtari AN. Association of body mass index (BMI) with overall survival (OS) in metastatic melanoma (MM) patients (pts) treated with combined anti-CTLA4 + anti-PD1. ASCO Annual Meeting 2018, 2018. e-Pub 2018.
60. Schvartsman G, Ma J, Bassett RL, Haydu LE, Amaria RN, Hwu P, Hwu WJ, Diab A, Patel SP, Wong MK, Woodman S, Davies MA, Glitza IC, Tawbi H. Outcomes of metastatic melanoma (MM) patients (pts) after discontinuation of anti-Programmed-Death 1 (PD1) therapy without disease progression. 2018 ASCO Annual Meeting, 2018. e-Pub 2018.
61. Peng W, Chunyu X, Melendez B, Jackson H, McKenzi JA, Williams LJ, Chen Y, Mbofung RM, Leahey SE, Lizee G, Davies MA, Yanamandra N, Hwu P. OX40 agonist antibody-based combination therapy with PI3Kβ selective inhibitor enhances T cell immunity. AACR Annual Meeting 2018, 2018. e-Pub 2018.
62. de Macedo PM, Wang F, Marzese DM, Hudges CW, Wani K, Haydu LE, Danaher P, Merritt C, Ong G, Warren S, Beechem JM, Hoon DSB, Peng W, Kwong L, Tetzlaff MT, Lazar AJ, Davies MA. In-depth Molecular and Immune Characterization of Melanomas with Heterogeneous PTEN Expression. Society of Immunotherapy of Cancer, 2017. e-Pub 2017.
63. de Macedo MP, Wang F, Marzese DM, Hudgens CW, Wani K, Siroy AE, Haydu LE, Danaher P, Merritt C, Ong G, Warren S, Beechem JM, Hoon DSB, Peng W, Tetzlaff M, Lazar A, Davies MA. In-depth molecular and immune characterization of melanoma with heterogeneous PTEN expression. World Congress for Melanoma, 2017. e-Pub 2017.
64. Schadendorf D, Long GV Grog JJ, Nathan P, Ribas A, Davies MA, Flaherty KT, Squires M, Jaeger S, Powell W, Tan P Robert C. PD-L1 and CD8 expression and association with outcomes in patients (pts) with BRAF V600E/K–mutant metastatic melanoma (MM) who received dabrafenib + trametinib (D+T) in the randomized phase 3 COMBI-v study. ASCO Annual Meeting 2017, 2017. e-Pub 2017.
65. Davies MA, Robert C, Long GV, Grob JJ, Flaherty KT, Arance A, Sileni-Chiarion V, Thomas L, Lesimple T, Mortier L, Moschos S, Hogg D, Rodas IM, Del Vecchio M, Lebbe C, Meyer N, Zhang Y, Huang Y, Mookerjee B, Saiag P. COMBI-MB: a phase 2 study of combination dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600–mutant (mut) melanoma brain metastases (MBM). 2017 ASCO Annual Meeting, 2017. e-Pub 2017.
66. Chen WS, Andrews MC, Spencer C, Tawbi HAH, Lazar A, Tetzlaff MT, Patel SP, Hwu P, Hwu WJ, Diab A, Glitza IC, Amaria RN, Burton EM, Woodman SE, Davies MA, Gershenwald JE, Sharma P, Allison JP, Futreal A, Wargo JA. Molecular and immune predictors of response and toxicity to combined CTLA-4 and PD-1 blockade in metastatic melanoma (MM) patients (pts). ASCO Annual Meeting 2017, 2017. e-Pub 2017.
67. Janku F, De Groot JF, Javle MM, Prado-Penas M, Shroff RT, Luthra R, Banks K, Lanman RB, Conley AP, Broaddus R, Davies MA, Kopetz S, Yung WKA, Heymach J, Fu S, Shaw KR, Meric-Bernstam F. Simultaneous molecular alterations in solid tumors with IDH1 or IDH2 mutations. ASCO Annual Meeting 2017, 2017. e-Pub 2017.
68. Wargo JA, Gopalakrishnan V, Spencer C, Karpinets T, Reuben A, Andrews MC, Tetzlaff MT, Lazar M, Hwu P, Hwu WJ, Glitza IC, Tawbi HAH, Patel SP, Lee JE, Davies MA, Gershenwald JE, Futreal A, Sharma P, Allison JP, Jenq RR. Diversity and composition of the gut microbiome are associated with enhanced responses and improved progression-free survival (PFS) in metastatic melanoma (MM) patients (pts) on anti-PD-1 therapy. ASCO Annual Meeting 2017, 2017. e-Pub 2017.
69. Wargo JA, Amaria RN, Prieto PA, Andrews MC, Tetzlaff MT, Futreal PA, Hwu P, Hwu WJ, Glitza IC, Tawbi HAH, Cormier JN, Lee JE, Patel SP, Simpson L, Burton EM, Jr BR, Ross MI, Gershenwald JE, Davies MA, Woodman SE. Treatment with neoadjuvant and adjuvant dabrafenib + trametinib (D+T) compared to standard-of-care (SOC) surgery and to identify targets to enhance responses in patients (pts) with high-risk resectable BRAF-mutant metastatic melanoma. ASCO Annual Meeting 2017, 2017. e-Pub 2017.
70. McKean MA, Haydu LE, Ma J, Jr BR, Hwu WJ, Patel, SP, Diab A, Glitza IC, Tawbi HAH, Wong MK, McQuade JL, Hwu P, Davies MA, Amaria RN. Prognostic factors for overall survival (OS) in metastatic melanoma (MM) treated with immune checkpoint inhibitors: A single institution study of 696 patients. ASCO Annual Meeting 2017, 2017. e-Pub 2017.
71. Menzies AM, Rozeman EA, Amaria RN, Scolyer RA, Tetzlaff MT, Guminski A, Davies MA, Blank CU, Wargo JA, Long GV. Preliminary results from the international neoadjuvant melanoma consortium (INMC). ASCO Annual Meeting 2017, 2017. e-Pub 2017.
72. Schvartsman G, Ma J, Jr BR, Haydu LE, Amaria RN, Hwu P, Hwu WJ, Diab A, Patel SP, Davies MA, Tawbi HAH. Incidence, patterns of progression and outcomes of melanoma brain metastasis (MBM) during programmed-death 1 inhibitor (PD1i) therapy. ASCO Annual Meeting 2017, 2017. e-Pub 2017.
73. Patel SP, Glitza IC, Diab A, Amari RN, Davies MA, Hwu P, Tawbi HAH, Hwu WJ. The safety and early efficacy of high-dose ipilimumab (IPI) and the combination nivolumab plus ipilimumab (NIVO + IPI) in patients (pts) with uveal melanoma (UM). ASCO Annual Meeting 2017, 2017. e-Pub 2017.
74. Teh, Jessica NIkbakht N, Purwin TJ, Chervoneva I, Davies MA, Aplin AA. In vivo E2F reporting on efficacious dosing schedule MEK plus CDK inhibition in melanoma. 2016 SMR Congress, 2016. e-Pub 2016.
75. Long DV, FLaherty KT, Schadendorf D, Nathan P, Robert C, Ribas A, Davies MA, Lane S, Legos JJ, Mookerjee B, Grob JJ. Patients characteristics associated with >36-mo clinical benefit with combination dabrafenib and trametinib (D+T) in COMBI-d. 2016 SMR Congress, 2016. e-Pub 2016.
76. McQuade JL, Wang DY, Rai R, Park J, Spencer C, McKean M, Beckermann K, Nahar K, Rubinstein S, Guminski A, Lo S, Sosman JA, Wargo JA, Daniel C, Long GV, Hwu P Hess K, Carlin MS, Menzies A, Johnson DB, Davies MA. High body mass index (BMI) is associated with improved clinical outcomes in metastatic melanoma patients treated with anti-PD1: differences by gender. 2016 SMR Congress, 2016. e-Pub 2016.
77. Cheng H, Chua V, Purwin TJ, Terai M, Liao C Kageyama K, Davies MA, Sato T, Aplin AE. Co-targeting HGF0cMET signaling with MEK inhibitors in metastatic uveal melanoma. 2016 SMR Congress, 2016. e-Pub 2016.
78. Capparelli, Purwin TJ, Davies MA, Aplin AE. Stromal neuregulin-1 modulates the response to MEK inhibitors in WT BRAF/WT NRAS (WT/WT) melanoma. 2016 SMR Congress, 2016. e-Pub 2016.
79. Bindal S, Ferguson S, Davies MA, Haydu L, Basset R JR, McCutcheon I, Glitza IC. Leptomeningeal disease (LMD) from metastatic melanoma: a single institution experience and predictors of survival. 2016 SMR Congress, 2016. e-Pub 2016.
80. Maria, RN, Prieto P, Tetzlaff M, Diab A, Patel S, Woodman SE, Hwu WJ, Glitza IC, Hwu P, Tawbi H, McQuade JL, Cormier J, Lucci A, Royal R, Lee J, Bassett R, Simpson L, Burton EM, Grimm EA, Reuben A, Spencer C, Gershenwald JE, Ross M, Davies MA, Wargo JA. Treatment with neoadjuvant + adjuvant dabrafenib and trametinib (D+T) is associated with imporoved relapse-free survival (RFS versus standard of care (SOC) therapy in ptients with high-risk resectable BRAF-mutant melanoma. 2016 SMR Congress, 2016. e-Pub 2016.
81. Long GV, Flaherty KT, Schadendorf D, Nathan P, Robert C, Ribas A, Davies MA, Lane S, Legos J, Mookerjee B, Grob JJ. Patient Characteristics Associated With ≥ 36-month Clinical Benefit With Combination Dabrafenib and Trametinib in COMBI-d. ESMO 2016 Scientific, 2016. e-Pub 2016.
82. Kim DW, Haydu LE, Joon A, Bassett RL, Siroy A, Tetzlaff MT, Lazar A, Woodman SE, Gershenwald JE, Davies MA. Pathological and clinical features of non-acral cutaneous melanoma (CM) patients (pts) with TP53 and BRAFnon-V600 (NonV600) mutations (muts). ASCO Annual Meeting 2016, 2016. e-Pub 2016.
83. Menzies AM, Johnson DB, Ramanujam S, Atkinson V, Wond ANM, Parker JJ, McQuade JL Shoushtari AN, Tsai KK, Eroglu Z, Klein O, Hassel JC, Sosman JA, Guminski A, Sullivan RJ, Ribas A, Carlin MS, Davies MA, Sandhu SK, Long GV. Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders (AD) or major toxicity with ipilimumab (IPI). ASCO Annual Meeting 2016, 2016. e-Pub 2016.
84. Barcena E, Trinh V, McIntyre SE, Simien R, Cain S, Diab A, Amaria RN, Patel SP, Glitza IC, Tawbi HAH, Davies MA, Hwu WJ. Responses in patients with BRAF V600-mutant metastatic melanoma receiving anti-PD1/PDL1 therapy alone or combined with BRAF inhibitors. ASCO Annual Meeting 2016, 2016. e-Pub 2016.
85. Shaw AC, Trinh V, Bassett RL, Glitza IC, Diab A, Amaria RN, Tawbi HAH, Davies MA, Hwu WJ, Hwu P, Patel SP. Retrospective analysis of safety and efficacy of ipilimumab in elderly patients with advanced melanoma. ASCO Annual Meeting 2016, 2016. e-Pub 2016.
86. Flaherty K, Davies MA, Grob JJ, Long DV, Nathan PD, Ribas A, Robert C, Schadendorf D, Frederick DT, Hammond MR, Valbuena-Jane J, Mu XJ, Squires M, Jaeger SA, Lane ST, Mookerjee B, Garraway LA. Genomic analysis and 3-y efficacy and safety update of COMBI-d: A phase 3 study of dabrafenib (D) + trametinib (T) vs D monotherapy in patients (pts) with unresectable or metastatic BRAF V600E/K-mutant cutaneous melanoma. ASCO Annual Meeting 2016, 2016. e-Pub 2016.
87. Sullivan RJ, Barbash Z, Edelheit O, Vidne M, Sosman JA, Flaherty K, Davies MA, Johnson DB, Tarcic G. Functional characterization of non-V600 BRAF mutations and their response to Trametinib (Tram). ASCO Annual Meeting 2016, 2016. e-Pub 2016.
88. Amaria RN, Haymaker CL, Bernatchez C, Forget MA, Patel V, Hwu WJ, Davies MA, Patel SP, Diab A, Glitza IC, Tawbi HAH, Woodman SE, Wargo JA, Ross MI, Lee JE, Gershenwald JE, Cormier JN, Royal RE, Lucci A, Hwu P. A phase I/II study of lymphodepletion plus adoptive cell transfer (ACT) with T cells transduced with CXCR2 and NGFR followed by high dose interleukin-2 (IL-2) in patients with metastatic melanoma (MM). ASCO Annual Meeting 2016, 2016. e-Pub 2016.
89. Grob JJ, Flaherty K, Long GV, Nathan PD, Schadendorf D, Ribas A, Robert C, Lane SR, Mak C, Legenne P, Davies MA. Pooled analysis of safety over time and link between adverse events and efficacy across combination dabrafenib and trametinib (D+T) registration trials. ASCO Annual Meeting 2016, 2016. e-Pub 2016.
90. Rohlfs, M, Bassett RL, Lacey C, McQual N, Mehta U, John I, Simien R, Tupue S, Dett TK, Glitza IC, Diab A, Amaria RN, Tawbi HAH, Davies MA, Hwu WJ, Hwu P, Patel SP. BRAF with or without MEK inhibition plus PD-1 checkpoint blockade for the treatment of metastatic melanoma. ASCO Annual Meeting 2016, 2016. e-Pub 2016.
91. McQuade JL, Haydu LE, Frankian S, Spencer C, Long GV, Brob JJ, Lane SR, Legenne P, Flaherty K, Hwu P, Hess KR, Davies MA. The impact of obesity on outcomes in metastatic melanoma (MM) patients (pts) treated with dabrafenib and trametinib. ASCO Annual Meeting 2016, 2016. e-Pub 2016.
92. Wargo JA, Amaria RN, Ross MI, Saw RPM, Gershenwald JE, Hwu P, Patel SP, Glitza IC, Diab A, Kefford R, Scolyer RA, Rizos H, Thompson JF, Shannon K, Spillane A, Carlino MS, Guminski A, Simpson L, Davies MA, Long GV. Neoadjuvant BRAF (dabrafenib) and MEK (trametinib) inhibition for high-risk resectable stage III and IV melanoma. ASCO Annual Meeting 2015, 2015. e-Pub 2015.
93. Amaria RN, Bassett RL, Simpson L, Delaney F, Hwu P, Kim K, Hwu WJ, Patel SP, Glitza IC, Davies MA, Woodman SE, Yee C, Bedikian AY. Phase I study of ipilimumab (IPI) with biochemotherapy (BCT) for chemonaïve patients with metastatic melanoma (MM). ASCO Annual Meeting 2015, 2015. e-Pub 2015.
94. Diab A, Martin A, Simpson L, Algazi AP, Chawla P, Kim DW, Santra S, Patel V, Jadhav N, Abhyankar D, Davies MA, Buch SC, Kim K, Daud A. Phase I trial of the CDK 4/6 inhibitor, P1446A-05 (voruciclib) in combination with the BRAF inhibitor (BRAFi), vemurafenib in advanced, BRAF-mutant melanoma. ASCO Annual Meeting 2015, 2015. e-Pub 2015.
95. McQuade JL, Chen G, Panka DJ, Reuben A, Bassett RL, Joon A, Lazar AJF, Tetzlaff MT, Simpson L, Mouton R, Patel SP, Glitza IC, Hwu WJ, Amaria RN, Diab A, Hwu P, Wargo JA, Sullivan RJ, Kim K, Davies MA. Phase II study of dabrafenib and trametinib following progression on BRAF inhibitor monotherapy in metastaticmelanoma: Exploration of clinical and molecular predictors of response. ASCO Annual Meeting 2015, 2015. e-Pub 2015.
96. Meric-Bernstam F, Brusco L, Daniels MS, Strong LC, Shaw KR, Lu KH, Qi Y, Lara-Guerra H, Litton JK, Zhao H, Eterovic AK, Arun B, Routbort M, Janku F, Davies MA, Kopetz S, Mendelsohn J, Mills GB, Chen K. Prevalence of incidental actionable germline mutations in 1,000 advanced cancer patients on a prospective somatic genomic profiling program. ASCO Annual Meeting 2015, 2015. e-Pub 2015.
97. Amaria RN, Wargo JA, Cooper ZA, Tetzlaff MT, Reuben A, Davies MA, Gershenwald JE, Jiang H, Austin-Breneman J, Lee JE, Hwu P, Hwu WJ, Cormier JN, Royal RE, Lucci A, Patel SP, Diab A, Glitza IC, Burton EM, Ross MI. Treatment with neoadjuvant BRAF Inhibition Yields Responses in Patients (pts) with High Risk Borderline Resectable Stage III Melanoma. ASCO Annual Meeting 2015, 2015. e-Pub 2015.
98. Bedard PL, Davies MA, Kopetz S, Flaherty KT, Shapiro G, Luke JJ, Spreafico A, Wu B, Gomez C, Cartot-Cotton S, Mazuir F, Micallef S, Demers B, Juric D. First-in-human phase I trial of the PI3Kb-selective inhibitor SAR260301 in patients with advanced solid tumors (NCT01673737). ASCO Annual Meeting 2015, 2015. e-Pub 2015.
99. Davies MA, Joon A, Bassett RL, Roszik J, Siroy A, Haydu LE, Chen K, Stingo F, Baladandayuthapani V, Shaw KR, Meric-Bernstam F, Tetzlaff MT, Gershenwald JE, Woodman SE, Lazar AJF. Demographics, tumor characteristics, and clinical outcomes associated with somatic mutations in 201 cancer-related genes in advanced melanoma patients (pts). ASCO Annual Meeting 2015, 2015. e-Pub 2015.
100. Haydu LE, Calderone TL, Miller J, Bassett RL, Joon A, Zhang J, Morgan MB, Shaw KR, Cooper ZA, Burton EM, Siroy A, Wani KM, Stingo F, Baladandayuthapani V, Tetzlaff MT, Wargo JA, Lazar AJF, Davies MA, Gershenwald JE. Comparison of DNA and RNA analyte extraction and melanin removal methods from formalin-fixed parraffin-embedded (FFPE) melanoma. ASCO Annual Meeting 2015, 2015. e-Pub 2015.
101. Roszik J, Joon A, Siroy A, Haydu LE, Stingo F, Baladandayuthapani V, Hwu P, Tetzlaff MT, Wargo JA, Chen JQ, Laszlo GR, Bernatchez C, Gershenwald JE, Lazar AJF, Davies MA, Woodman SE. A novel algorithm applicable to cancer next-generation sequencing panels to predict total tumor mutation load and correlation with clinical outcomes in melanoma. ASCO Annual Meeting 2015, 2015. e-Pub 2015.
102. Oba J, Wang WL, Eterovic AK, Stephan CC, Roszik J, Kale CR, Haymaker CL, Routbort M, Haydu LE, Bernatchez C, Davies MA, Lazar AJF, Grimm EA, Woodman SE. A global genomic and small molecule inhibitor interrogation of KIT mutant melanoma to reveal underlying biology and novel molecular targets. ASCO Annual Meeting 2015, 2015. e-Pub 2015.
103. Patel SP, L S, Rohlfs ML, Fox PS, Richard J, Iqbal M, Bernzen T, Glitza IC, Papdopoulos NE, Hwu P, Davies MA. BRAF and NRAS mutations in Metastatic Melanoma Patients with Leptomeningeal Disease. ASCO Annual Meeting 2015, 2015. e-Pub 2015.
104. Kemnade J, Roszik J, Joon A, Stingo F, Baladandayuthapani V, Lazar AJF, Woodman SE, Davies MA. Identification of potentially actionable mutations in RTKs in melanoma detected by next generation sequencing (NGS). ASCO Annual Meeting 2015, 2015. e-Pub 2015.
105. Joon A, Haydu L, Baladandayuthapani V, Stingo F, Woodman S, Amaria A, Wargo J, shaw K, Meric-Bernstam F, Mills G, Gershenwald J, Hwu P, a L, Davies MA. Next generation sequencing of 201 cancer-related genes in melanoma. Society for Melanoma Research 2014 Congress, 2014. e-Pub 2014.
106. Yan Jiang, Farias, R., Holly, A, E., Levy, E. J., Klein, L., Rains, J., Sirmans, E., Burton, E. M., Wang, Amaria, R. N, Davies, M. A., Glitza, I. C., Patel, S. P., Diab, A., Tawbi, H. A., Wong, M. K. K., Ikeguchi, A., Wargo, J. A, Daniel-MacDougall, C., McQuade, J. L.. The DIET study: A randomized controlled trial of a high fiber diet intervention (HFDI) in melanoma patients (pts) receiving immune checkpoint blockade (ICB).
107. Afsaneh Amouzegar, Merve Hasanov, Ahmed Ali, Denái R Milton, Julie M Simon, Jene Samuels, Khalida M Wani, Debora Ledesma, Elizabeth Burton, Courtney W. Hudgens, Hussein Tawbi, Jeffrey E. Gershenwald, Alexander J. Lazar, Davies MA. Association of KIT mutations with risk of central nervous system (CNS) metastasis (met) in patients (pts) with mucosal melanoma (MM). ASCO Annual Meeting 2025.

Book Chapters

1. Hasanov, M, Acikgoz, Y, Davies, MA. Melanoma Brain Metastasis. In: Hematology/Oncology Clinics of North America, 1027-1043, 2024.
2. Safa H, Mattei J, Bishop AJ, Keung EZ, Yadugiri S, Davies MA, Glitza IC. Melanoma. In: The MD Anderson Manual of Medical Oncology. 4. McGraw Hill, 2022.
3. Margolin K, Davies MA, Kluger H, Tawbi H. Melanoma Brain Metastases: Unique Biology and Implications for Systemic Therapy. In: Cutaneous Melanoma. 6th. Springer, Cham, 1-34, 2019.
4. Fischer GM, Davies MA. Melanoma Brain Metastasis: Insights, Progress Challenges, and Opportunities. In: Melanoma. Springer, 1-21, 2019.
5. Glitza IC, Heimberger AB, Sulman EP, Davies MA. Prognostic factors for survival in melanoma patients with brain. In: Brain Metastases from Primary Tumors. Academic Press, 267-297, 2016.
6. Siroy AE, Davies MA, Lazar AJ. The PI3K-AKT Pathway in Melanoma. In: Genetics of Melanoma. Cancer Genetics, 165-180, 2016.
7. Davies MA, Garraway LA. Molecular Biology of Cutaneous Melanoma. In: Cancer: Principles and Practice of Oncology. Primer of the molecular biology of cancer. 2nd edition. Wolters Kluwer, 308 - 320, 2015.
8. Davies MA. Parallel and Serial Blockade Strategies in BRAF-Mutant Melanoma. In: BRAF Targets in Melanoma. Humana Press, 105.135, 2015.
9. Davies MA, Garraway LA. Molecular Biology of Cutaneous Melanoma. In: Cancer Principles & Practice of Oncology. 10th. Wolters Kluwer, 1337-1345, 2015.
10. Kupferman ME, Davies MA. Melanoma of the Head and Neck: General Principles and Management. In: Head and Neck Cancer A Multidisciplinary Approach. 4th. Wolters Kluwer Lippincott Williams & Wilkins, 672-691, 2013.
11. Ahmed KB, Davies MA. New Molecular Targets for Systemic Therapy of Melanoma. In: Research on Melanoma - A Glimpse into Current Directions and Future Trends. InTech - Open Access Publisher, 161-180, 2011.
12. Kim KB, Davies MA, Rapini RP, Hwu P, Bedikian AY. Malignant Melanoma. In: The MD Anderson Manual of Medical Oncology, Second Edition. 2nd. McGraw Hill, 1077-1109, 2011.
13. Davies MA, Patel S, Kim K. Targeted Therapy in Melanoma. In: Targeted Therapy in Cancer. 1. Humana Press, 183-211, 2008.
14. Davies MA. PTEN, a tumor suppressor gene frequently mutated in glioblastomas. In: Genomic and Molecular Neuro-Oncology. Jones and Bartlett, 47-61, 2004.

Letters to the Editor

1. Paleker M, Davies MA, Raubenheimer P, Naude J, Boulle A, Hussey H. Change in profile of COVID-19 deaths in Western Cape Province, South Africa, during the fourth wave. S Afr Med J 112: 185-186, 2022.
2. Schomaker M, Davies MA, Cornell M, Ford N. Assessing the risk of dolutegravir for women of childbearing potential. Lancet Glob Health 6: e958-e959, 2018.
3. Davies MA, Saiag P, Long GV. Primary medical therapy for BRAF(V600E)-mutant melanoma brain metastases-is this good enough? - Authors' reply. Lancet Oncol 18: e509, 2017.
4. Koller M, Patel K, Chi BH, Wools-Kaloustian K, Dicko F, Chokephaibulkit K, Chimbetete C, Hazra R, Ayaya S, Leroy V, Trong HK, Egger M, Davies MA. Authors' Reply: Early Initiation of Antiretroviral Therapy Among Young Children: A Long Way to Go. J Acquir Immune Defic Syndr 70: e71-2, 2015.
5. Bohlius J, Maskew M, Davies MA, Egger M. HHV-8 seroprevalence in HIV-positive and HIV-negative populations. Int J Cancer 136: 1243, 2015.
6. Koller M, Althoff KN, Davies MA, Egger M. Authors' reply: immunodeficiency at the start of combination antiretroviral therapy: steady improvement or step changes?. J Acquir Immune Defic Syndr 68: e16-7, 2015.
7. Jilaveanu LB, Zito CR, Aziz SA, Chakraborty A, Davies MA, Camp RL, Rimm DL, Dudek A, Sznol M, Kluger HM. In vitro studies of dasatinib, its targets and predictors of sensitivity. Pigment Cell Melanoma Res 24: 386-9, 2011.
8. Munetz MR, Davies MA. Smoking by patients. Hosp Community Psychiatry 38: 413-4, 1987.